Development of the preterm gut microbiota in infants at risk of necrotising enterocolitis and sepsis by Stewart, Christopher
Citation:  Stewart,  Christopher  (2014)  Development  of  the  preterm  gut  microbiota  in  
infants  at  r isk  of  necrotising  enterocolit is  and  sepsis.  Doctoral  thesis,  Northumbria  
University.
This  version  was  downloaded  from  Northumbria  Research  Link:  
ht tp://nrl.northumbria.ac.uk/16488/
Northumbria  University  has developed Northumbria  Research  Link  (NRL)  to  enable 
users to access the University’s research output. Copyright  © and moral r ights for i tems 
on NRL are retained by the individual author(s) and/or other copyright  owners.  Single 
copies of full  i tems can be reproduced, displayed or performed, and given to third parties 
in  any format  or medium for  personal  research or study, educational,  or not-for-profi t  
purposes  without  prior  permission  or  charge,  provided  the  authors,  t i t le  and  ful l  
bibliographic  details  are  given,  as  well  as  a  hyperlink  and/or  URL  to  the  original 
metadata page. The content must not be changed in any way. Full  i tems must not be sold 
commercially  in  any  format  or  medium  without  formal  permission  of  the  copyright  
holder.  The full  policy is available online: http://nrl.northumbria.ac.uk/policies.html
  
Development of the preterm 
gut microbiota in infants at risk of 
necrotising enterocolitis and sepsis 
 
 
CHRISTOPHER JAMES STEWART 
 
 
 
PhD 
 
2014 
Development of the preterm 
gut microbiota in infants at risk of 
necrotising enterocolitis and sepsis 
 
CHRISTOPHER JAMES STEWART 
 
A thesis submitted in partial fulfilment of 
the requirements of the University of 
Northumbria at Newcastle for the degree of 
Doctor of Philosophy 
 
Research undertaken in the School of Life 
Sciences and in collaboration with the 
Royal Victoria Infirmary and Freeman 
Hospitals in Newcastle upon Tyne. 
 
March 2014
  
 
 
 
In loving memory of  
 Irene Stewart (1928 – 2012)
Abstract 
The gut microbiota comprises all the microorganisms colonising the gastrointestinal 
tract. It is a complex and dynamic community influenced by genetic and environmental 
factors. While the gut microbiota has crucial roles in micronutrient production and 
immunomodulation, it has also been associated with necrotising enterocolitis (NEC) and 
sepsis in preterm infants, which can exist exclusively or concurrently. As the number of 
babies born preterm continues to rise, so too will the incidence of these disease states. 
Exploring the development of the preterm gut microbiota longitudinally may offer 
important insights into the role of modern clinical practises in shaping the community 
and its subsequent role in disease pathogenesis. 
To explore the development of the preterm gut microbiota we compared routine culture 
data with denaturing gradient gel electrophoresis (DGGE). Both techniques revealed 
differential profiles between patients with NEC and sepsis, compared to healthy 
controls. This was due, in part, to an increased abundance of Staphylococcus spp. 
identified in patients with NEC and sepsis. Based on these findings we explored the 
differential community development utilising a more extensive molecular approach, 
advancing on previous studies by exploring both the bacterial and fungal communities 
and also exploring the viability of each organism. For the fungal community, only non-
viable fungal species were detected but showed no significant association with NEC or 
sepsis. Conversely, the viable bacterial community largely corresponded to that of the 
total community and showed Sphingomonas sp. was significantly associated with NEC. 
Interestingly, antifungal treatment had a significantly effect on the bacterial community 
and antibiotics limited the bacterial diversity which may have important consequences 
in the pathogenesis of disease. 
We further analysed a twin cohort to investigate the role of host genetics in influencing 
the development of the gut microbiota and the subsequent risk of disease. Twins 
showed comparable gut microbiota development with antibiotics attributable for major 
shifts in the community. A twin discordant for NEC showed a reduction in diversity and 
prevalence of an Escherichia sp. prior to the diagnosis which was not observed in the 
control twin. To further explore the discrepancies in the organisms associated with NEC 
and sepsis, overcoming the limitations of previous studies, we utilised next generation 
sequencing (NGS) in a large cohort with regular sampling pre and post disease 
diagnosis, matched to controls. Gestational age was shown to have important influences 
on the community development. No consistent associations between reduced diversity 
or increased dominance prior to disease diagnosis were observed, although Escherichia 
coli was prevalent prior to diagnosis of NEC. The organism identified in sepsis cases 
was present in the gut microbiota and was usually a dominant member. A diverse 
community seems to be important to the health of a neonate supporting the notion that a 
stable and diverse gut microbiota is important for preterm neonatal health. 
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1. Introduction 
 
Microorganisms have long been recognised as fundamental to the cause and prevention 
of human disease, as demonstrated by the early work of Pasteur, Lister, and Koch. 
Indeed, Louis Paster is quoted as saying: 
“The role of the infinitely small in nature is infinitely great” 
This is particularly true of the microbial communities present in the gastrointestinal 
tract (GIT) of mammals, termed the gut microbiota, which has received significant 
interest over the last decade. There is an increasing understanding of the role of the gut 
microbiota in maintaining health through immunomodulation, protection, nutrition and 
metabolism and in contributing to disease through inflammation, diabetes, autism, 
obesity and allergy (Scanlan et al. 2006; Neish 2009; Sekirov et al. 2010). As a 
consequence, many studies have looked at the development of the gut microbiota at all 
stages of life from birth to old age and related how the community structure changes 
due to demographic (patient) variables (Echarri et al. 2011; Jalanka-Tuovinen et al. 
2011; Arboleya et al. 2012; Claesson et al. 2012). While the gut microbiota may contain 
a variety of microorganisms, including species of fungi, archaea, and virus, in this thesis 
the focus is on assessing the bacterial community. 
The human GIT represents a highly complex ecosystem. At birth, an infant’s GIT is 
regarded as sterile but rapidly becomes colonised with bacteria derived from the 
maternal and environmental flora. The initial development of the gut microbiota is 
critical for the development and maturation of the adaptive immune system, protection 
against pathogens, and metabolism of otherwise indigestible nutrients (Sekirov et al. 
2010). Modelling the gut microbiota in term infants suggests that competition between 
three phyla: Bacteroidetes, Proteobacteria and Firmicutes, explain most community 
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dynamics (Palmer et al. 2007; Trosvik et al. 2010). However, studies typically assess 
the total community and thus shifts within the viable, that is the living or metaboloically 
active portion of the gut microbiota remain undetected. While analysis of the total gut 
microbiota provides a phylogenetic picture of the community, it does not reflect 
viability as the deoxyribonucleic acid (DNA) extracted and sequenced could originate 
from metabolically active, dormant, lysed, or dead cells (Tannock et al. 2004). The 
viable gut microbiota has been shown to differ to the total community. Statistical 
analysis of adult populations indicated a decrease in viable Bacteroidetes and an 
increase in Firmicutes, which was masked if only the diversity of the total community 
was considered (Peris-Bondia et al. 2011). There is no comparable study exploring the 
viability of the gut microbiota in the neonate, however, these observations suggest it is 
important to distinguish how the viable and total communities differ in the early stages 
of life. 
During the first year of life the infants gut microbiota is assembled and undergoes a 
series of significant changes associated with life events such as feeding (with formula or 
breast milk), the adoption of solid foods, exposure to the home environment, and 
antibiotic treatment for infection (Koenig et al. 2010; Morowitz et al. 2011). After the 
first year of life the gut microbiota profile will resemble that of the adult for 
composition, although it will still be unique to the individual (Adlerberth & Wold 
2009). In comparison, the adult gut microbiota has much greater temporal stability and 
is estimated to contain between 400 and 1000 bacterial species, primarily to the phyla 
Bacteroidetes and Firmicutes (Peris-Bondia et al. 2011). The shift from neonate to adult 
gut microbiota is perhaps defined most by the increased abundance of the genus 
Bacteroides and a substantial reduction in the Proteobacteria. The Bacteroidetes are 
specialised in the breakdown of complex plant polysaccharides, which when introduced 
3 
 
into the diet at weaning probably explains the increased contribution of Bacteroidetes to 
the gut microbiota (Sellitto et al. 2012).  
In adults the gut microbiota influences a diverse range of health outcomes from obesity, 
diabetes, asthma and allergy to seemingly ‘remote’ diseases like Parkinson’s disease 
(Turnbaugh et al. 2007). In preterm infants, establishment of the gut microbiota is also 
of importance for key morbidities like sepsis (specifically late onset sepsis) and 
necrotising enterocolitis (NEC), both significant causes of mortality (Berrington et al. 
2012). Many episodes of sepsis are with gut derived organisms and changes in the 
intestinal barrier contribute to both NEC and sepsis (Vergnano et al. 2011). The gut 
microbiota is key to developing barrier function, integrity, and mucosal and systemic 
immune function. It also ‘educates’ the gut associated lymphoid tissue, allowing the 
establishment of a ‘tolerant’ state between microbiota and the immune system, affecting 
intestinal function including tight junction structure and immune function (Rakoff-
Nahoum & Paglino 2004; Bäckhed 2011; Bevins & Salzman 2011). Furthermore, 
patterns of initial colonisation affect host metabolic function: fat deposition, circulating 
leptin levels, and insulin resistance (Bäckhed 2011). 
Due to the complexity and variability of community development in a niche like the 
GIT, where environmental, biological and genetic backgrounds are significantly 
different and in some cases are constantly changing between and within subjects, 
studies that have attempted to control for such variation where possible are most 
informative. One such variable relates to the host genetic predisposition. Twin studies, 
therefore, offer important insights into the significance of the host genetic background 
in affecting GIT microbiota development. Healthy twins have been shown to develop a 
comparable gut microbiota when compared following term birth (Palmer et al. 2007), in 
childhood (Stewart et al. 2005) and in adulthood (Zoetendal et al. 2001), suggesting 
genetic factors shape the gut microbiota. However, due to a lack of similarity with 
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siblings from a different birth and the high similarity observed in both monozygotic and 
dizygotic twins, it is conceivable that the environment is more influential in shaping the 
gut microbiota (Palmer et al. 2007). 
In the preterm gut, structural and immunological immaturity contributes to 
inflammatory necrosis and abnormal bacterial colonisation, termed dysbiosis. This may 
result in a limited microbial diversity and an increased inflammatory response 
exacerbated by an immature innate immune response that increases the risk of diseases 
like NEC or sepsis. An improved understanding of the microbiota of infants cared for in 
neonatal intensive care units (NICUs) and how this is affected by current practices may 
allow clinicians to promote more ‘healthy’ gut microbiota patterns, thus resulting in 
reductions in mortality and improvements in long term outcomes (Caicedo et al. 2005). 
The microbiota of a full term vaginally delivered neonate, who receives its own 
mother’s breast milk and remains healthy, is regarded as the ideal ‘gold standard’. 
However, the optimum microbial colonisation process can be disrupted by premature 
birth, mode of delivery, diet, and antibiotic and antifungal administration. 
 
1.1 Factors influencing neonatal gut microbiota development 
 
1.1.2 Premature birth 
The development of the gut microbiota differs between premature and full term 
neonates. In general, neonates harbour a very simple community at birth that increases 
in diversity over time. In full-term infants the pioneering bacteria detected are taxa 
belonging to enterococci, streptococci, and Enterobacteriaceae (Favier et al. 2002). The 
bacterial community is initially very dynamic and studies that have modelled the gut 
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microbiota in full-term infants have shown that competition between three phyla, 
Bacteroides, Proteobacteria and Firmicutes, exerts the greatest effects on the community 
dynamics (Trosvik et al. 2010). 
In contrast, preterm infants are cared for in hygienically controlled intensive care units 
and have a relatively simple gut microbiota compared to term babies (Berrington et al. 
2013). This is likely due to a combination of several environment factors relating to the 
care of preterm infants including sterile practise, housing in incubators, increased 
antibiotic and antifungal administration, and enteral feeding by catheter (no skin 
contact). Like full-term infants, the pioneering bacteria in preterm infants commonly 
include members of enterococci, streptococci, and Enterobacteriaceae (Cilieborg et al. 
2012). However, preterm infants show subsequent delayed colonisation with potentially 
important ‘beneficial bacteria’ such as bifidobacteria and lactobacilli. In healthy breast 
fed term infants bifidobacteria dominate by day seven, but not in preterm infants (Butel 
et al. 2007). It is postulated that the degree of gut maturation at birth may be important 
to colonisation with these organisms (MacDonald & Baker 1998; Feja et al. 2005). 
 
1.1.2 Mode of delivery  
Vaginally delivered infants initially harbour bacterial communities which resemble the 
vaginal microbiota. Thus, for infants whose birth involves passage through the birth 
canal, the dominant bacteria are initially composed of the genera Lactobacillus, 
Prevotella, Atopobium, and Sneathia (Dominguez-Bello et al. 2010). Moreover, the 
infant gut microbiota is more similar to its own mothers vaginal microbiota than that of 
non-related mothers. Higher levels of Bifidobacteria and Bacteroides, with less 
Clostridium (importantly Clostridium difficile), have been reported in vaginally 
delivered infants (Penders et al. 2006). Caesarean delivery is more common in preterm 
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infants and has been shown to result in delayed colonisation with a gut initially 
dominated by environmental bacteria, specifically a high prevalence of Clostridium, 
Escherichia, Streptococcus and Staphylococcus (Thompson-Chagoyán et al. 2007). 
Interestingly, infants born by caesarean section initially harbour a gut microbiota 
reflective of adult skin communities; but noteworthy is a lack of distinct similarity with 
the respective maternal skin microbiota (Dominguez-Bello et al. 2010).  
 
1.1.3 Feeding  
Breast feeding has been associated with an increased abundance of Lactobacilli and 
Bifidobacteria, with a reduction in Clostridium spp. compared to formula feeding 
(Penders et al. 2005). Formula fed infants typically show greater diversity with 
increased levels of facultative and obligate anaerobes, particularly Bacteroides, 
Clostridium, and Enterococcus compared to breast fed infants. Feeding very preterm 
infants with artificial formula rather than expressed maternal breast milk (EBM) 
increases the risk of NEC and sepsis. Interestingly, after weaning (introduction of solid 
food), the gut microbiota of breast fed infants changes to reflect that of formula fed 
infants. This occurs as a result of a significant increase in the abundance of the genera 
Enterococcus and Enterobacter, and the appearance of Bacteroides, Clostridium, and 
other anaerobic Streptococci (Adlerberth & Wold 2009). 
 
1.1.4 Antibiotics and antifungals 
To reduce fungal infections, preterm neonates may undergo a short course of antifungal 
prophylaxis, usually with nystatin or fluconazole (Manzoni et al. 2011). Fluconazole 
remains the most reported and useful antifungal for use in prophylaxis, although the 
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direct contribution of antifungal prophylaxis in the development of the neonatal gut 
microbiota remains elusive. Fluconazole prophylaxis has been shown to be effective in 
the prevention of Candida colonisation and infection in neonates. Although little work 
exists on the antibacterial activity of fluconazole, as a member of the imidazoles it is 
feasible that the antifungal will also have bacteriostatic and bactericidal properties, with 
particular action against Gram positive bacteria (Samuelson 1999). Conversely, it is 
known that frequent use of broad-spectrum antibiotics, particularly third generation 
cephalosporins, increase the risk of colonisation and infection with multidrug-resistant 
bacteria and fungi (Kaufman & Fairchild 2004; Feja et al. 2005; Chapman 2007). 
Concerns of antibiotic and antifungal treatment related to the gut microbiota include the 
spread of antibiotic resistance among pathogens and that alteration of the microbiota 
will interfere with human–microbe interactions that are fundamental to human 
development. Antibiotics have been demonstrated to play a significant and long term 
role in altering the bacterial composition within the gut microbiota (Dethlefsen & 
Relman 2011; Pérez-Cobas et al. 2012). Antibiotics are commonly prescribed to 
neonates, particularly preterm infants where standard practise is to administer 
antibiotics for 48 hours unless proven infection. This is likely to result in the delayed 
development of a diverse gut microbiota in preterm infants (Cotton 2009). 
Understanding the impact of antibiotic administration on the developing gut 
microbiome is extremely challenging. The type of antibiotics, the combination used, 
their dosage and length of time of administration vary hugely between individual infants 
reflecting the patients’ needs and the preference and experience of the clinicians treating 
the individual. These variables mean that monitoring the exact effects on the gut 
microbiota in vivo is extremely difficult. This is particularly true for neonates where 
robust sampling, which will be key to tracking the response of the gut microbiota to 
each antibiotic, is problematic. Thus, the majority of studies to date lack the statistical 
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power to convincingly guide clinical practise. Nonetheless, when the role of ceftriaxone 
was studied in term breast fed infants a decreased count of total bacteria, particularly 
Enterobacteriaceae, enterococci and lactobacilli, was observed (Savino et al. 2011). 
Ceftriaxone was also shown to cause a disappearance of Bifidobacterium spp. with a 
preservation of potentially pathogenic Streptococcus spp. and Staphylococcus spp. 
Frequent use of broad-spectrum antibiotics, particularly third generation cephalosporins, 
increase the risk of colonisation and infection with multidrug-resistant bacteria and 
fungi. These results highlight the need for greater research into the role of different 
types of antibiotics on the gut microbiota. Briefly, in adults, the effect of ciprofloxacin 
on the gut microbiota was profound and rapid, with a loss of diversity and a shift in 
community composition after 3 days. However, 1 week following treatment 
communities began to return to their initial state, but importantly the return was often 
incomplete and varied between patients (Dethlefsen & Relman 2011). 
 
1.2 Techniques to explore the microbiota 
 
Pioneering studies exploring the vast ecosystem of the gut microbiota relied on culture 
based approaches. However, the advent of molecular approaches has revolutionised 
microbiomic studies by enabling the contribution and identification of uncultivable 
organisms to be explored. The increasing reliance on sequence data to generate data on 
microbial composition presents new challenges. One of which is the adherence to 
Linnean classification (seven hierarchical taxa from kingdom to species) which relied 
on pragmatic definitions of species, integrating phenotypic, biochemical and 
phylogenetic data. However, for prokaryotes there is no accepted conceptual definition 
for a species (Sutcliffe et al. 2012). Table 1.1 summarises common current molecular 
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methodologies and standard culture approaches. These approaches and the importance 
of sampling are discussed in detail in subsequent sections. 
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Table 1.1 Comparison of techniques  
Technique Standard culture Fingerprinting methods qPCR Next Generation Sequencing 
Example Culture on blood MacConkeys 
agar for Gram-negative species 
Temperature or Denaturing 
Gel electrophoresis 
(T/DGGE) 
SYBR Green I florescent 
dye; TaqMan probes 
454 pyrosequencing (Roche); 
sequence by synthesis (Illumina) 
Brief 
description 
Viable bacteria grown in a 
laboratory on specific media 
with specific conditions; 
physical/chemical 
characteristics used to speciate 
DNA extracted and 
amplified. Separation by 
sequence differences within 
amplicons using temperature 
or chemical gradient 
DNA extracted and 
amplified with the number 
of copies of the target gene 
shown real-time 
DNA extracted and sequenced; 
utilises extensive databases of 16S 
gene to identify species 
Advantages Lots of experience in 
technique; cheap; limited 
equipment needed; target key 
organisms 
Greater depth of analysis than 
culture; relatively cheap (for 
molecular technique) 
Accurately quantifies the 
presence of a gene in a 
sample; quick 
Very detailed information; 
complex communities can be 
examined; quick 
Disadvantages ∼90% species remain 
undetected; need to already 
know species of interest 
Time consuming; PCR bias; 
sequence identification is 
time consuming and not 
robust 
Can be costly; PCR bias; 
requires highly skilled 
technician; data must 
conform to very stringent 
criterion 
Costly; PCR bias; specialised 
equipment needed, available in 
few localities; enormous amounts 
of data generated require storing 
and specialist analysis 
1
0
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1.2.1 Sampling strategy  
Studies exploring the gut microbiota typically utilise stool samples as a convenient non-
invasive means of exploring its diversity. However, the gut microbiota is not uniformly 
distributed throughout the GIT due to the changing physicochemical conditions, 
exerting selective pressures on the community. These physicochemical conditions 
include intestinal motility, pH, redox potential, nutrient supplies, water content, and 
host secretions such as hydrochloric acid, digestive enzymes, bile and mucus (Booijink 
et al. 2007). While it is well known the gut microbiota is not homogeneous throughout 
the GIT, the exact differences in diversity have not been definitively determined 
(Gerritsen et al. 2011). This has implications when exploring disease states using stool 
samples, for example NEC, where the origin of inflammation is known to be the 
terminal ileum and proximal colon. Eckburg et al. (2005) postulated that the stool 
microbiota represented a combination of shed mucosal bacteria and a separate 
nonadherent luminal population. Further work assessing the biostructure of microbiota 
in adult stool showed a clear structure from the outside of stool (closest to the mucosa) 
toward the centre (luminal bacteria), which was distorted in patients with idiopathic 
diarrhoea (Swidsinski et al. 2008). However, microbiota structure did not differ when 
comparing the front and end of a stool pellet, thus a section of a stool pellet is an 
accurate representative of the whole stool (Mai et al. 2010). In contrast, there is only 
limited insight in the composition of the microbiota that resides in the small intestine, 
particularly the ileum, which is difficult to sample (Booijink et al. 2007). Due to the 
relatively large amounts of gastric acid, bile and pancreatic secretions in this region 
creating a harsh niche for microbial growth, it is feasible that microbial diversity will be 
low compared to other regions. Indeed, ileal effluent from ileostomy patients was 
shown to clearly differ from the stool microbiota with lower diversity and stability and a 
higher relative abundance of potentially pathogenic species (Booijink et al. 2010). Due 
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to the ease of utilising stool samples in clinical research, the majority of publications 
referenced in this thesis are based on results from stool samples. Future studies will 
continue to utilise stool when analysing the gut microbiota, but more detail on how the 
stool microbiota differs from the distinct niches throughout the GIT is warranted. 
Storage of samples is an important factor in ensuring consistency and scientific 
accuracy in many biological experiments. Studies exploring the effect of storage, for 
example in the postage of sputum samples for cystic fibrosis (CF) analysis, have shown 
that microbial profiles can be significantly altered with an overall reduction in diversity 
when left at room temperature for 24 hours compared to immediate cold storage. 
Importantly in the case of CF, an increase in the abundance of Pseudomonas spp. and a 
reduction in Haemophilus influenzae were observed in samples left at room temperature 
(mimicking postage), leading to a misrepresentation of the original and true profiles 
(Nelson et al. 2010). Freeze-thaw cycles are known to lyse cells and so it especially 
important for viable work, such as culture based experiments, to avoid this and where 
possible prepare the culture from freshly collected material (Sharma et al. 2006). 
However, it has been shown that storage of stool samples for up to two weeks at room 
temperature does not significantly alter the observed bacterial community in molecular 
based approaches when exploring total community using extracted DNA (Lauber et al. 
2010). Nonetheless, preservation at -80 ºC and avoidance of repeated freeze-thaw cycles 
is recommended to prevent loss of diversity. 
 
1.2.2 Culture based techniques 
Initial studies exploring gut microbiota in neonates relied on the ability to cultivate 
different species and carry out subsequent colony counts and biochemical methods to 
identify organisms (Blakey et al. 1982; Stark & Lee 1982; Westra-Meijer et al. 1983). It 
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has since been estimated that only 20% of the gut microbiota is cultivable (Eckburg et 
al. 2005). Successful culture of microorganisms allows their phenotypic and metabolic 
capacities and behaviour in co-culture to be analysed. Importantly for the GIT, which 
consists of many distinct niches, co-culture studies have shown that many ecological 
niches can only be filled by syntrophic consortia of different microbes. For instance, co-
culture of the xylanolytic Roseburia intestinalis with H2-utilizing Ruminococcus 
hydrogenotrophicus dramatically increased butyrate production (Chassard & Bernalier-
Donadille 2006). 
Although culture dependent approaches are regarded by many as inadequate for 
exploring the full diversity of the gut microbiota, there have been efforts to optimise this 
technique with the implementation of selective media and anaerobic incubation. 
Advances in mass spectrometry (MS) techniques coupled with matrix-assisted laser 
desorption ionisation time-of-flight (MALDI-TOF) have also improved the accuracy 
and time needed to identify large numbers of colonies (Seng et al. 2009). Furthermore, 
there is evidence to suggest that culture may still offer important insights. For example, 
a patient with low bacterial load had more bacterial species identified by culture 
dependent approaches compared to next generation sequencing (NGS) 454 
pyrosequencing (Dubourg et al. 2013). 
As greater knowledge is gained on the composition of niches by molecular techniques, 
it may directly improve the ability to cultivate organisms previously deemed 
uncultivable. More insight into what other organisms are present, particularly relating to 
the metabolites they produce as well as other available nutrients, might allow the 
simulation of specific growth conditions leading to successful isolation. What is 
important in the modern era, when researchers are increasingly realising the power of 
molecular techniques, is that the power of culture based techniques are not forgotten. 
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1.2.3 Culture independent techniques 
Since the 1990s, molecular techniques have been increasingly applied to clinical 
investigations as they offer much greater coverage of the microbial community 
compared to culture dependant approaches (Petrosino et al. 2009). Molecular techniques 
allow the gut microbiota to be characterised and monitored without prior knowledge of 
its structure or composition. The basis of molecular techniques is the extraction of 
nucleic acid (DNA and/or RNA) from samples (Nechvatal 2008). 
Both DNA and ribonucleic acid (RNA) can be used to analyse microbial communities 
in stool by molecular approaches. DNA analysis is more common as a result of the 
added difficultly and potential for degradation when working with RNA. RNA is 
unstable at room temperature and thus requires stringent sample handling procedures to 
ensure the sample is transported to the laboratory without degradation or a shift in 
microbial profiles. To prevent this degradation during transit it is paramount the sample 
is stored in an RNA stabilisation reagent (Hernandez et al. 2009). Carrying out 
subsequent analysis on extracted RNA allows the characterisation of the metabolically 
active community. This is of particular importance when aetiology is explored as the 
causative agent is most likely to be metabolically active. It is feasible that an organism 
is present in a dormant state and so not metabolically active, but when environmental 
conditions shift they can become active and play a part in the community function 
(Prosser et al. 2007). Similarly, to achieve full coverage of potential viral communities 
then both DNA and RNA need to be examined. Thus, in order to gain the most 
comprehensive insight into the pathology of diseases like NEC, analysis of both DNA 
and RNA is warranted. 
After nucleic acid extraction from biological samples, subsequent diversity studies 
require amplification by polymerase chain reaction (PCR), typically based on the 16S 
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ribosomal RNA (rRNA) gene. These amplified regions (amplicons) are then 
differentiated into groups that share a pre-defined similarity to each other known as 
operational taxanomic units (OTUs). The 16S rRNA gene is a component of the small 
subunit in the prokaryotic ribosome. This ribosomal gene is functionally conserved and 
it is ubiquitously expressed in bacteria. It represents a rational target for comparative 
studies between bacterial communities and is also the most widely used gene for 
bacterial classification and identification (Isenbarger et al. 2008). The gene contains 
nine ‘hypervariable regions’ showing considerable sequence diversity, flanked by 
‘conserved regions’ of homologous sequence (Chakravorty et al. 2007) (Figure 1.1). 
This allows universal PCR primers, complimentary to conserved regions, to be designed 
facilitating the amplification of the intervening hypervariable regions. Bacterial 
classification can then be determined by comparing the amplicons to homologous 16S 
rRNA sequences from characterised bacteria within open access sequence databases. 
The copy number of the 16S rRNA gene varies between species from 1 to 15 
(Klappenbach et al. 2001) with the number of nucleotides that are different between any 
pair ranging from 0 to 19 (Coenye & Vandamme 2003). While copy numbers are 
generally species specific, there is reported variation among strains of the same species 
(Acinas & Marcelino 2004). This is believed to be a life strategy by bacteria owing the 
rRNA copy number correlating with the ability to respond to favourable growth 
conditions (Klappenbach et al. 2000). Noteworthy is that multiple copies of the same 
target gene in PCR analysis is not limited to the bacterial kingdom. The linking of cell 
abundance and PCR amplicons abundance is also limited by the multiple copy nature 
and intragenomic variability of the common molecular marker of fungi; the ITS region 
of the rRNA gene from the 28S subunit (Amend et al. 2010). The specific limitations 
conferred by both heterogeneous and homogeneous copies of the target gene in PCR are 
discussed in more detail in the subsequent sections. 
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Figure 1.1 – Schematic representation demonstrating the 16S ribosomal RNA gene used in molecular studies. 
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1.2.4.1 Polymerase Chain Reaction (PCR) 
PCR was originally described by Mullis et al. (1986) and has become one of the most 
widely used techniques in molecular biology. It is fundamental for the majority of 
molecular approaches including molecular fingerprinting techniques and NGS. PCR 
involves adding template DNA to a reaction containing primers (synthetic 
oligonucleotides complementary to a part of the target sequence), each deoxynucleoside 
triphosphate (dNTPs; dATP, dCTP, dGTP and dTTP), polymerase (enzyme responsible 
for incorporating the dNTPs into the complementary sequence), and cofactors needed 
by the polymerase such as buffer containing stabilising salts and magnesium chloride 
(MgCl2). Polymerase, including the frequently used Taq polymerase, is derived from 
thermophilic microbes such as the Thermus aquaticus. The reaction is principally 
carried out at 3 temperature ranges in subsequent cycles of 1) high temperature for 
denaturation of the DNA, 2) low temperature based on the annealing temperature of the 
primers for annealing of the primers, and 3) medium temperature for extension of the 
complementary sequence by addition of free dNTPs. The number of amplicons, which 
is the sequence generated based on the fragment of sequence between the forward and 
reverse primers, increases exponentially after each cycle of the reaction (Mullis et al. 
1986). 
Like all techniques, PCR is not without limitations and bias. The primers used in PCR 
reactions are inherently biased toward certain OTUs. Bias is introduced by universal 
primers through differential annealing in the amplification of a heterogeneous template, 
affecting the amplification efficiency of some OTUs (Wang & Qian 2009). Ideally, 
universal primers will amplify all bacteria in a mixed population but this is impossible. 
For instance, the longest number of conserved nucleotides in the 16S rRNA gene that 
are 100% conserved is 11 (Baker et al. 2003). Primers which match 95% of sequences 
in the Ribosomal Database Project (RDP) from typically dominant gut organisms have 
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been found to miss specific OTUs; the reverse primer at position 1492 (Escherichia coli 
16S rDNA position) detects only 61% of Actinobacteria and 54% of Proteobacteria 
(Hamady & Knight 2009). To overcome this bias, sites of primer mismatch can be 
identified and a degenerate base can be incorporated into the primer sequence. By 
addition of a degenerate base pair to the -357F/926R primer set (Muyzer et al. 1993), 
Sim et al. (2012) were able to increase the bifidobacteria detection rate in stool samples, 
without diminishing the amplification of other OTUs. The potential for improved 
detection of bifidobacteria has important consequences in the analysis of neonatal 
samples where bifidobacteria is regarded as an important species for health, but is often 
found to only constitute a minor component of the gut microbiota (Picard et al. 2005; 
Palmer et al. 2007). Artifacts may also arise due to the formation of heteroduplex and 
chimeric sequences. A heteroduplex is formed in PCR by the cross-hybridization of 
heterologous sequences, giving rise to sequences for non-existent genes (Thompson et 
al. 2002). While it is known to occur during mixed template PCR using universal 
primers, it can be decreased by the addition of Taq polymerase and reducing the number 
of PCR cycles (Michu et al. 2010). A chimera on the other hand is formed by the 
incomplete extension of a primer and template switching which also gives rise to 
artificial gene diversity (Shuldiner et al. 1989; Patel et al. 1996). 
 
1.2.4.2 Quantitative PCR (qPCR) 
Quantitative PCR (qPCR) is another PCR based technique which enables the 
quantification of the target gene in real-time. qPCR is a robust, highly reproducible and 
sensitive method which can be used to quantitatively track phylogenetic and functional 
gene changes (Smith & Osborn 2009). In microbial ecology, this technique can be used 
to accurately quantify bacteria, typically at the family or genus levels (Palmer et al. 
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2007; Bucher et al. 2011). The technique relies on the detection of fluorescence, where 
the signal intensity is relative to the number of amplicons generated on completion of 
each cycle in the PCR. The concentration of target DNA in the sample is then calculated 
based on the exponential phase of the PCR when reaction components are in abundance 
by calculating the Ct (cycle threshold) value (Smith & Osborn 2009). 
Two different fluorescent based systems are commonly used for qPCR; SYBR Green I 
which is based on fluorescent chemistry and TaqMan technology which is based on a 
reporter-quencher system. Firstly, owing to its affordability, SYBR Green I is the most 
commonly used dye for non-specific detection. SYBR Green I is a double-stranded 
DNA (dsDNA) intercalating dye which emits fluorescence when bound to the DNA 
(Valasek & Repa 2005). Thus, as the target is amplified the dye will bind to the 
amplicons and the amount of fluorescence will be proportional to the amount of target 
gene generated. As this is non-specific binding, the SYBR Green I will bind to any 
dsDNA in the reaction including primer dimers, heteroduplex formations, and chimera 
sequences which will introduce bias into the quantification (Gibson 2006). For this 
reason it is important that the qPCR has been optimised, which can be confirmed by a 
well-defined peak on the melt curve (Smith & Osborn 2009). The second commonly 
used system is the TaqMan probe. Here, a fluorophore is attached to the 5ʹ end of the 
probe and a quencher to the 3ʹ end. The technique relies on FRET (Fluorescence 
Resonance Energy Transfer) from the fluorophore (high energy) and the quencher (low 
energy) (Gibson 2006). The probe is designed to anneal at a sequence downstream of 
one of the PCR primers and binds to the amplicon during each annealing step in the 
PCR. While the fluorophore and the quencher are in close proximity, the fluorescence is 
quenched and not detectable. However, as the new strand is synthesised from the primer 
by Taq polymerase, the 5ʹ exonuclease activity of the enzyme cleaves the labelled 5ʹ 
nucleotide of the probe, releasing the reporter from the probe (Smith & Osborn 2009). 
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As cleavage continues the remaining probe melts off the amplicon releasing the 
fluorophore and quencher into solution, spatially separating them, leading to an increase 
in the detection of fluorescence (Valasek & Repa 2005).  
In an attempt to overcome the lack of sufficient experimental detail in publications 
reporting qPCR analysis, the minimum information for publication of quantitative PCR 
experiment (MIQE) guidelines have been proposed (Bustin et al. 2009). The idea of the 
guidelines is “to help ensure the integrity of the scientific literature, promote 
consistency between laboratories, and increase experimental transparency” (Bustin et al. 
2009). 
 
1.2.4.3 Molecular fingerprinting 
First generation molecular fingerprinting techniques include denaturing gradient gel 
electrophoresis (DGGE) and temperature gradient gel electrophoresis (TGGE). These 
techniques are only capable of separating short amplicons, not exceeding 500 bp 
(Temmerman & Masco 2003). For this reason the variable 3 (V3) region within the 16S 
rRNA gene (Figure 1.1) is ideally suited to this analysis with primers targeting the 
conserved regions at positions 341 to 518 (E. coli 16S rDNA position) (Muyzer et al. 
1993). Molecular fingerprinting approaches exploit the different number of 
intermolecular hydrogen bonds between G-C and A-T base pairs. G-C base pairs have 
three hydrogen bonds and A-T have two, thus G-C base pairs require greater denaturant 
concentration to dissociate the extra hydrogen bond. Therefore, following 
electrophoresis, fragments with a higher G-C content will travel further through a 
denaturing gel, separating amplicons on the basis of their base pair content (Muyzer et 
al. 1993). The gels can be stained and observed under UV to visualise the position of 
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the amplicons, which appear as bands. DGGE is a semi-quantitative technique so the 
intensity of the band positively correlates with the abundance of the OTU in the sample. 
While in theory the technique is capable of separating amplicons with a single base pair 
difference, in practise the resolution obtainable from gels is limited. There are two main 
limitations of molecular fingerprinting techniques. The first is multiple sequences 
migrating to the same position on a gel and as a result only one band is detected. This 
leads to an underrepresentation of the true number of unique OTUs in a mixed 
population sample, masking the true diversity (Muyzer & Smalla 1998). A single band 
which incorporates mixed sequences will also lead to false classification of abundance, 
potentially leading to the assumption of a highly abundant OTU. The second important 
limitation involves a single organism containing multiple copies of the target gene. If 
the multiple copies are homogenous then this may lead to an overestimation of the true 
abundance of an organism, as described above. However, if the multiple copies of the 
target gene are heterogeneous then multiple bands from the same organism will appear 
on the gel at different positions (Kang et al. 2010). This will lead to an over 
representation of the true diversity of samples. Moreover, if sequence information is 
required for taxonomic classification from the molecular fingerprint then individual 
bands can be excised and sequenced. This process can be time consuming and the added 
expense can be relatively high. Furthermore, the hypervariable regions utilised typically 
generate short amplicons of around 200 bp which limits the resolution of taxonomic 
identification (Temmerman & Masco 2003). 
1.2.4.4 Metagenomics (next generation sequencing) 
Metagenomic technology has revolutionised studies of microbioal diversity. The advent 
of NGS has facilitated the generation of unprecedented amounts of data, at a depth and 
resolution far greater than previously possible. There are several NGS platforms 
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available with each involving a complex interplay of enzymology, chemistry, high-
resolution optics, hardware, and software engineering. Multiplexing of samples is 
typically used to reduce costs. Here, barcodes unique to each sample are incorporated 
into the primers resulting in the generation of barcoded amplicons, which can be 
mapped back to the original sample during bioinformatic processing (Siqueira et al. 
2012). Ultimately each technology aims to amplify single fragments and perform 
sequencing reactions on the amplified fragments.  
454 pyrosequencing was the first NGS platform available as a commercial product 
(Margulies et al. 2005). This platform requires a 454 GenomeSequencer FLX 
instrument (Roche Applied Science). In this system, DNA fragments are ligated with 
adapters which cause the binding of one fragment to a 28 μm bead. Emulsion PCR is 
then carried out for fragment amplification, which is necessary to obtain sufficient light 
signal intensity for reliable detection in the subsequent sequencing by synthesis steps 
(Ansorge 2009). Following emulsion PCR, beads are treated with denaturant (removing 
untethered strands) before hybridisation based enrichment for amplicon bearing beads. 
A sequencing primer is then hybridised to the universal adaptor and sequencing is 
performed based on the pyrosequencing method (Ronaghi & Karamohamed 1996). 
Beads are deposited into a picotiter plate, which is designed to hold a single bead in 
each well. Smaller beads containing the enzymes adenosine triphosphate (ATP) 
sulfurylase and luciferase are also added. The picotiter plate is positioned opposite a 
charge coupled device (CCD) camera. The first four nucleotides on the adapter 
fragment are TCGA which correspond to the sequential flow of nucleotides into the 
flow cell. This allows the 454 base calling software to calibrate the light emitted by the 
incorporation of each nucleotide as the dNTPs are sequentially added (Mardis 2008). 
Unlabelled dNTPs continue to be added to the reaction sequentially, when this results in 
an incorporation event pyrophosphate (PPi) is released. The PPi is subsequently 
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converted to ATP by sulfurylase which provides the energy to luciferase to oxidiase 
luciferin into oxyluciferin, generating of a burst of visible light which is detected by the 
CCD camera. Remaining nucleotides are degraded by apyrase before the next dNTP is 
added to the reaction system and the process is repeated (Ronaghi 2001). Because 
nucleotides are added sequentially, it is known which dNTP was incorporated into the 
sequence to produce the light signal. The amount of light signal emitted corresponds to 
the number of a specific nucleotide incorporated at that cycle. However, the base calling 
software is unable to accurately interpret long homopolymer runs (E. Mardis 2008). It 
has been shown that a maximum of 10 identical adjacent nucleotides can be 
incorporated in the presence of apyrase, but this may require specific software 
algorithms (Ronaghi 2001). 
More recently the sequencing by synthesis chemistry (Bentley & Balasubramanian 
2008) used in the Illumina sequencer has gained popularity with the release of the 
HiSeq 2000 in 2010 followed by the benchtop MiSeq in 2011 (Loman et al. 2012). 
Sequence by synthesis is based on the sequence information being obtained during the 
synthesis of a DNA strand. First, DNA fragments are ligated at both ends to adapters, 
denatured into single strands, and immobilised at one end to a flow cell which is coated 
densely with the adapters and the complementary adapters (Ansorge 2009). The flow 
cell is an 8-channel sealed glass microfabricated device which ensures amplified 
sequences from the template library remain locally tethered near the point of origin. 
Each single stranded fragment immobilised at one end to the flow cell hybridises with 
its free end to the complementary adapter on the flow cell, creating a bridge structure 
(Ansorge 2009). The adapters on the surface act as primers and, in the presence of the 
PCR amplification reagents, amplified sequence features are generated by bridge PCR 
(Adessi et al. 2000). Following PCR, each clonal cluster contains ~1,000 copies of the 
sequence from the template library (Shendure & Ji 2008). After cluster generation the 
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clusters are denatured into single stranded molecules prior to sequencing. The reaction 
mixture for the DNA synthesis and sequencing is supplied onto the surface of the flow 
cell which contains: primers flanking the target gene, DNA polymerase, and four 
reversible terminator nucleotides that carry a base-unique fluorescent label and have the 
3ʹ-OH chemically inactivated to ensure only a single base is incorporated per cycle 
(Mardis 2008). Imaging follows each nucleotide incorporation step where the specific 
terminator nucleotide and its position on the flow cell is detected and identified via its 
base-unique fluorescent label by the CCD camera (Ansorge 2009). The terminator 
group at the 3ʹ-end of the base is chemically removed allowing the incorporation of the 
next fluorescent nucleotide in the sequence by DNA polymerase (Mardis 2008). 
Because another nucleotide cannot be incorporated into the sequence until the previous 
nucleotide has been recorded, the Illumnia HiSeq and MiSeq platforms do not suffer 
from errors in homopolymer runs. The MiSeq was also recently compared to other 
bench top high throughput sequencing platforms and found to have the highest 
throughput and lowest error rate (Loman et al. 2012). However, in the same study, the 
454 pyrosequencing bench top instrument (454 GS Junior) generated the longest reads 
and best assemblies (Loman et al. 2012). 
A problem currently limiting all NGS platforms is the short length of reads generated 
and the tendency for the poorer quality scores at the beginning and end of reads, which 
results in subsequent bioinformatic trimming of already relatively short sequences 
(Clarridge 2004). As less phylogenetic information is available from short sequence 
reads the reliability of taxonomic classification is reduced (Shendure & Ji 2008). 
Nonetheless, targeting the hypervariable regions of the 16S rRNA gene can provide 
informative bacterial identification, despite the shorter read lengths (Huse et al. 2008). 
Further advances in sequencing technology are focused on generating longer reads. 
Some recent advances in so called ‘third generation’ platforms are capable of generating 
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reads greater than 400 bp, allowing identification of many OTUs to the species level 
(Siqueira et al. 2012). NGS is also subject to PCR bias with errors in the sequencing 
reaction and the risk of chimera formation when incomplete PCR products serve as 
primers amplifying related fragments (Petrosino et al. 2009; Schloss 2009). To 
overcome this, PCR primers targeting multiple variable regions of the 16S rRNA gene 
have been designed and such issues can be further minimised by the application of 
stringent quality filtering steps (Schloss 2009). The most significant problem facing 
NGS is currently the bioinfomatic processing of the raw sequencing reads. As vast 
amounts of data can be generated in relatively little time, the computing power needed 
to process the data is providing a major bottleneck in the workflow. Many bioinformatic 
pipelines for the processing and analysis of data have been developed. The main 
software programmes available for microbial ecology are Mothur (Schloss et al. 2011) 
and QIIME (quantitative insights into microbial ecology) (Caporaso et al. 2010), each 
of which implements algorithms from various developers into a step by step pipeline.  
 
1.3 Polymicrobial disease in preterm neonates  
 
As research shifts toward the ‘next generation’ of microbial ecology, led by the 
advances in NGS technology, it is becoming increasingly clear that the pathophysiology 
of several diseases do not satisfy Kochs postulates (Nelson et al. 2012). These 
postulates are based on the isolation of one pathogenic organism, which is responsible 
for the disease. There is now support for the gut microbiota as a ‘super organ’ involved 
in a range of clinical conditions including sepsis, obesity, autism, diabetes and 
particularly inflammatory mediated conditions including Crohn’s disease and NEC 
(Finegold et al. 2002; Conte et al. 2006; Scanlan et al. 2006; Mai et al. 2013). These 
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diseases are polymicrobial, where an element of the pathophysiology of the diseases is a 
function of the microbial community present. 
Exploring how intervention is affecting the development of the neonatal gut microbiota 
will be vital to guiding clinical practise. There is significant interest in understanding 
whether clinical interventions could be tailored to engineer a gut microbiota reflective 
of a healthy term delivered breast fed infant. In this exciting and fast moving field, the 
application of systems biology (inter-disciplinary approach) to disease states will go 
beyond exploring ‘what is there’ and also address ‘what it is doing’. This latter 
functional aspect will be key to exploring polymicrobial infections which will not fulfil 
Kochs postulates. Where reproducible single causative organisms are not involved, 
functional aspects of the ecosystem may exist which are independent of the exact 
microbial ecology. 
The combination of poor host defences and invasive life support mechanisms make 
premature infants who have extended stays in NICUs particularly susceptible to 
infection (Kaufman & Fairchild 2004). Despite increased survival and improving long-
term outcomes among preterm infants, the prevalence of NEC and sepsis remains high. 
Combined, these major neonatal pathologies cause more late neonatal deaths than any 
other single cause, accounting for 21% of deaths within the worldwide preterm 
population (Berrington et al. 2012). Infants who develop NEC and/or sepsis are also at 
higher risk of poor growth, cerebral palsy, and vision and hearing impairment (Stoll et 
al. 2004). Rates vary between neonatal units depending on case-mix and care practices, 
and correlate tightly with degree of prematurity. These two major morbidities associated 
with the preterm population are discussed in detail below. 
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1.3.1 Necrotising Enterocolitis (NEC) 
Despite over 3 decades of research, NEC remains the most common cause of mortality 
and morbidity affecting the gastrointestinal tract of infants in the NICU (Hunter et al. 
2008). NEC occurs in 5 - 10% of very preterm infants, but is difficult to define robustly 
unless there is histological confirmation at surgery or at post-mortem. The incidence of 
NEC is rising, largely due to advances in neonatal care resulting in increased survival of 
preterm neonates (Fox & Godavitarne 2012). There is an inverse relationship between 
the risk of NEC and birth weight or gestational age, so that very low birth weight 
(VLBW; <1500 g) and significantly preterm infants (<28 weeks gestation) carry the 
greatest burden of disease (Lin et al. 2008; Caplan & Frost 2011). NEC is also 
associated with subsequent sequelae including serious neurodevelopmental delay, poor 
growth, intestinal obstruction due to scarring, short bowel syndrome, and potential liver 
failure due to prolonged hyperalimentation (Embleton & Yates 2008). NEC is rare in 
term neonates, occurring in 1 in 1000 term births, due to the increased maturity and the 
differential development of the microbiota compared to preterm neonates (Berrington et 
al. 2012). 
NEC is a severe inflammatory disorder with the exact mechanism and role of infectious 
agents in the disease yet to be fully established (Berman & Moss 2011). The disease can 
arise in any area of the GIT but it most commonly found in the terminal ileum, caecum, 
and ascending colon (Santulli et al. 1975). The pathophysiology of NEC is understood 
to be multifactorial, conditioned primarily by immaturity of the gastrointestinal tract 
(Lin et al. 2008). More specifically, the triad of key factors in the development of NEC 
are gut mucosal damage, enteral feeding (especially formula feeding), and abnormal 
bacterial colonisation and translocation (Neu 2005; Martin & Walker 2006; Caplan & 
Frost 2011). It is increasingly clear that NEC is not a single ‘disease’ but is likely to 
represent the end result of several interacting and modulating factors. The triad of key 
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factors together cause a cascade of events, involving an exaggerated and uncontrolled 
pro-inflammatory response, ultimately leading to necrosis of the gut epithelium. The 
radiological hallmark is the presence of pneumatosis intestinalis, characterised by 
bacterial production of hydrogen gas in the intestinal wall, and the pathological findings 
include necrosis, mucosal oedema, intramural air, and haemorrhage (Mannoia et al. 
2011). 
In preterm neonates the mucosal defences are weakened as the GIT is not fully 
developed and the intestinal villi height and barrier functions are compromised (Santulli 
et al. 1975). In a weakened GIT the bacteria and their products may translocate from the 
lumen, across the mucosa, into the systemic circulation (Harpavat et al. 2012). Mature 
enterocytes can distinguish between commensal and pathogenic bacteria, removing the 
latter. However, immature enterocytes lining the preterm GIT may mount an 
exaggerated immune response to the commensal organisms. This leads to a cycle of 
destructive intestinal damage allowing bacteria more access, which in turn stimulates an 
increasing inflammatory response (Nanthakumar et al. 2000). Thus, the pathogenesis of 
NEC focuses on the abnormal immune response to commensal organisms and 
researchers are currently exploring this immune response mechanistically. One key 
pathway is increased expression of toll-like receptor 4 (TLR4) which is a pattern 
recognition receptor (PRR) that responds to lipopolysaccharide (LPS) in the cell walls 
of Gram-negative bacteria and leads to increased apoptotic and proinflammatory 
responses (Fusunyan et al. 2001; Jilling et al. 2006; Lin et al. 2008). Commensal 
bacteria suppress the inflammatory response through inhibition of nuclear factor kappa-
B (NF-κB), a transcription factor (Wu et al. 2012). TLR4 is increased in formula-fed 
and hypoxia-stressed rats (simulating NEC development) and it is known that endotoxin 
binds to and activates TLR4 and immature enterocytes also express high levels of TLR4 
(Jilling et al. 2006). LPS binds to TLR4 causing the activation of chaperone and signal 
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transduction molecules, which result in NF-κB translocation from cytoplasm to the 
nucleus where it promotes the expression of multiple proinflammatory cytokines (Wu et 
al. 2012). One such inflammatory cytokine up-regulated by NF-κB is interleukin-8 (IL-
8) which is up-regulated strongly in the presence of LPS by fetal intestinal cells, but not 
in mature enterocytes (Nanthakumar et al. 2000). IL-8 serum levels have also been 
shown to positively correlate with NEC severity (Nanthakumar et al. 2011). Up-
regulation of other cytokines including IL-12 and IL-18 has also been implicated in 
NEC development using rat models (Halpern & Holubec 2002). Greater understanding 
of the inflammatory cascade in NEC is paramount to developing a prevention strategy 
which targets critical stages within the cascade. For example, levels of platelet 
activating factor (PAF) have been found to rise in stool following NEC and 
administration of PAF to hypoxic-stressed rats induces NEC, but PAF antagonists 
reduced the incidence and severity (Caplan & Hedlund 1997; Amer et al. 2004). 
Comparably, tumor-necrosis factor alpha (TNF-α) is secreted by activated macrophages 
to promote inflammation and may trigger the production of PAF in neighbouring cells 
(Harpavat et al. 2012). TNF-α may be implemented in the pathogenesis of NEC and 
might have potential use as a biomarker in predicting disease as it is found in elevated 
levels in serum of NEC infants compared to controls (Caplan et al. 1990). Interestingly, 
TNF-α is also important in mediating the inflammation seen in inflammatory bowel 
disease (IBD), with IBD therapy specifically targeting TNF-α in inflamed tissue 
(Harpavat et al. 2012).  
Studies have shown bacterial colonisation is a pre-requisite for NEC by (i) intestinal 
necrosis being absent in bacterium-free animal models, (ii) outbreaks of organisms that 
commonly colonise the gastrointestinal tract in NICUs have been associated with 
epidemics of NEC, and (iii) NEC does not occur in-utero when the gut is sterile 
(Kaufman & Fairchild 2004). Despite previous studies supporting dysbiosis of the gut 
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microbiota in disease development, no single causative agent has been reproducibly 
identified by standard culture or molecular approaches. Recent molecular based studies 
exploring the gut microbiota in NEC have shown that the diversity of the community is 
substantially reduced prior to diagnosis and this can lead to dysbiosis and the 
dominance of a single organism. Bacterial organisms reported to be associated with 
NEC are normally from the phylum Proteobacteria, commonly within the 
Enterobacteriaceae family (Carlisle et al. 2011; Mai et al. 2011). Cronobacter 
sakazakii (formerly Enterobacter) in particular has been responsible for NEC outbreaks 
in NICUs and was shown to greatly exacerbate the extent of NEC in animal models 
(Hunter et al. 2008). In one human study, standard culture identified a predominance of 
Staphylococci in NEC, although sample timing in relation to NEC was unknown, but 
this was not confirmed by molecular methods (Smith et al. 2012). In another study, an 
increase in the abundance of Enterobacter, Klebsiella and Pseudomonas spp. was 
reported (Björkström et al. 2009). Molecular analysis of stool after development of 
NEC indicated that the gut microbiota post NEC diagnosis was lower in diversity, with 
a greater relative abundance of Proteobacteria (Wang et al. 2009). Similarly, a 
pyrosequencing study sampling the gut microbiota prior to NEC diagnosis and within 
72 h of diagnosis, identified a bloom in Proteobacteria and a decrease in Firmicutes 
during the interval between sampling (Mai 2011). In other studies, no significant 
differences in the community profiles of infants with NEC compared to controls was 
found (Mshvildadze et al. 2010).  
Due to the inconsistencies in identifying a candidate organism between studies, it is 
unlikely a single organism is accountable for NEC. The complex multifactorial 
pathophysiology appears to be influenced by a variety of bacterial genera, acting 
individually or promoting shifts in communities. Host-bacterial interactions have been 
characterised, with the activation of a pro-inflammatory, pro-apoptotic, or antiapoptotic 
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pathway involving the interaction of microbial-associated molecular patterns (MAMPs) 
with a specific PRR on host cells, as in the NF-κB pathway (Collier-Hyams & Neish 
2005; Lin & Stoll 2006). The neonatal intestine first encounters MAMPs following birth 
with the introduction of gut microbiota from the surrounding environment. As outlined 
previously, commensal bacteria can suppress inflammatory signalling in intestinal 
epithelia by inhibition of the NF-κB pathway. Thus, it has been proposed that 
hyperactive inflammation in preterm infants could be caused by dysbiosis of the normal 
commensal bacteria, and subsequent lack of bacterially-mediated dampening of 
inflammatory pathways (Lin & Stoll 2006). 
Noteworthy is pathogenic causes of NEC are also not limited to bacteria, with fungal 
species also being implicated in the disease pathophysiology (Gibbs et al. 2007). Fungi 
represent a large kingdom of eukaryotic organisms that are separate from plants and 
animals, with the major difference arising due to fungal cell walls containing chitin. A 
retrospective study found that 15% of all infants diagnosed with NEC had concurrent 
invasive candidiasis (Coates et al. 2005). However, in these cases it is difficult to assess 
whether the presence of Candida spp. was contributing to the disease pathophysiology, 
or rather presenting as an opportunistic infection as a result of the disease. Importantly, 
Candida albicans has been found in cohorts despite universal prophylaxis with oral 
nystatin suggesting suppression of C. albicans rather than elimination to prevent 
invasive disease (LaTuga et al. 2011). The same authors also showed the presence of 
Candida parapsilosis and Candida tropicalis which are less susceptible to nystatin and 
uniquely Candida quercitrusa, typically described in fruit crops, was identified in 6 of 
the 7 infants (LaTuga et al. 2011). Despite their resistance to nystatin, it is unclear if 
these species play a role in the pathogenesis of NEC. 
Archaea, one of the three domains of life (with eubacteria and eukaryote), are highly 
diverse prokaryotes consisting largely of extremophiles that thrive in extreme 
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environments including hot water springs, salt brines, and extremely acidic and anoxic 
niches (Liu & Whitman 2008; Jarrell et al. 2011). However, with the advent of NGS it 
increasingly recognised that archaea are not relegated to existence in extreme 
environments. Indeed, anaerobic archaea have recently been detected in human stool, 
vaginal, and oral microbiota demonstrating their ability to colonise the human host 
(Kulik & Sandmeier 2001; Eckburg et al. 2003; Vianna & Conrads 2006). Although 
work on archaea in the gut microbiota of neonates is limited, particularly for preterm 
infants, a study by Palmer et al. (2007) explored the gut microbiota in full term health 
infants and showed the prevalence of archaea was considerably lower and more variable 
than fungi or bacteria. Using qPCR, archaea was not detected in all infants and appeared 
only transiently over the first few weeks of life. Only one infant was found to still 
harbour archaea after week 5 of life. However, it is important to note that the DNA 
extraction was optimised for bacteria (Palmer et al. 2007). In healthy human adults, 
hydrogen consuming methanogens are the predominant archaea in the GIT with 
Methanobacter smithii comprising up to 10% of all anaerobes (Human Microbiome 
Project Consortium 2012; Miller & Wolin 1986). Methanosphaera stadmanae and 
Crenarchaeotes have also been detected but comprise only a minor portion of the gut 
microbiota (Rieu-Lesme et al. 2005). A study exploring the gut microbiota in Korean 
adults also recovered sequences from halophilic archaea, with Halorubrum koreense 
strain B6 showing the greatest prevalence, reported to be a consequence of diet (Nam et 
al. 2008). Archael diversity in the GIT was found to be more similar in each individual 
than the bacterial or fungal community (Nam et al. 2008). Whether archaeal pathogens 
exist is still open to debate due to lack of definitive evidence. Characterisation of the 
structure and function of archaea is challenging due to difficulties in the isolation and 
cultivation (Eckburg et al. 2003). In contrast, archaea in mutualistic relationships may 
provide health benefits to the host. For example, Methanobrevibacter smithii 
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cocolonization with Bacteroides thetaiotaomicron was found to produce a significant 
increase in host adiposity in a mouse model (Samuel & Gordon 2006). In terms of NEC 
development, a parallel might be drawn from findings in IBD; the presence of 
methanogenic archaea in the human gut was indicative of a healthy microbiota, with 
reduced methanogen presence in individuals with IBD (Scanlan et al. 2008). 
Studies exploring the role viruses in the pathogenesis of NEC are limited, despite their 
potential importance. Entero-pathogenic viruses generally infect epithelial cells causing 
cell destruction which can trigger increased intestinal fluid output (diarrhea) in mature 
infants (Lodha et al. 2005). However, for the preterm neonate who may be incapable of 
initiating increased intestinal fluid output, the viral infection may lead to epithelial 
damage and intestinal perforation (Kliegman et al. 1993). Due to reduced regenerative 
capacity of preterm neonates, the epithelial damage caused by entero-pathogenic viruses 
may lead to the development of NEC. Torovirus is one such virus and was shown to 
have a much greater prevalence in the stools from patients with NEC (48%) compared 
to controls (14.5%) (Lodha et al. 2005). In a study exploring only infants with NEC, 
human astrovirus was found in 19% of the patients but had no significant effect on 
disease severity (Bagci & Eis-Hübinger 2008). In a recent case report, NEC was found 
to be associated with cytomegalovirus (CMV) and Proteobacteria providing evidence of 
the potential for viral-bacterial interaction influencing the hosts susceptibility to NEC 
(Tran et al. 2013). Interestingly, in adult IBD, concomitant CMV infection is associated 
with increased disease severity and it has been suggested that CMV increases 
vulnerability to bacterial invasion and exaggerates the intestinal immune response 
(Garrido et al. 2013; Tran et al. 2013). While conserved marker genes such as 16S can 
be used for detection of all bacteria, there are no RNA or DNA sequences capable of 
detecting all viruses (Thurber et al. 2009). To overcome this, deep sequencing of all 
viral RNAs and DNAs has been applied to GIT to accurately characterise the diversity 
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and complexity of the viral community. It has been shown that a large number of 
viruses within both the infant and adult GIT are bacteriophages (viruses that infect 
bacteria), although the adult community had much greater diversity (Breitbart et al. 
2003; LaTuga et al. 2011). In a healthy term neonate the meconium was absent of viral 
particles, but samples obtained after 1 and 2 weeks of life showed the infant harboured 
10
8
 viral particles per gram of faeces and the overall viral community composition 
changed dramatically between each week (Breitbart et al. 2008). This suggests the viral 
community in the neonate is dynamic but, importantly, the abundant viral sequences did 
not originate from feed suggesting acquisition is non-dietary. Phage may influence the 
composition of bacterial populations in the intestine by infecting and lysing a specific 
host, allowing another bacterial strain the opportunity to become abundant (Thingstad & 
Lignell 1997). This model of predator-prey dynamics is termed “kill the winner” and 
involves blooms of a specific microbial species leading to blooms of their 
corresponding phage, followed by decreasing abundances of both (Thingstad 2000). 
This may relate to the dysbiosis event reported prior to NEC and of subsequent 
dominance of the gut microbiota by a single organism (Morrow et al. 2013). If the 
observed dysbiosis is causative to the disease then the initial event may be triggered 
intrinsically, as a result of phages infecting other abundant hosts. Additionally, through 
lysogenic conversion of the gut microbiota, phages may introduce new phenotypic 
traits, such as antibiotic resistance and the ability to produce exotoxins (Breitbart et al. 
2003). 
Because the candidate organism varies between studies it is unlikely that NEC is the 
result of colonisation with a specific organism, rather it is a polymicrobial disease 
arising as a consequence of community interplay. An important consideration when 
interpretating any results is whether the observed dysbiosis in the gut microbiota is 
involved in the pathophysiology of NEC or if it is simply a consequence of disease 
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progression. For example, in cases of concurrent invasive candidiasis in NEC infants, it 
is difficult to assess whether the presence of Candida spp. is contributing to disease 
pathophysiology, or rather presenting as an opportunistic infection as a result of the 
disease.  
 
1.3.2 Sepsis 
Neonatal sepsis is the most common cause of neonatal death worldwide with the 
incidence in the developed world thought to be around 4 cases per 1000 live births. The 
incidence is higher in the developing world with up to 38 cases per 1000 live births. 
Analogous to NEC, the level of maturity, measured as birth weight or gestational age, is 
the most potent indicator of susceptibility to infection (Stoll 1994; Guthrie et al. 2003). 
Thus sepsis is also most common in preterm neonates as a result of the immaturity of 
the intestinal motility and barrier function. In infants born preterm, around 20 - 30% of 
all very-low-birth-weight (VLBW; <1500g) infants held in NICU’s will suffer from 
sepsis at some stage; this risk increases to 35% in neonates of extremely-low-birth-
weight (ELBW; <1000g) and to nearly 50% in neonates of less than 750g (Stoll et al. 
2004). Neonatal sepsis can be divided into two types, early onset sepsis (EOS; occurring 
with 72 hours of birth) which occurs in about 1.5% and late onset sepsis (LOS; 
occurring after 72 of birth) which occurs in about 21% of VLBW infants. The two types 
can be grouped under the term ‘sepsis’ which refers to an infant developing at least one 
case of proven sepsis irrespective of hours since birth. Due to the increased involvement 
of the microbial community in LOS, the term sepsis will be used throughout this thesis 
but will refer, in large, to LOS. 
Sepsis is caused by the direct bacterial translocation from the gut into the bloodstream 
and is typically diagnosed by positive blood culture, along with antibiotic treatment for 
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a minimum of 5 days and clinical signs suggestive of infection. Sepsis is associated with 
subsequent sequelae including prolonged ventilation and need for intravascular access, 
bronchopulmonary dysplasia, NEC, and an increased length of hospital stay. In terms of 
the gut microbiota in sepsis, there is comparison with the development of NEC. Like 
NEC, dysbiosis of the gut microbiota is associated with sepsis facilitated by prolonged 
broad spectrum antibiotic treatment, which profoundly decreases the gut microbial 
diversity and promotes pathogen predominance (Mai et al. 2013). While microbial 
patterns in the meconium are similar, infants at high risk of sepsis have been shown to 
possess a less diverse gut microbiota from birth until the onset of sepsis (Madan et al. 
2012). The gut microbiota in infants who are diagnosed with sepsis is significantly 
different from that of control infants, with an increased prevalence of Proteobacteria and 
Firmicutes. Contrary to the inconsistency of a dominant organism in NEC, 
Staphylococcus spp. are regarded as the most frequent bacterial species in the 
pathogenesis of sepsis worldwide, with increased abundances of these species shown in 
infants diagnosed with the disease (Venkatesh & Abrams 2010).  
Colonisation of the gut microbiota in sepsis by fungi remains relatively unstudied 
compared to bacteria, despite the incidence of candidemia rising steadily (Benjamin et 
al. 2003). As with bacterially mediated sepsis, blood culture is the ‘gold standard’ for 
the diagnosis of neonatal candidemia. Although sensitive for bacterial pathogens, it is a 
poor diagnostic tool for invasive fungal infections, with as many as 50% of candidemia 
not being directly detected (Manzoni et al. 2008). C. albicans is the most prevalent 
species in the gut and despite antifungal prophylaxis Candida spp. remain a leading 
cause of infectious mortality in the NICU, accounting for around 50% of the cases 
(Tirodker et al. 2003; Zaoutis et al. 2007). 
As outlined in the previous section, archaea and viruses colonising the gut may also 
influence the disease status of the human host. As with NEC, no specific research has 
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been carried out on these domains in the pathogenesis of sepsis. However, it is likely the 
whole consortium of the gut will be influencing dysbiosis events to some degree. As 
previously described, viruses may damage the epithelial cell and subsequently host 
defences allowing the translocation of pathogenic species, such as Staphylococcus spp. 
which may proliferate and ultimately cause sepsis (Venkatesh & Abrams 2010). As with 
NEC, the question remains; does dysbiosis in the gut microbiota cause sepsis or is it a 
result of disease progression? Future work will need to employ large cohorts with robust 
sampling pre and post disease to address this issue of cause or effect. 
 
1.4 Biomarkers for NEC and sepsis 
 
Early identification of developing NEC and sepsis in preterm infants is essential to 
reduce the devastating effects of the diseases. The current best definition of a biomarker 
is provided by the National Institute for Health (NIH) working group who define a 
biomarker as “a characteristic that is objectively measured and evaluated as an indicator 
of normal biological processes, pathogenic processes, or pharmacologic responses to a 
therapeutic intervention” (Atkinson et al. 2001). The diagnosis of NEC and sepsis 
remains difficult with advanced stages of disease usually present before symptoms can 
be detected and in the case of blood culture for sepsis, results may take more than 48 
hours and false negatives due to low sample volume are common (Ng et al. 2010). Thus 
culture alone lacks the ability to identify quickly which infants really need antibacterial 
treatment, and which do not. Concerns around development of antibiotic resistance and 
adverse effects on the faecal microbiome suggest ‘unnecessary’ antibiotic use should be 
minimised. Consequently, much research is currently focused on the detection of an 
appropriate non-invasive biological biomarker which is capable of predicting which 
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infants are likely to develop the disease so appropriate timely intervention can be made. 
As NEC and sepsis are both associated with the gut microbiota, one approach might 
seek to detect specific organisms related to gut health. It has been shown that 
Enterococcus faecalis can induce anti-inflammatory cytokine IL-10 via regulation of the 
nuclear receptor Peroxisome proliferator-activated receptor gamma (PPAR-γ) (Are et al. 
2008). Conceivably, systematic monitoring of an E. faecalis in the preterm gut 
microbiota could be a valuable biomarker in predicting NEC and sepsis (Braniste & 
Pettersson 2012). 
Neonatal sepsis and NEC is associated with hyper-inflammatory host response and 
much research has focused on a specific panel of acute phase protein biomarkers as 
potential markers of the inflammatory cascade as well as cell surface antigens. For 
example, calprotectin, a heterodimeric peptide (36 kDa) which is released following 
intestinal neutrophil influx is readily detectable in stool and plasma (D’Incà et al. 2007). 
Stool calprotectin, which represents gut wall inflammation, was recently shown to hold 
promise as a non-invasive diagnostic marker for both NEC and sepsis (Thuijls et al. 
2010; Dhas et al. 2012). Furthermore, stool calprotectin levels have been previously 
validated as an accurate marker of IBD in both adults and children (Carroccio et al. 
2003). Although more than 170 different biomarkers have been evaluated for prognosis 
and diagnosis in sepsis alone, none have sufficient specificity or sensitivity for clinical 
use (Pierrakos & Vincent 2010). Rather than focus on a single biomarker it has been 
proposed that combinations of multiple biomarkers may be more effective, thus further 
acute phase protein biomarkers have also been explored. It has been shown that serum 
amyloid A (SAA) is equally effective as the commonly used C-reactive protein (CRP) 
and procalcitonin (PCT) and that serial measurement of all three markers could be used 
in combination in the diagnosis of NEC (Çetinkaya et al. 2011).  
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More recently the search for a diagnostic test for NEC and sepsis has focused on 
cytokines and chemokines, particularly IL-6, -8, and -10 and TNF-α (Mussap et al. 
2012). The serum concentrations of these potential biomarkers change over the course 
of systemic inflammation with disease progression linked to an exaggerated 
proinflammatory response without adequate anti-inflammatory compensation (Ng et al. 
2003). IL-6 is the most investigated cytokine as a potential biomarker for neonatal 
disease as it is very sensitive; however, it has a very short half-life leading to decreased 
sensitivity after the start of therapy (Procianoy & Silveira 2004). Cell marker 
biomarkers have also been explored with neutrophil CD64 perhaps the most commonly 
investigated. CD64 is the first of three receptors that bind the Fc portion of IgG 
antibodies and when the immune system encounters an infectious agent the surface 
expression of CD64 is greatly up-regulated (Standage & Wong 2011). Advances in flow 
cytometry have enabled rapid and accurate quantification of CD64 and importantly for 
neonates only minimal blood volume is required (Bhandari et al. 2008). CD64 is more 
sensitive and specific than CRP for detecting systemic infection in adults and children 
(Gude 2012). It has been shown to be a highly specific indicator of neonatal sepsis but 
with only moderate sensitivity (Ng et al. 2004; Streimish & Bizzarro 2012). In a study 
by Ng et al. (2004), using an optimal cut-off value CD64 was able to correctly identify 
all sepsis cases and a case of severe NEC. However, 5 infants with clinical pneumonia 
were missed and 43 infants were incorrectly classified into the infected group. Thus, as 
alluded to previously, combinations of biomarkers used in parallel may provide the 
most robust classification of a neonates disease status.  
Although candidate markers are targeted based on their crucial roles in inflammation 
and infection, this methodology is limited to markers of known proteins. To overcome 
this limitation, Ng et al. (2010) used mass spectrometry (MS) based proteomic profiling 
technology as an unbiased approach to explore host response biomarkers for predicting 
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NEC and sepsis in preterm infants. From a large consortium of proteins, SAA and 
apolipoprotein CII (apoC2) were detected as potential biomarkers from plasma capable 
of early detection of NEC and sepsis with great accuracy. Both of these potential 
biomarkers are apolipoproteins, which bind lipids to form lipoprotein. Lipoprotein binds 
to LPS and, as discussed previously, this can trigger a cascade of inflammatory 
responses (Ng et al. 2010). 
Another field which is currently emerging for biomarker research is transcriptomics. 
This methodology evaluates gene-expression patterns and involves the study of all 
messenger RNA (mRNA) molecules or transcripts and the evaluation in transcription 
initiation, processing, and degradation of proteins (Young et al. 2009). As samples are 
amplified by PCR only small amounts of biological material are required that can be 
obtained non-invasively. This approach will require the extraction of high quality RNA 
which can be difficult and will still be subject to PCR bias. Metabolomics on the other 
hand does not involve PCR and is receiving increased interest for neonatal biomarker 
discovery. Metabolomics is the systematic study of the complete set of metabolites in a 
biological sample in which the metabolic status of the individual is an accurate 
representation of the disease status (Mussap et al. 2012). The technique is able to utilise 
non-invasive sampling of urine which reflects changes to the metabolic state and extent 
of absorption and stool which reflects differences in gut flora diversity and any impact 
on gut permeability and function. Urine is considered the best biological sample to use 
in metabolomics as it contains the intermediate metabolites which reflect specific 
metabolic processes related to the current disease status in real time (Fanos et al. 2011). 
While studies utilising transcriptomics and metabolomics for biomarker discovery in 
NEC and sepsis are currently lacking, it is reasonable to propose that in future a systems 
biological approach will yield some major advancements in the field. 
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1.5 Preventative strategies and treatment for NEC and sepsis 
 
As NEC frequently progresses from minor signs of intestinal inflammation to major 
necrosis within hours, even the most highly specific and sensitive biomarkers may fail 
to predict the disease. Thus, the development of preventative strategies is paramount 
(Wu et al. 2012). However, as the exact pathogenesis of NEC is yet to be determined, 
formulating effective preventative and treatment plans remains challenging (Lin et al. 
2008). Breast milk contains several immune-protective and growth factors, bioactive 
immune-modulatory cells and other ‘immunonutrients’ including amino acids, fatty 
acids, lysozyme, lactoferrin, minerals and metals such as zinc, and prebiotic 
oligosaccharides (Bhatia 2010). Glutamine and arginine influence gut integrity and 
sepsis and several vitamins have key roles in antioxidant protection (Embleton & Yates 
2008). EBM also contains live bacteria which regulate host-microbe interactions and 
modify infant gut microbiota development, although to what extent the gut microbiota 
reflects EBM is currently unclear. For example, passive immunoprotection is provided 
by maternal secretory Immunoglobulin A (IgA). IgA is thought to promote biofilm 
formation to facilitate colonisation by protective bacteria, subsequently preventing 
colonisation by pathogenic species. Consequently, receipt of maternal breast milk is 
considered a key factor facilitating the development of a healthy microbiota (Martín et 
al. 2009; Roger et al. 2010).  
The notion that breast milk stimulates a gut microbiota dominated by Bifidobacteria is 
still an area of active debate with many recent studies finding no association, 
particularly in preterm populations (Palmer et al. 2007). Also provoking controversy is 
the role and extent to which Bifidobacterium sp. are beneficial to human health. This 
stems from inconclusive research into the effectiveness of probiotic and prebiotic 
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supplementation at supporting healthy development of the gut microbiota (Szajewska 
2010). In preterm birth it is more challenging to adhere to the feeding ideology of 
exclusive maternal breast milk, thus much interest is currently focused on manipulations 
of the microflora with prebiotics and probiotics. Prebiotics are non-digestible short 
chain length carbohydrates that promote the growth and activity of desired beneficial 
organisms (Lee 2011). They appear to reduce the number of coliforms, stimulate the 
growth of Bifidobacterium and Lactobacillus spp., and could potentially stimulate a 
balanced and effective mucosal immune system in newborns and infants (Nakamura et 
al. 2009). A serendipitous increase in Lactobacillus spp. in preterm infants was 
associated with 1% lactulose added to feeds, potentially attributable to its prebiotic 
effects (Riskin et al. 2010). 
Probiotics consist of viable microorganisms, predominantly Bifidobacterium and 
Lactobacillus spp., in sufficient quantity to influence the gut microbiota by colonisation. 
Probiotics have received the greatest interest compared with prebiotics and it is 
hypothesised that administering probiotics results in a reduction in the growth of 
potential pathogens including enterobacteria, enterococci and clostridia (Deshpande et 
al. 2007). They may also improve intestinal permeability and modulate the development 
and persistence of an appropriate mucosal immune response. While current research 
into probiotic supplementation yields mixed results in terms of efficiency, it should be 
noted that probiotics are not considered dangerous nor have they been shown to have a 
detrimental effect on the host (Li et al. 2013; Nair & Soraisham 2013). Probiotics 
reduce the incidence of NEC in many studies, but interestingly do not affect sepsis 
(Deshpande et al. 2010). Few have explored associated changes in the microbiota as a 
result of probiotic administration. Work that has been reported indicates increased 
probiotic numbers (Bifidobacterium and Lactobacillus spp.) at the expense of 
Enterobacter, Enterococci and Clostridia — all organisms previously associated with 
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NEC (van Acker et al. 2001; France et al. 2007). Supplementing Lactobacillus casei 
increased the amount in infant stool and stabilised bowel flora (Cox et al. 2010). As 
prebiotics, probiotics, and synbiotics (a combination of prebiotics and probiotics) are 
increasingly implemented into the practises of neonatal units, future research will be 
able to explore the age of commencement, optimal dose, and species combinations to 
maximise and potential benefit. The ability to define and then replicate a ‘healthy’ gut 
microbiota would be of practical benefit to infants. 
The supplementation of the neonate’s diet is an attractive area of research due to 
possible antimicrobial activity and therapeutic potential of the supplement. Lactoferrin 
has received significant interest recently with application aimed particularly for preterm 
infants. Lactoferrin is the major whey protein in human colostrum and breast milk and 
is a key component of the immune response. It enhances cell proliferation of enterocytes 
and aids tight endothelial cell junctions (Bäckhed 2011). At lower concentrations, 
lactoferrin stimulates differentiation of enterocytes and expression of intestinal digestive 
enzymes. Lactoferrin also suppresses free radical activity when iron is added to milk 
suggesting further anti-inflammatory actions that could modulate the pathogenesis of 
diseases linked with free radical generation: NEC, retinopathy of prematurity (ROP) 
and bronchopulmonary dysplasia (BPD) (ELFIN 2013). Studies on the mechanisms by 
which lactoferrin exerts its effect in vivo show it is bacteriostatic by inhibiting growth 
by sequestering iron (Ochoa et al. 2006). It has also been shown to bind to LPS on the 
cell surface of a number of Gram-negative enteropathogens, inhibiting surface 
expressed virulence factors (Kaur et al. 2010). It can also inhibit viral attachment and 
replication and exerts a fungicidal activity. A recent study showed promise, 
demonstrating that oral lactoferrin prophylaxis reduced the incidence of sepsis in 
preterm infants, with the greatest effect occurring amongst ELBW infants (Venkatesh & 
Abrams 2010). As a positive candidate for regulating a healthy gut microbiota, future 
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research on the mechanisms and mode of actions, particularly on the composition of the 
gut microbiota, will be of great importance. 
Treatment of NEC and sepsis is carried out on a case by case basis and often relies 
heavily on the attending clinician. Treatment of NEC is through the administration of 
broad-spectrum antibiotics following diagnosis for a minimum of 5 days. If the 
symptoms persist following medical management or in the most severe cases the infant 
may undergo surgery to remove areas of necrotic bowel segments. Treatment of sepsis 
is based on antibiotic or antifungal prophylaxis for a minimum of 5 days for the 
management of bacterial or fungal mediated sepsis, respectively. In cases of negative 
blood culture but signs suggestive of infection the average days of antibiotic treatment 
is 5 ±3 days (Cordero & Ayers 2003). Prolonged administration of antimicrobial agents 
for greater than 5 days is associated with NEC and death (Cotten et al. 2009; Alexander 
et al. 2011).  
 
1.6 Aims and objectives  
 
The research conducted in this thesis primarily aimed to follow preterm neonates at risk 
of NEC and sepsis longitudinally, to explore the temporal progression of the gut 
microbiota from birth until discharge from the NICU. A range of culture dependent and 
molecular techniques were used to explore both the bacterial and fungal communities. 
The role of the gut microbiota as a causative agent in the pathogenesis of NEC and 
sepsis was the focus of analysis. 
The specific aims of each chapter are outlined below… 
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Chapter 3: The gut microbiota is a highly complex ecosystem increasingly associated 
with disease pathophysiology. Despite revolutionary advances in traditional culture and 
molecular based techniques, the coherence of these techniques remains elusive. We 
aimed to compare the performance of these techniques in assessing the gut microbiota 
of preterm infants. 
Chapter 4: To describe gut colonisation in preterm infants using standard culture and 
16S rRNA profiling, exploring differences in healthy infants and those who developed 
late onset infections. 
Chapter 5: Evidence suggests that microbial communities in the preterm gut may 
influence the development of NEC and sepsis. Existing data often neglect fungi and 
whether bacteria were metabolically active or not. We sought to characterize the 
bacterial and fungal stool flora of preterm neonates and organism viability and evaluate 
any associations with NEC and sepsis 
Chapter 6: The preterm gut microbiota is a complex dynamic community influenced 
by genetic and environmental factors and is implicated in the pathogenesis of NEC and 
sepsis. We aimed to explore the longitudinal development of the gut microbiota in 
preterm twins to determine how shared environmental and genetic factors may influence 
temporal changes and compared this to the expressed breast milk (EBM) microbiota. 
Chapter 7: The gut microbiota is significantly associated with the development of NEC 
and sepsis. Previous studies are limited by cohort size, poor sampling, and 
methodological restrictions. We aimed to extensively explore the differential 
community development in patients with NEC and sepsis, matched to controls. 
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2. Methods 
 
2.1 Patient cohort and samples 
 
Stool samples were collected from preterm infants <32 weeks gestation cared for in the 
Royal Victoria Infirmary, Newcastle upon Tyne. Stool samples were collected directly 
from the nappy and when possible were immersed in RNAlater (Ambion), which is a 
bacteriostatic agent offering immediate RNA stabilisation and protection. All samples 
were transferred to the microbiology department at the Freeman Hospital where they 
were stored at -20 °C.  
Clinical information was obtained from notes: Information on discrete (diagnosis of 
sepsis and NEC, gender, caesarean or vaginal birth, antifungal prophylaxis, mortality, 
and antibiotic administration) and continuous (day of life (DOL), birth weight, gestation 
age) variables were given for every patient relating specifically to each sample. NEC 
was categorised independently by two clinicians (Janet Berrington and Nicholas 
Embleton) from notes, x-ray and operative findings and classified as surgical (diagnosis 
confirmed operatively) or medical NEC (un-equivocal pneumatosis). Sepsis was 
defined by positive blood culture, along with antibiotic treatment for a minimum of 5 
days and signs suggestive of infection. 
 
2.1.1 Technique comparison 
11 preterm infants had 17 stool samples collected as part of routine surveillance. In 3 
patients additional longitudinal samples were collected. 200 mg of fresh sample was 
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subjected to quantitative aerobic and anaerobic culture; the remainder of the sample was 
stored at -20 °C for subsequent molecular analysis. 
 
2.1.2 Culture and DGGE: preliminary study 
The first and weekly stool samples were collected from preterm infants when available 
and subjected to quantitative aerobic and anaerobic culture, the remainder of the sample 
was stored at -20 °C. 38 infants contributed 99 stool samples to the routine microbial 
culture analysis. Sample volume allowed for 27 patients contributing 44 stool samples 
to be further analysed using DGGE.  
 
2.1.3 Bacterial and fungal viability 
A total of 32 preterm infants had 136 first and weekly stool samples collected and 
frozen at -20 °C. Of these samples, in 25 infants contributing 65 samples a portion was 
preserved in RNAlater (Ambion) and thus available for analysis of the viable 
community.  
 
2.1.4 Twin comparison 
In 12 sets of twins and 1 set of triplets (n = 27) a total of 173 stool samples (n = 173) 
were collected from birth until 8 weeks. 18 expressed breast milk samples salvaged 
from residual feeds in 3 sets of twins and the set of triplets were also analysed. 
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2.1.5 Gut microbiota in NEC and sepsis 
A total of 42 preterm infants were enrolled in the study contributing a total of 747 stool 
samples. Patients were split into two groups; Extremely Preterm (group “EP”: 
gestational age 23 - 26 weeks) and Very Preterm (group “VP”: gestation age 27 – 30 
weeks). Each group consisted of 21 patients where 7 patients developed proven NEC 
and/or sepsis matched to 14 patients who acted as controls. 408 samples were included 
in EP (mean 19 per patient, range 8 - 26) and 339 samples were included in VP (mean 
16 per patient, range 8 - 25) owing to the increased stay on the NICU common to the 
more preterm infants. Sampling aimed for daily collection where possible and the most 
informative samples, based on diseased status matched to healthy controls, were 
retrospectively chosen for analysis. Where possible, daily samples were analysed for the 
first 10 DOL, then every other day up to day 10-20, then every third day up to day 30, 
then every fourth day up to day 40 and so on until post day 70 where weekly samples 
were selected until discharge. In cases of NEC and/or sepsis, an increased number of 
samples preceeding and following diagnosis were also analysed. 
 
2.2 Routine culture of stool samples 
 
Routine culture of stool was carried out at the Freeman hospital. Briefly, suspensions 
were prepared from 200 mg stool material suspended, then serially diluted to 10
-5
 in 
quarter-strength Ringers Solution (Oxoid). An aliquot of each dilution (10 μL) was 
cultured onto Uriselect™ 4 agar (Bio-Rad) incubated aerobically (37 °C; 24 h) and also 
onto blood agar and blood agar containing 30 mg/L nalidixic acid - both incubated in an 
anaerobic chamber at 37 °C undisturbed for 72 hours. Lawns of the 10
-1
 suspension 
were spread onto Sabouraud agar and incubated aerobically at 30 °C for 72 hours. 
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Bacterial identification of each colony type was achieved using a combination of 
matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-
TOF-MS) (Bruker Daltonics) and, where necessary, appropriate API kits (bioMérieux). 
Colony counts were performed on each species and calculated by the relevant dilution 
factor to give an indication of the relative amounts of each species in the sample. 
UriSelect 4 agar was employed for the enumeration of Enterobacteriaceae, non-
fermentative Gram-negative bacteria, staphylococci and enterococci. Streptococci, 
lactobacilli and anaerobes were enumerated from blood agar plus nalidixic acid whereas 
Sabouraud agar was used only for enumeration of yeasts and fungi. 
 
2.3 Nucleic acid extraction 
 
All Nucleic acid extraction was carried out in a class II microbiological safety cabinet 
(Envair Bio 2+). Extractions were performed at room temperature unless otherwise 
stated. 
 
2.3.1 DNA extraction of cultured isolates (DNeasy Blood and Tissue Kit) 
DNA was extracted from cultured isolates using the DNeasy Blood and Tissue Kit 
(QIAGEN). The initial stages of extraction were dependent on whether the isolate was 
Gram-negative or Gram-positive. Initially, the bacterial cells were harvested in a 
microcentrifuge tube by centrifuging for 10 minutes at 5,000 × g. Gram-negative 
bacterial cell pellets were then resuspended in 180 µL Buffer ATL. 20 µL of proteinase 
K was added and the suspension vortexed and incubated for 1 hour at 56 °C with 
occasional vortexing allowing the digestion of proteins. Vortexing after each step, 200 
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µL of Buffer AL and 200 µL of ethanol were added to the suspension. For Gram-
positive bacteria, cell pellets were resuspended in 180 µL enzymatic lysis buffer 
(Appendix 1) and incubated for 30 minutes at 37 °C allowing lysis of the bacterial cells 
by damage to the cell walls. 25 µL of proteinase K and 200 µL of Buffer AL were then 
added and suspensions were incubated for 30 minutes at 56 °C. 200 µL of ethanol was 
then added and the suspension vortexed. After these differing pre-treatment steps, both 
Gram-negative and Gram-positive underwent the same process as follows. The mixture 
was pipetted into a DNeasy Mini spin column placed in a 2 mL collection tube and 
centrifuged for 1 minute at 6,000 × g. The collection tube containing the flow-through 
was discarded and the DNeasy Mini spin column was placed in a new 2 mL collection 
tube and 500 µL Buffer AW1 was added and the column centrifuged for 1 minute at 
6,000 × g. The collection tube containing the flow-through was discarded and the 
DNeasy Mini spin column was placed in a new 2 mL collection tube and 500 µL Buffer 
AW2 was added and the column centrifuged for 1 minute at 20,000 × g to dry the 
DNeasy membrane. The collection tube containing the flow-through was discarded and 
the DNeasy Mini spin column was placed in a new 1.5 mL microcentrifuge tube and 
100 µL Buffer AE was pipetted directly onto the DNeasy membrane. Following 
incubation for 1 minute the column was centrifuged for 1 minute at 6,000 × g to elute 
the extracted DNA. 
 
2.3.2 DNA extraction of stool (PowerLyzer™ PowerSoil® DNA Isolation Kit) 
DNA was extracted from 100 mg of stool sample for analysis of the total community 
using the PowerLyzer™ PowerSoil® DNA Isolation Kit (MoBio). Briefly, the stool 
sample was added to a glass bead tube containing 0.1 mm glass beads before 750 µL of 
Bead Solution was added and the mix vortexed gently for 10-15 seconds. 60 µL of 
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solution C1 was then added and the mix inverted several times. Solution C1 is a cell 
lysis buffer which contains SDS to break down fatty acids and lipids associated with the 
cell membrane. The glass bead tube was secured in a vortex adapter (MoBio) and 
vortexed at full speed for 15 minutes to mechanically lyse microbial cells. The glass 
bead tube was centrifuged at 10,000 × g for 3 minutes and the supernatant (400-500 µL) 
was transferred to a sterile collection tube. 250 µL of Solution C2 was added, the mix 
vortexed for 5 seconds and incubated at 4 °C for 5 minutes to precipitate humic 
substances, cell debris, and proteins. The suspension was centrifuged for 1 minute at 
10,000 × g to separate the liquid phase containing the DNA from the solid phase 
containing the non-DNA organic and inorganic material. Avoiding the transfer of any of 
the pellet, up to 600 µL of supernatant was transferred to a sterile collection tube and 
200 µL of solution C3 was added before a brief vortex and incubation at 4 °C for 5 
minutes. Like solution C2, this is a second reagent to precipitate additional humic acid, 
cell debris, and proteins. The suspension was centrifuged for 1 minute at 10,000 × g, 
again to separate the liquid phase containing the DNA from the solid phase. Avoiding 
the transfer of any of the pellet, up to 750 µL of supernatant was transferred to a sterile 
collection tube and 1.2 mL of solution C4 was added to the supernatant and vortexed for 
5 seconds. Solution C4 is a high salt solution which facilitates DNA binding to the silica 
membrane of the spin filter. 675 µL of the supernatant mix was loaded onto a spin filter 
and centrifuged at 10,000 × g for 1 minute and the flow through discarded. This was 
repeated until all of the supernatant mix had passed through the spin filter leaving only 
DNA bound to the membrane. 500 µL of solution C5, ethanol wash solution, was then 
added to the spin filter and centrifuged for 30 seconds at 10,000 × g to clean the DNA 
bound to the spin filter membrane by removing residual salt and other contaminants. 
The flow though was discarded and the spin filter centrifuged again for 1 minute at 
10,000 × g to remove all traces of ethanol which can interfere with downstream 
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applications. The spin filter was then transferred to a sterile collection tube and 100 µL 
of solution C6 was added to before centrifugation for 30 seconds at 10,000 × g to elute 
DNA from the spin filter membrane. Solution C6 is a low salt sterile elution buffer 
which causes DNA bound to the spin filter in the presence of high salt to be selectively 
released. The spin filter was discarded and the eluted DNA was stored at -20 °C for use 
in downstream application. 
 
2.3.3 DNA extraction of milk (PowerFood™ Microbial DNA Isolation Kit) 
DNA was extracted from milk and syringe samples for analysis of the total community 
using the PowerFood™ Microbial DNA Isolation Kit (MoBio). Breast milk samples 
were obtained from frozen stores of expressed breast milk. Syringe samples were 
obtained by washing the milk residue from fresh syringes using 2 mL of sterile water. 
Briefly, 1.8 mL of the of the sample was added to a 2 mL collection tube and 
centrifuged at 13,000 × g for 1 minute. The supernatant was decanted and the tubes 
centrifuged at 13,000 × g for an additional 1 minute before removing the remaining 
supernatant. The pellet, which contains the microbial cells, was resuspended in 450 µL 
of Solution PF1. Solution PF1 is a strong lysing reagent which includes a detergent to 
break cell walls and help removed non-DNA organic and inorganic material. The 
suspension was added to a MicroBead tube which was secured in a vortex adapter 
(MoBio) and vortexed at full speed for 15 minutes to mechanically lyse microbial cells. 
The MicroBead tube was centrifuged at 13,000 × g for 1 minute and the supernatant 
(approximately 400 µL) which contains the DNA was transferred to a sterile collection 
tube. 100 µL of Solution PF2 was added, the mix vortexed for 5 seconds and incubated 
at 4 °C for 5 minutes to precipitate cell debris, and proteins. The suspension was 
centrifuged for 1 minute at 13,000 × g to separate the liquid phase containing the DNA 
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from the solid phase containing the non-DNA organic and inorganic material. Avoiding 
the transfer of any of the pellet, up to 450 µL of supernatant was transferred to a sterile 
collection tube and 900 µL of solution PF3 was added to the supernatant and vortexed 
for 5 seconds. Solution PF3 is a highly concentrated salt solution which facilitates DNA 
binding to the silica membrane of the spin filter. 650 µL of the supernatant mix was 
loaded onto a spin filter and centrifuged at 13,000 × g for 1 minute and the flow through 
discarded. This was repeated until all of the supernatant mix had passed through the 
spin filter leaving only DNA bound to the membrane. The spin filter was then placed in 
a sterile collection tube and 650 µL of solution PF4, an ethanol wash solution, was then 
added to the spin filter and centrifuged for 1 minute at 13,000 × g to clean the DNA 
bound to the spin filter membrane by removing residual salt and other contaminants. 
The flow through was discarded and 650 µL of Solution PF5 was added and centrifuged 
for 1 minute at 13,000 × g to ensure the complete removal of solution PF4 resulting in 
higher purity and yield. The flow though was discarded and the spin filter centrifuged 
again for 2 minute at 13,000 × g to remove all traces of PF5, which can interfere with 
downstream applications. The spin filter was then transferred to a sterile collection tube 
and 100 µL of solution PF6 was added to before centrifugation for 1 minute at 13,000 × 
g to elute DNA from the spin filter membrane. Solution PF6 is a low salt sterile elution 
buffer which causes DNA bound to the spin filter in the presence of high salt to be 
selectively released. The spin filter was discarded and the eluted DNA was stored at -20 
°C for use in downstream application. 
 
2.3.4 RNA extraction of stool (PowerMicrobiome™ RNA Isolation Kit) 
RNA was extracted from 100 mg of stool samples stored in RNAlater (Ambion) for 
analysis of the viable community using the PowerMicrobiome™ RNA Isolation Kit 
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(MoBio). Briefly, the stool sample was added to a glass bead tube containing 0.1 mm 
glass beads before 650 µL of PM1 and 6.5 µL of β- mercaptoethanol (β-ME) (Sigma-
Aldrich) was added prior to the sample fully thawing. Solution PM1 is a cell lysis buffer 
which contains SDS to break down fatty acids and lipids associated with the cell 
membrane and β-ME is a reducing agent that permanently denatures RNases. The glass 
bead tube was secured in a vortex adapter (MoBio) and vortexed at 13,000 × g for 10 
minutes to mechanically lyse microbial cells. The glass bead tube was centrifuged at 
13,000 × g for 1 minute and the supernatant (500-600 µL) was transferred to a sterile 
collection tube. A 150 µL aliquot of Solution PM2 was added, the mix vortexed for 5 
seconds and incubated at 4 °C for 5 minutes to precipitate humic substances, cell debris, 
and proteins. The suspension was centrifuged for 1 minute at 13,000 × g to separate the 
liquid phase containing RNA and DNA from the solid phase containing the protein and 
cellular debris. Avoiding the transfer of any of the pellet, up to 650 µL of supernatant 
was transferred to a sterile collection tube and 650 µL of solution PM3 and 650 µL of 
solution PM4 were added before briefly vortexing. Solution PM3 contains the binding 
salts for total nucleic acid purification and Solution PM4 is 100% ethanol facilitating 
DNA binding to the silica membrane of the spin filter. 650 µL of the supernatant mix 
was loaded onto a spin filter and centrifuged at 13,000 × g for 1 minute and the flow 
through discarded. This was repeated until all of the supernatant mix had passed 
through the spin filter leaving only total nucleic acids bound to the membrane. 650 µL 
of solution PM5, an isopropanol containing wash buffer to remove salts from the 
membrane, was then added to the spin filter and centrifuged for 1 minute at 13,000 × g 
for optimal performance of the on-column DNase step. The flow though was discarded 
and the spin filter centrifuged again for 1 minute at 13,000 × g to remove and residual 
wash. The spin filter was then transferred to a sterile collection tube and 50 µL of 
DNase I Solution was added, prepared by mixing 45 µL of Solution PM6 with 5 µL of 
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DNase I stock solution. The reaction was incubated for 15 minutes allowing the DNase 
in solution PM6 to soak into the membrane and digest the genomic DNA on the 
column. 400 µL of solution PM7 was added to the spin filter and centrifuged for 1 
minute at 13,000 × g and the flow through discarded. This inactivates the DNase 
enzyme and removes it from the column along with the digested DNA. 650 µL of 
solution PM5 was added to the spin filter and centrifuged for 1 minute at 13,000 × g and 
the flow through discarded. 650 µL of solution PM4 was added to the spin filter and 
centrifuged for 1 minute at 13,000 × g and the flow through discarded. These solutions 
are wash buffers and are reapplied to desalt the column before the elution step. The 
column was centrifuged again at 13,000 × g for 2 minutes to remove residual wash 
solution. The spin filter was then transferred to a sterile collection tube and 50 µL of 
solution PM8 was added to the centre of the membrane and allowed to sit for 1 minute 
before centrifugation for 1 minute at 13,000 × g to elute RNA from the spin filter 
membrane. Solution PM8 is RNase-Free water which causes RNA bound to the spin 
filter in the presence of high salt to be selectively released. The spin filter was discarded 
and the eluted RNA was subject to further DNA removal. 
 
2.3.4.1 Removal of contaminating DNA (TURBO DNase) 
The extracted RNA underwent additional DNase treatment using TURBO DNase 
(Ambion) to further remove contaminating DNA. 5 µL of 10X TURBO DNase buffer 
and 1 µL of TURBO DNase was added to the extracted RNA and the reaction mixed 
gently. The reaction was incubated at 37 °C for 20-30 minutes. 5 µL of resuspended 
DNase inactivation reagent was then added and the reaction mixed well. The reaction 
was incubated for 5 minutes at room temperature with occasional mixing to redisperse 
the DNase inactivation reagent. The reaction was centrifuged at 10,000 × g for 1.5 
minutes before the supernatant containing the RNA was transferred to a fresh tube. 
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2.3.5 Confirmation of successful extraction 
A 1% (w/v) agarose gel was prepared to confirm that nucleic acid extraction had been 
successful by electrophoresis of the extracted DNA or RNA. The agarose gel was 
submerged in 1× TAE and a 5 μL aliquot of nucleic acid was added to 1 μL of 6× 
bromophenol blue (Appendix 3), mixed by pipetting, and then loaded in to the wells of 
the agarose gel alongside a 5 μL of Hyperladder 1 (Bioline). In RNA gels a lane 
containing an ssRNA ladder (New England Biolabs) was also included. The 
electrophoresis tank was run at a constant current of 120 mA for 24 minutes. For DNA 
staining, 5 μL of SYBR Safe (Invitrogen; 10,000×) was added to the molten agarose 
prior to it setting. For RNA staining, following electrophoresis the gel was placed in a 
staining container with 10 μL of SYBR Gold (Invitrogen; 10,000×) added to 100 mL of 
1× TAE. The gel was stained in the dark for 30 minutes at room temperate with gentle 
agitation. Gels were viewed under U.V. light using the Gel Doc 2000 gel documentation 
system (Bio-Rad) and quantity one™ software (v4.1.1.) to confirm the presence of 
nucleic acid product of correct size by comparison with fragments from the standard 
ladder. Print outs were obtained using Mitsubishi Video copy processor (Model P91). 
 
2.4 Reverse transcription polymerase chain reaction (RT-PCR) 
 
A 10 μL aliquot of RNA was pipetted into a PCR tube along with 1 μL of dNTPs (New 
England Biolabs; 25 mM) and 1 μL of random hexamer primers (QIAGEN; 0.4 μg/μL) 
and the mixture was heated to 65 ºC for 5 minutes. The mixture was then chilled on ice 
and 4 μL of 5× first strand buffer, 2 μL of Dithiothreitol (0.1 M ) and 1 μL of 
RNaseOUT™ (Invitrogen; 40 U/μL) was added and mixed by pipette. The mixture was 
incubated at 25 ºC for 2 minutes and 1μL of Superscript™ II RT (200 U) was added and 
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mixed by pipette. The mixture was incubated in a c1000 Touch™ thermal cycler (Bio-
Rad) at 25 ºC for 10 minutes, 42 ºC for 50 minutes and 70 ºC for 15 minutes. The 
resulting cDNA can be used as a template in a conventional PCR reaction. 
 
2.5 Polymerase chain reaction (PCR) 
 
All PCR was carried out in a PCR Workstation™ (C.B.S. Scientific) to minimise the 
risk of contamination and the same C1000 Touch™ thermal cycler (Bio-Rad) was used 
to avoid potential variation in amplification by different instruments. 
 
2.5.1 Bacterial 16S rRNA amplification 
PCR amplification of the V3 region of the bacterial 16S rRNA gene was performed to 
analyse the bacterial community. The primers used were V3FC (5'- CGC CCG CCG 
CGC GCG GCG GGC GGG GCG GGG GCA CGG GGG GCC TAC GGG AGG CAG 
CAG -3') and V3R (5'- ATT ACC GCG GCT GCT GG -3') (Muyzer et al. 1993). In 
order to run the PCR product on DGGE the forward primer contains a 40 bp GC-clamp 
attached to the 5' end. The reaction was performed with 0.5 mM each primer 1x EX-Taq 
buffer, 0.3 mM each dNTP, 1 mM of MgCl2, 500 mg BSA, 1.25 U Ex-Taq (Takara) and 
1 μL of gDNA or cDNA template made up to 50 μL with sterile 18.2 MΩ H20. The 
cycling conditions used were an initial denaturation for 5 min at 95 ˚C followed by 20 
cycles of 95 °C for 1 min, 65 °C (-0.5 °C per cycle) for 1 min and 72 °C for 30 s 
followed by 15 cycles of 95 °C for 1 min, 55 °C for 1 min and 72 °C for 3 min with a 
final extension at 72 °C for 30 min. The 30 minute final extension step was included in 
all PCR cycles that were to be analysed by DGGE to prevent visualisation of spurious 
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double bands which would hinder accurate analysis of the gel images and make excision 
of bands difficult (Janse et al. 2004). 
 
2.5.2 Fungal 28S rRNA amplification 
PCR amplification of the fungal community was amplified using PCR primers specific 
for the 28S rRNA region of the fungal genome. The primers used were U1 (5'- GTG 
AAA TTG TTG AAA GGG AA -3') and U2C (5'- CGC CCG CCG CGC GCG GCG 
GGC GGG GCG GGG GCA CGG GGG GGA CTC CTT GGT CCG TGT T -3') 
(Sandhu et al. 1995). The reaction was performed with 0.5 μM each primer 1x Ex Taq 
buffer, 0.3 mM each dNTP, 1 mM of MgCl2, 500 mg BSA, 1.25 U Ex Taq (Takara) and 
1 μL of cDNA template, the reaction was made up to 50 μL with sterile 18.2 MΩ H20. 
The cycling conditions used were an initial denaturation for 5 min at 95 ˚C followed by 
10 cycles of 95 °C for 1 min, 60 °C (-1 °C per cycle) for 1 min and 72 °C for 30s 
followed by 25 cycles of 95 °C for 1 min, 50 °C for 1 min and 72 °C for 30 s with a 
final extension at 72 °C for 30 min (Janse et al. 2004). 
 
2.5.3 Confirmation of successful PCR 
A 1% (w/v) agarose gel was prepared to confirm that PCR had been successful by 
electrophoresis of the PCR product. Electrophoresis was carried out as described 
previously (2.3.4) according to the protocol for DNA. Successful PCR was confirmed 
by the presence of PCR product of correct size by comparison with fragments from 
Hyperladder 1 and the absence of a band in the negative control lane.  
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2.6 Denaturing gradient gel electrophoresis (DGGE) 
 
2.6.1 Culture of common stool isolates for ladder 
Common bacterial isolates from preterm infants were cultured in order to construct a 
“ladder” of known organisms that could be loaded onto a DGGE gel along with samples 
to allow alignment across multiple gels (Tourlomousis & Kemsley 2010). These species 
used in the ladder are shown in Table 2.1. Cultured isolates were obtained from fully 
identified wild type strains from the Freeman hospital. DNA was extracted using the 
DNeasy Blood and Tissue Kit and amplified as described above. 
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Table 2.1 - Organisms used to generate DGGE ladder 
Bacterial species
a
 Fungal species
b
 
Pseudomonas aeruginosa Candida parapsilosis 
Serratia marcescens Candida dubliniensis 
Citrobacter freundii Candida albicans 
Staphylococcus epidermidis Candida glabrata 
Clostridium perfringens Aspergillus fumigatus 
Bacteroides fragilis Exophiala dermatitidis 
Acinetobacter baumannii Scedosporium apiospermum 
a
Ladder used only for alignment of multiple gels. Sequencing of bands was carried out 
for identification 
b
Ladder used for alignment and identification 
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2.6.2 Gel preparation 
The DCode™ Universal Mutation Detection System (Bio-Rad) was used to cast and run 
the DGGE gels. Glass plates were cleaned prior to use using 100% ethanol before use to 
remove any residue and static that may interfere with the gel casting. A thin layer of 
silicon grease was applied to the 1mm spacers and the sponge in the casting stand to 
prevent leakage of the denaturant during casting and running (Brinkhoff & Hannen 
2001). With the spacers placed on either side of the vertical edges between the large (20 
cm x 16 cm) and small (16 cm x 16 cm) glass plates, the alignment card was inserted 
between the glass plates and the sandwich clamps were tightened to each side of the 
glass plates. The alignment card was then removed and the gel cast was securely fixed 
in the casting stand ensuring the base of the glass plates was submerged in the sponge. 
For optimal results, only the front gel was ran and therefore a balance plate was setup as 
above without the spacers to prevent the buffer leaking from the upper chamber during 
electrophoresis. 
For the casting of the gel, a 19 gauge needle fitted with a tube and Y-fitting was 
attached to the centre of the plates. Two plastic 50 mL tubes, labelled high and low, 
were stood in a rack and the denaturant solutions described below were added to the 
tubes, the lids secured, and inverted to mix. Bacterial DGGE analysis utilised a 
denaturant gradient of 34 – 55% denaturant, whereas fungal DGGE employed a 
denaturant gradient of 40 – 60% denaturant (with 100% denaturant corresponding to 7 
mol l
-1
 urea plus 40% v/v formamide). In all cases 12% polyacrylamide gels were used.  
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Reagent High Low 
DCODE dye (Appendix 3) 100 μL 0 μL 
Denaturing solution (Appendix 4) 25 mL 25 mL 
APS (10% w/v) 216 μL 216 μL 
TEMED 21.6 μL 21.6 μL 
 
The high and low denaturing solutions were each drawn up into a separate 25 mL 
syringe with rubber tubing. Each syringe was then attached to the Y-fitting before being 
secured in a Model 475 gradient former (Bio-Rad) and the cam wheel turned to dispense 
the solutions into the gel cast. Once the solutions had been dispensed into the cast the 
needle was removed and a well comb was placed the two glass plates, ensuring no 
bubbles existed in the gel. The gel was left for a minimum of 1.5 hours to polymerise. 
 
2.6.3 Running conditions 
To make up the 1× TAE buffer used in the DGGE, 140 mL of 50× TAE (Appendix 2) in 
7 L of distilled water was mixed in the electrophoresis tank. The control module was 
placed on the electrophoresis tank, the thermostat was set to heat the buffer to 60 ºC and 
the stirrer was switched on. Following polymerisation, the gel was removed from the 
casting stand and attached to the core in the front orientation and the balance plate was 
attached to the core at the rear. Once the buffer had come to temperature, the control 
module was removed and the core was lowered into the buffer chamber in the correct 
orientation (red mark on the right hand side) and then the upper chamber was filled with 
the heated buffer. A 15 μL aliquot of sample was mixed with an equal volume of 2x 
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DGGE loading buffer (Appendix 3) and loaded onto gel. The control module was 
replaced and once the temperature had returned to 60 ºC the power pack was set to 200 
V for 4.5 hours for bacterial community analysis or 70 V for 17 hours for fungal 
community analysis. 
 
2.6.4 Staining 
The core was removed from the buffer tank and the cast disassembled. A 25 μL aliquot 
of SYBR gold (Invitrogen, 10,000x) was diluted in 250 mL of 1x TAE in a staining 
container. The gel was removed from the glass plates and submerged in the staining 
solution in the dark for 30 minutes at room temperate with gentle agitation. The gel was 
de-stained in dH2O to remove any excess stain and viewed under U.V. light using the 
Gel Doc 2000 gel documentation system (Bio-Rad) and quantity one™ software 
(v4.1.1.). Print outs were obtained using Mitsubishi Video copy processor (Model P91). 
 
2.7 Sequencing of excised DGGE bands 
 
2.7.1 Gel storage 
Following visualisation, gels were stored for retrospective excision of bands to obtain 
sequence information. Excess moisture was removed before the gel was placed between 
two A4 sheets of acetate, which was then wrapped in cling film. The gel was then 
placed in a labelled A4 plastic sleeve and stored in a folder at -80 °C. 
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2.7.2 Band excision 
Bands of interest were excised from either stored or freshly re-ran DGGE gels. The 
desired stored gel was removed from the -80 °C freezer and carefully transferred from 
the protective acetate to the Gel Doc platform before it defrosted. Fresh gels were 
simply placed on the Gel Doc platform following staining. Whilst exposed to U.V. light, 
bands of interest were excised from the gels using a sterile blue (1 mL) pipette tip and 
placed in a sterile 1.5 mL microfuge tube. The bands were immersed in 10 μL of 18.2 
MΩ H20 and vortexed for 1 minute. The tubes were stored at 4 ºC overnight to allow 
DNA to elute from the gel.  
  
2.7.3 Amplification and clean-up of excised band 
Following overnight incubation, the tubes containing the excised band were vortexed 
and centrifuged before the full 10 μL aliquot of the eluate provided a template for PCR. 
The PCR was carried out as above only the primer containing the 40 bp GC-clamp was 
replaced by the unclamped primer. Once confirmation of successful PCR was carried 
out, as above, the PCR product was subject to ExoSAP-IT PCR clean-up (Affymetrix). 
Briefly, 5 μL of PCR product was mixed with 2 μL of ExoSAP-IT and incubated in a 
c1000 Touch™ thermal cycler (Bio-Rad) at 37 °C for 15 minutes to degrade unused 
primers and nucleotides. The reaction was then heated to 80 °C for 15 minutes to 
inactivate the ExoSAP-IT. 
 
2.7.4 Preparation of E. coli chemically competent cells 
A sterile 30 mL glass universal containing 10 mL LB media was inoculated with a 
single fresh colony of TOP10 E. coli cells (Invitogen). This culture was incubated for 
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16 h at 37°C with orbital shaking at 200 rpm for 2 – 3 hours. When the OD600 reached 
0.35 – 0.4 nm, the cells were then transferred aseptically into two sterile ice cold 
universals and incubated on ice for 10 minutes. The cells were then centrifuged for 10 
min at 2,700 x g, 4 °C. The supernatant was discarded and the each of the pelleted cells 
were resuspended in 7.5 mL sterile ice cold MgCl2 by gentle mixing. The cells were 
pelleted again by centrifugation for 10 min at 2,700 x g, 4°C. The supernatant was 
discarded and each of the cell pellets were finally resuspended in 0.5 mL of sterilised 
ice cold CaCl2 and incubated on ice for at least 1.5 h to become competent. For long 
term storage the appropriate volume of sterile 50% (v/v) glycerol was added to give a 
final concentration of 15% (v/v). Since transformation required the cells at 50 µL per 
reaction, 65 µL of cells (in 50% (v/v) glycerol at a final concentration of 15% (v/v)) was 
aliquoted into individual sterilised 1.5 mL microcentrifuge tubes and stored at -80°C for 
future use. The full 65 µL aliquot was used per transformation reaction. 
 
2.7.5 Ligation 
The ExoSAP-IT treated PCR product was cloned using the pGEM-T® Easy Vector and 
the 2X Rapid Ligation Buffer (Promega). Tubes were centrifuged to collect the contents 
at the bottom. Ligation reactions were performed as set out according to Table 2.2. The 
ligation reaction was mixed by pipetting and incubated overnight at 4 °C to for 
maximum number of transformants. 
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Table 2.2 – Ligation reaction 
Reaction Component Standard 
Reaction 
Positive 
Control 
2X Rapid Ligation Buffer,  5 μL 5 μL 
pGEM®-T Easy Vector (50 ng) 1 μL 1 μL 
PCR product 3 μL   - 
Control Insert DNA   - 2 μL 
T4 DNA Ligase (3 Weiss units/μL) 1 μL 1 μL 
18.2 MΩ H20   - 1 μL 
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2.7.6 Transformation 
Aliquots of previously prepared TOP10 competent cells were removed from storage (-
80 °C) and thawed on ice for approximately 5 minutes. Meanwhile, 2 μL of ligation 
reaction were added to a sterile 1.5 mL microfuge tube on ice. The 65 μL aliquot of 
TOP10 competent cells were carefully added to the ligation reaction and mixed by 
gentle flicking. The tubes were incubated on ice for 20 minutes and then heat-shocked 
at 42 °C for 50 seconds and immediately returned to ice for a further 2 minutes. 950 μL 
of room temperature SOC medium (Appendix 5) was then added and the tubes were 
incubated for 1.5 hours at 37 °C in an orbital incubator with shaking at 150 rpm. 
Duplicate LB/ampicillin/IPTG/X-Gal plates (Appendix 6) were warmed in an incubator 
at 37 °C for 30 minutes prior to spreading a lawn from 100 μL of the ligation reaction 
onto each of the two plates which were incubated at 37 °C overnight (16-24 hours).  
 
2.7.7 Inoculation and confirmation of successful incorporation of insert 
White colonies were used as a marker for successful incorporation of the PCR product 
into the plasmid. The majority of a white colony was inoculated into an LB/ampicillin 
broth (Appendix 6) which was incubated at 37 °C overnight. PCR amplification was 
performed to confirm successful incorporation of the insert. The primers used were M13 
Forward (5'- CGC CAG GGT TTT CCC AGT CAC GAC -3') and M13 Reverse (5'- 
TCA CAC AGG AAA CAG CTA TGA C -3'). An initial PCR was set up containing 0.5 
mM each primer 1x EX-Taq buffer, 0.3 mM each dNTP, 1 mM of MgCl2, 500 mg BSA, 
made up to 49.75 μL with sterile 18.2 MΩ H20 in the absence of template DNA and 
1.25 U Ex-Taq (Takara). Using a sterile pipette tip, the remainder of the white colony 
was transferred to the PCR reaction before the Ex-Taq was added and the PCR was 
initiated. The cycling conditions used were an initial denaturation for 5 min at 95 ˚C 
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followed by 35 cycles of 95 °C for 30 s, 65 °C for 30 s and 72 °C for 3 min and 72 °C 
for 3 min with a final extension at 72 °C for 10 min. An agarose gel was performed as 
previously described, successful visualisation of a band corresponding to the correct 
fragment length was used to confirm successful incorporation of the insert. 
 
2.7.8 Plasmid DNA purification (PureYield™ Plasmid Miniprep kit) 
Plasmid DNA was purified using the PureYield™ Plasmid Miniprep kit (Promega) 
alternative protocol for larger culture volumes. Prior to beginning the experiment the 
cell lysis buffer was warmed to 37 ˚C and inverted to dissolve any precipitate. Briefly, 
1.5 mL of the LB/ampicillin overnight bacterial culture was added to a 2 mL microfuge 
tube and centrifuged at 13,000 × g for 30 seconds and the supernatant discarded, this 
step was repeated once to process a total volume of 3 mL. The cell pellet was 
resuspended in 600 μL of sterile 18.2 MΩ H20 and 100 μL of cell lysis buffer was added 
before the tube was inverted 6 times until the solution changed from opaque to clear 
blue. The cell lysis buffer contains SDS to lyse cell membrane and sodium hydroxide 
which breaks down the cell wall but also causes DNA to linearise by breaking hydrogen 
bonds. Within 2 minutes, 350 μL of cold neutralization solution was added and the 
solution was mixed by inversion causing a precipitate to form. The neutralisation 
solution contains potassium acetate which reduces the alkalinity of the solution causing 
renaturation of the plasmid DNA but leaving gDNA linearised allowing it to be 
separated from the plasmid DNA by centrifugation. The solution was centrifuged at 
13,000 × g for 3 minutes to pellet the precipitate and the supernatant (~900 μL) was 
transferred to a PureYield™ Mini-column. The column was centrifuged at 13,000 × g 
for 15 seconds and the flow through discarded. 200 μL of Endotoxin removal wash was 
added to the column and centrifuged for 15 seconds, followed by addition of 400 μL of 
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column wash solution to the column and a 30 second centrifugation at 13,000 × g. The 
column was transferred to a 1.5 mL microcentrifuge tube and 30 μL of elution buffer 
was added to the column membrane which was incubated at room temperature for 1 
minute. The column was centrifuged at 13,000 × g for 15 seconds and the eluted DNA 
was stored at -20 ˚C. 
 
2.7.9 DNA quantification (NanoDrop 1000) 
For custom DNA sequencing (Eurofins MWG Operon), plasmid DNA is required in a 
concentration of 50 - 100 ng/μL in a total volume of 15 μL. To quantify the plasmid 
DNA a NanoDrop 1000 Spectrophotometer (Thermo Scientific) was used. Briefly, 1 μL 
of dH2O was applied to the pedestal, followed by 1 μL of the PureYield™ Plasmid 
Miniprep kit elution buffer to calibrate the instrument. The purified plasmid DNA was 
mixed and 1 μL was applied to the pedestal and readings were measured in triplicate. 
An average of the triplicates was calculated and the concentration adjusted as 
appropriate for sequencing. Samples were either diluted in sterile 18.2 MΩ H20 or 
concentrated using a RVC 2-18 rotational vacuum concentrator (Christ) at 60 °C. 
 
2.7.10 Sequencing reaction 
Sequencing was carried out commercially by Eurofins MWG Operon using the Value 
Read service based on Sanger sequencing methods (Sanger et al. 1977). Sequencing 
was performed using the ABI 3730 XL capillary sequencer with BigDye v.3.1 dye-
terminator chemistry as per manufacturer’s instructions (Applied Biosystems). Briefly, 
the M13 reverse primer bound to the complementary DNA strand was extended linearly 
until by chance the corresponding dideoxy terminator nucleotide was incorporated and 
70 
 
thus the extension of the fragment was terminated. Each of the four dideoxy terminators 
was tagged with a different fluorescent dye which fluoresced upon illumination at 
specific wavelengths and produced a chromatogram from which sequences were 
deduced. 
 
2.7.11 Database mining for homologous sequences (NCBI Blastn) 
The NCBI Vec Screen tool was employed to identify segments of a nucleic acid 
sequence that may be of vector origin, these sequences were subsequently removed. The 
remaining sequence was then input into the Nucleotide Basic Local Alignment Search 
Tool (BLASTn) in FASTA format and the nucleotide collection was used for 
comparison.  
 
2.8 Quantitative PCR (qPCR) 
 
2.8.1 Preparation of standard curve 
In order to obtain a control strain to prepare the qPCR standard curve, a Lactobacillus 
sp. was isolated by culture from patient 13 (sample 340082K) and DNA was extracted 
using the DNeasy Blood and Tissue Kit as described above. Different primer sets which 
both encompass the V3 region of the 16S rRNA gene were used to quantify total 
bacterial load and genus specific Lactobacilli load (Table 2.3). To generate the standard 
for the total bacterial analysis, conventional end point PCR was carried out on the 
extracted DNA using Buffer I (NEB), 0.5 μM each primer, 0.2 mM each dNTP, 1 μL 
DNA template made up to 49.5 μL with sterile 18.2 MΩ H2O. After an initial 
denaturation step of 95 °C for 5 minutes the thermocycler was held at 80 °C while 2.5 
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units of Taq DNA polymerase (NEB) was added to each reaction giving a total volume 
of 50 μL per reaction. PCR was resumed with 35 cycles of 95 °C for 30 s, 65 °C for 30 
s, and 72 °C for 30 s, followed by a final extension step of 72 °C for 10 min. To 
generate the standard for the Lactobacillus genus specific analysis, conventional end 
point PCR was carried out on the extracted DNA using Buffer I (NEB), 0.5 μM each 
primer, 0.2 mM each dNTP, 1.5 mM MgCl2, 1 μL DNA template made up to 49.5 μL 
with sterile 18.2 MΩ H2O. After an initial denaturation step of 94 °C for 5 minutes the 
thermocycler was held at 80 °C while 2.5 units of Taq DNA polymerase (NEB) was 
added to each reaction giving a total volume of 50 μL per reaction. PCR was resumed 
with 35 cycles of 95 °C for 15 s, 62 °C for 1 min, and 72 °C for 1 min, followed by a 
final extension step of 72 °C for 10 min (Tamrakar et al. 2007). Successful PCR was 
confirmed by 1% agarose gel electrophoresis as described above. The PCR products 
were cleaned to remove unincorporated dNTPs and primers using Exo-SAP-IT and 
cloned using the p-GEMT easy vector cloning kit before purification of the plasmid 
using the PureYield™ Plasmid Miniprep kit as described above. The purified plasmids 
were then pooled into a single microcentrifuge tube and the plasmid DNA was 
quantified using the NanoDrop 1000. 
To achieve absolute quantification of the total or genus specific bacterial load a standard 
curve with 10 fold dilutions was generated. This requires the calculation of plasmid 
DNA which is needed to generate the standards. Firstly, the size of the plasmid DNA in 
base pairs (bp) was calculated based on the combined length of the PCR amplicon and 
the plasmid (p-GEMT easy vector is 3015 bp). The mass of the plasmid was then 
calculated by multiplying the size of the plasmid (bp) by the average weight of one bp 
which is 1.096 × 10
-21
 (g/bp). The average weight of one bp was calculated by dividing 
the average molecular weight of a double stranded DNA molecule (660 g) by 
Avagadro’s number (6.023 × 10-23). The mass of plasmid containing the copy number 
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needed to achieve a suitable standard curve was then calculated based on a standard 
curve quantifying between 3 × 10
6 
and 30 copies/g in 10-fold dilutions. Therefore, to 
calculate what mass of plasmid will contain the copy number of interest, the previously 
calculated mass of the plasmid was multiplied by the desired copy number for the 
standard curve. The figure produced by this calculation could then be divided by the 
required by the volume in the final PCR reaction mix to give the final concentration of 
the plasmid DNA (g/µL). It was then possible to prepare a standard curve by 
rearranging the formula M1V1 = M2V2 to V1 = M2V2 / M1. Where V1 is the final volume 
required to achieve the concentration (unknown), M2 is the concentration of the stock 
plasmid, V2 is the volume in which the plasmid will be diluted, and M1 is the final 
concentration of the plasmid which was calculated in the previous step. 
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Table 2.3 – Primers used in qPCR assay 
Primer Sequence (5'-3') Target Reference 
Eub 338 ACTCCTACGGGAGGCAGCAG All bacteria J Lane, 1991 
Eub 518 ATTACCGCGGCTGCTGG All bacteria Muyzer et al., 1993 
Lacto F TGGAAACAGRTGCTAATACCG All lactobacilli Byun et al., 2004 
Lacto R GTCCATTGTGGAAGATTCCC All lactobacilli Byun et al., 2004 
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2.8.2 Reaction setup 
The reaction mix was prepared in a PCR Workstation and pipette filter tips (Fisher) and 
pipettes designated solely for qPCR setup were used to limit the potential for 
contamination. No template controls (NTCs) were included in every reaction to check 
for contamination of all the reagents, plastics and pipettes used in preparing the 
reaction. Each reaction was performed in triplicate to ensure accuracy. The qPCR 
protocol was based on the previously described method (Baxter & Cummings 2008). 
The unknown DNA samples were firstly diluted 1:20. Dilutions were performed in 
microcentrifuge tubes using sterile 18.2 MΩ PCR grade water as the diluent. These 
diluted unknown samples and an aliquot of the plasmid DNA stock was heated at 95 °C 
for 10 minutes to ensure any tertiary structures which may have formed had been 
eliminated so that efficient amplification was possible. The plasmid DNA was then used 
to prepare the serial dilutions as calculated previously. The unknown samples (diluted 
1:20) were further diluted 1:5 and the equivalent volume of sterile 18.2 MΩ water was 
used as the NTC. Once the dilutions of the standard curve and unknown samples was 
complete and the NTC was prepared, the reaction mix was setup ensuring that 
ABsolute™ QPCR SYBR® mix (Thermo Scientific) had limited exposure to light to 
prevent degradation. The final reaction mix contained 1x ABsolute™ QPCR SYBR® 
Green Mix (Thermo-Start™ DNA Polymerase, 3 mM MgCl2) , 0.35 mM each primer, 
12.5 μg BSA and 5 μl of DNA in a final volume of 25 μL.  
qPCR was carried out on the RotorGene RG-3000 instrumentation (Corbett life 
sciences). For total bacterial analysis, the cycling conditions used were an initial 
enzyme activation step at 95 °C for 15 min, then 50 cycles of 95 °C 10 seconds, 65°C 
for 15 seconds and extension at 72 °C for 20 seconds. For Lactobacilli genera specific 
analysis, the cycling conditions used were an initial enzyme activation step at 95 °C for 
15 min, then 50 cycles of 95 °C 15 seconds, 62°C for 1 minute and extension at 72 °C 
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for 20 seconds. Target copy numbers for each reaction were calculated from the 
standard curve and were used to ascertain the number of copies per g of stool then log 
transformed. Standard deviation was determined (by the Rotor-Gene 6 software) on the 
replicate threshold cycle (CT) value and reactions repeated if the deviation was above 
0.4. Samples were considered to be below reasonable limits of detection if the CT value 
was above 30 cycles (Karlen et al. 2007). 
 
2.9 Next generation sequencing 
 
Data for the initial technique comparison study (chapter 3) and twin study (Chapter 6) 
was generated using the 454 pyrosequencing (Roche) platform. Data for the large 
disease matched control study (chapter 7) was generated using the benchtop MiSeq 
(Illumina) platform. 
 
2.9.1 454 Pyrosequencing 
454 pyrosequencing was carried out commercially by the Research and Testing 
Laboratory (RTL; USA) using shipped extracted DNA samples. The DNA sequencing 
was performed on the 454 GS FLX Titanium Sequencing System (Roche) using 
previously described methods (Dowd et al. 2008). Two different primer sets were used 
in the 454 pyrosequencing. Firstly, for the initial technique comparison (Chapter 3), a 
portion of 16S RNA (position 341 to 907; E. coli numbering) was amplified using the 
primer set 341F (5’-CCTACGGGAGGCAGCAG-3’) (Muyzer et al. 1993) and 907R 
(5’-CCGTCAATTCCTTTGAGTTT-3’) (Muyzer et al. 1995). For the twin study 
(Chapter 6), 454 pyrosequencing was carried out using the bifidobacteria-optimised 
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primer set (position 357 to 926; E. coli numbering) 357F (5'-
CTCCTACGGGAGGCAGCAGAN-3') and 926Rb (5'-CCGTCAATTYMTTTRAGT-
3') (Sim et al. 2012). 
 
2.9.2 MiSeq 
The 16S sequencing on the MiSeq platform was carried out in house based on the 
‘Schloss wet-lab MiSeq SOP’ (available at - http://www.mothur.org/wiki/MiSeq_SOP). 
Paired end indexed reads were used to multiplex 192 samples per run (188 samples, 2 
positive, and 2 negative controls). Briefly, extracted DNA from the samples was aliquot 
into 96 well plates and the last two wells left empty for controls. In a new 96 well plate, 
17 μL of Accuprime Pfx Supermix (Life Technologies Ltd.) was dispensed into each 
well, before 1 μL of the DNA template and 2 μL of each paired set of index primers was 
transferred to the corresponding well. 1 μL of PCR grade dH2O was added to the 
negative control well and 1 μL of a mock community was added to the positive control 
well on each plate. Plates were vortexed briefly and span down before being placed in 
the thermocycler (BioRad CFX96 Touch). PCR was carried out using the following 
cycling conditions; initial step at 95 °C for 2 min, then 30 cycles of 95 °C 20 seconds, 
55°C for 15 seconds, extension at 72 °C for 5 min, and a final extension at 72 °C for 10 
min. Successful PCR was confirmed using an agarose gel (1%) on a subset of 12 
samples per plate. 
Normalisation was performed by transferring 18 μL of PCR product to the 
corresponding well on a normalisation plate. 18 μL of binding buffer was then 
transferred and the contents mixed by pipetting and vortexing before being spun down. 
Plates were incubated at room temperature for 1 hour. Being careful not to touch the 
sides of the wells, liquid was removed and 50 μL wash buffer was added and briefly 
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mixed by pipetting and removed immediately removed leaving no residue. 20 μL of 
elution buffer was then added and mixed by pipetting and vortex before being spun 
down. Following incubation at room temperate for 5 minutes 5 μL from each well was 
pooled and the plates frozen for later use.  
Library quality control was carried out using a Bioanalyser (Agilent bioanalyser 2100) 
and qPCR using KAPA SYBR FAST qPCR Master Mix (Anachem Ltd.). The pooled 
library underwent serial dilutions to generate the following dilutions; 1:1, 1:10, 1:1000, 
1:2000, and 1:4000. For the Bioanalyser, the gel dye mix, ladder, and 1 μL of the 1:1 
and 1:10 dilutions were loaded into the necessary wells of a high sensitivity chip. For 
Kapa qPCR library quantification reactions were carried out in a 10 μL reaction volume 
with 6 μL of master mix and 4 μL of standards and library dilutions, in triplicate. qPCR 
was carried out using the following cycling conditions; initial activation step at 95 °C 
for 5 min, then 35 cycles of denaturation at 95 °C for 30 seconds and annealing at 60°C 
for 45 seconds. From these results a further dilution was carried out on the median pool 
dilution amongst the standards, as all pools were normalised to the lowest dilution pool 
selected. 
For the sequencing a 500 cycle reagent cartridge and all reagents and samples were 
thawed prior to setup. 3.4 μL of read 1 sequencing primers was placed in well 12, 3.4 
μL of the index primer was placed into well 13, and 3.4 μL of read 2 sequencing 
primers was placed in well 14. Sampled were prepared by mixing 10 μL of library and 
10 μL of 0.2 NaOH and the PhiX spike was prepared by mixing 2 μL of PhiX, 3 μL 
PCR grade H2O, and 5 μL of NaOH. Following 5 min incubation, samples and PhiX 
were made up to 1 ml with HT1 and then HT1 was used to dilute the library and PhiX to 
10 pM. A 5% PhiX run was used so 950 μL of 3.5 pM library and 50 μL PhiX were 
mixed in a tube and 600 μL of this mixture was loaded into well 17. The flow cell was 
rinsed with Milli-Q water, wiped with 80% ethanol, and carefully dried prior to 
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placement within the MiSeq instrument. The cartridge, flow cell, and PR2 bottle were 
then loaded and on the on screen instructions followed. 
 
2.9.3 Processing the raw sequencing reads  
Raw data generated using next generation sequencing technology was bioinformatically 
processed to reduce the error rate by trimming the primer and barcode sequences and 
removing reads with a poor quality score. Two pipelines, Mothur and quantitative 
insights into microbial ecology (QIIME), were utilised in the processing of raw 
sequence reads. 
 
2.9.2.1 Mothur 
For the initial technique comparison study (chapter 3) the raw 454 pyrosequencing .sff 
files were filtered using Mothur version 1.22 (Schloss 2009). The Schloss lab standard 
operating procedure (SOP) for 454 data was followed with the following criteria: 1) 
maximum of 1 mismatch to barcode tags; 2) no ambiguous bases; 3) maximum of 2 
mismatches to primer sequence; 4) average quality score of >35 in a sliding window of 
100 bp. Detection of potentially chimeric sequences was performed using 
Chimera.uchime and chimeric sequences were removed from downstream analysis. 
Following filtering of reads, taxonomic classification information was generated via the 
Silva database (Schloss et al. 2011). 
For the large disease control matched study (chapter 7) the fastq files generated were 
processed using Mothur version 1.31.2 (Schloss 2009). The Schloss MiSeq SOP was 
followed according to the following criteria: 1) no ambiguous bases; 2) maximum 
length of 275 bp; 3) maximum of 8 homopolymers; 4) within 2 mismatches of the 
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sequence being considered. Detection of potentially chimeric sequences was performed 
using Chimera.uchime and chimeric sequences were removed from downstream 
analysis. Alignment was generated via the Silva database (Schloss et al. 2011). A cutoff 
of 70 was applied to assign sequences to the trainset9_032012. In total 44,515,418 reads 
passed processing and were included in the subsequent analysis for Chapter 7. 
 
2.9.2.2 QIIME 
For the twin study (Chapter 6), the raw sequencing reads were quality filtered in QIIME 
(version 1.6.0) (Caporaso et al. 2010) using the split-library.py script with the following 
criteria: 1) exact matches to barcode tags; 2) no ambiguous bases; 3) maximum of 5 
mismatches to primer sequence; 4) read-lengths between 200-700 base pairs (bp); 5) 
average quality score of >25 in a sliding window of 50 bp. Remaining high quality 
sequences were clustered into operational taxonomic units (OTUs) at 97% similarity 
using UCLUST (Edgar 2010). Representative sequences for each OTU were aligned 
using PyNAST (Caporaso et al. 2010) and taxonomic identities were assigned using 
RDP-classifier (version 2.2) (Wang et al. 2007) with 50% as confidence value 
threshold. Detection of potentially chimeric sequences was performed using 
ChimeraSlayer (Haas et al. 2011) and chimeric sequences were removed from 
downstream analysis prior to tree building using FastTree (Price et al. 2010). Sequences 
were deposited in MG-RAST under the accession numbers 4516545.3 - 4516585.3 
(twin study: Chapter 6). 
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2.10 Analysis of data 
 
2.10.1 DGGE gel processing (TotalLab Phoretix 1D) 
Images captured using quantity one™ software (v4.1.1.) were exported in tagged image 
file format (.TIFF) at 276 dots per inch (DPI) into a new experiment folder. The lanes of 
the gels were created using the automatic lane creation function and the frames 
manually adjusted so that all bands were central in the lanes. The background from the 
lanes was subtracted using a rolling ball method with a radius of 100 pixels. The band 
detection setting was applied to the gels using a minimum slope of 100, noise reduction 
of 4, and a %max peak of 2, then bands were added/removed and the band width 
adjusted manually. As stated previously, a ladder of known organisms was loaded to the 
outside and middle lanes on each DGGE gel in the experiment so that successful gel 
alignment could be achieved (Tourlomousis & Kemsley 2010). Bands from the DGGE 
ladder were assigned standard retention factor (Rf) values based upon the distance they 
had migrated through the gel, each corresponding band from all gels in the experiment 
was given the same value. A minimum of five bands per standard has been suggested 
for accurate interpolation of multiple gels which was exceeded for both the bacterial (6 
bands) and fungal (7 bands) analysis (Tourlomousis & Kemsley 2010). 
A new database was created in Phoretix 1D Pro based on the analysed gels. The 
successful alignment of the gels was confirmed by matching all lanes in the database 
then creating a dendrogram based on the Dice coefficient. Alignment of multiple gels 
was deemed successful if the ladders clustered together (Appendix 6). An OTU matrix 
was then created by the software using the Rf values of all bands and the relative 
intensities, which was exported to Microsoft Excel 2010 to be used for further statistical 
analysis.  
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2.10.2 NGS basic data analysis 
 
2.10.2.1 Conversion of biom table 
The convert_biom.py command was used to convert the biom formatted OTU table to 
the classic OTU matix. This command creates a tab delimitated text file which was 
opened in Microsoft Excel 2010 and saved in the Excel workbook format for 
downstream data analysis. 
 
2.10.2.2 Rarefaction 
The alpha_diversity.py command was used to generate the rarefaction curves based on 
the ‘Observed Species’ metric. This is the count of unique OTUs found in each sample. 
The rarefaction curves were plotted in Microsoft Excel 2010. The number of sequences, 
sample coverage, and number of OTUs was calculated for each sample using the 
summary.single command in Mothur. 
 
2.10.2.3 Bar chart 
The summarize_taxa_through_plots.py command was used to group the OTU 
sequences by taxonomic assignment. The html file was used to determine which 
taxonomic level (from Kingdom to Genus) was the most informative and this was then 
plotted in Microsoft Excel 2010. 
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2.10.2.4 Core Microbiome 
The compute_core_microbiome.py was used to generate text files ranging from 50% to 
100% (at 5% increments), to show which OTUs were present in the particular 
percentage across all samples. A cut off a less than 85% was implemented (Seekatz et 
al. 2013). 
 
2.10.2.5 Phylogenetic trees (MEGAN) 
Phylogenetic trees to explore the distribution of OTUs were generated using the 
MEtaGenome Analyser (MEGAN) (version 4.70.4). Biom tables generated during the 
raw sequencing processing were used as the input files. 
 
2.10.3 Diversity indices 
Diversity indices were calculated for data generated using all techniques to examine the 
structure of the microbial communities present in the preterm gut using PAST (Hammer 
& Harper 2001). Species richness (R) was calculated based on the total number of 
different species present per sample. For culture this was based on the number of 
different isolates, DGGE was based on the total number of distinct bands, and NGS was 
based on the number of unique OTUs. For DGGE and NGS, where abundance 
information was also obtained, Shannon diversity and evenness were also calculated. 
The Shannon diversity index (H’) was calculated using the formula;  
 
H’ = -Σ (pilog[pi]) 
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The symbol pi is the relative intensity of each species. The log of the relative intensity 
was multiplied by the relative intensity for every species in all of the samples 
(pilog[pi]). The sum of these values for each lane was taken and multiplied by -1 (-Σ) 
which gives the Shannon diversity of the sample. Species evenness (E) was calculated 
using by dividing H’ by the log of R. Dominance (D) was calculated based on 
D=sum((ni/n)
2
) where ni is number of individuals of taxon i. Dominance scores range 
from 0 (all taxa are equally present) to 1 (one taxon dominates the community 
completely). 
 
2.10.4 Similarity and distance indices 
The Bray-Curtis indices (Bray & Curtis 1957) was used to compared relatedness 
between communities using PAST (Hammer & Harper 2001). This indices calculates a 
relatedness score based on the abundance of OTUs in the samples which ranges from 0 
(compleltey different communities) to 1 (identical communities). 
 
2.10.5 Multivariate analysis 
OTU matrix files were generated in Microsoft Excel for data generated using all techniques. 
The OTU matrix for culture data contained the identity of all cultured isolates and either a 1 
or 0 to represent presence or absence, respectively. For DGGE and NGS data, where 
abundance data was obtained, the OTU matrix contained the normalised abundance of each 
band (for DGGE) or OTU (for NGS). Unless otherwise stated, for the DGGE analysis, all 
bands were included based on the Rf value and where possible the actual identity of the 
band replaced the Rf value. 
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2.10.5.1 Canoco 
Canoco version 4.5.1 (Braak 1986) was chiefly used for constrained ordination analysis 
and principal coordinate analysis (PCoA), with images produced using Canodraw (v4.14). 
Firstly, the OTU matrices were copied from the Microsoft Excel spreadsheet to the 
clipboard. The information from the clipboard was input into Canoco using WCanoImp 
(4.5.2.0) to convert the data from the species matrices in to a format compatible with 
Canoco. 
For constrained ordination analysis, discrete patient variables were assigned positive (1) or 
negative (0) values and the continuous patient variables were not manipulated before input 
into the spreadsheet. The OTU matrices were first analysed by detrended correspondence 
analysis (DCA) using normalised relative intensities followed by either redundancy 
discriminate analysis (RDA) or canonical correspondence analysis (CCA) in combination 
with Monte Carlo permutation testing under full model (499 permutations) depending on 
the DCA axis length (<3.5 RDA; >3.5 CCA). The results from the Monte Carlo 
permutations were deemed statistically significant if the P-value was < 0.05. Discrete 
variables were assigned as nominal variables to distinguish between discrete and continuous 
variables, with discrete variables assigned a centroid and continuous variables represented 
by an arrow.  
PCoA was used to explore the presence/absence relationship between the culture profiles. 
The Canoco formatted OTU matrix was uploaded into the PrCoord (1.0) program and the 
Bray-Curtis distance measure was selected. The file produced by PrCoord was then 
visualised using the principal component analysis (PCA) method with scaling of scores 
focused on inter-sample distances, no post-transformation of species scores and centring by 
species only. Plots were manually edited within Canodraw to aid clarity according to 
important variables. 
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2.10.5.2 SIMCA 
OTU matrices generated from both DGGE and NGS data also underwent multivariate 
partial least squares discriminant analysis (PLS-DA) using SIMCA 13.0 (Eriksson et al. 
2006). OUT matrices were uploaded into SIMCA and each sample in the analysis was 
assigned to a specific group, with the scores of the model visualised in a score plot. The 
loadings plot was used to determine which OTUs were associated with each of the 
variables based on the assigned grouping. To check that data was adhering to 
multivariate normalities, Hotelling’s T2 tolerance limits were calculated and set at 0.95. 
Plots were edited within Windows picture viewer to aid clarity according to important 
variables. 
 
2.10.5.3 UniFrac 
The sequence reads generated using NGS were analysed using weighted UniFrac 
(Hamady et al. 2009) and visualised using principal coordinate analysis (PCoA). The 
analysis was carried out within QIIME by providing the OTU table (.biom file which is 
similar to the OTU matrix), phylogenetic tree file (Newick format phylogenetic tree), 
and mapping file (text file containing the sample information). Both unweighted and 
weighted UniFrac plots were produced where the unweighted analysis was based on 
presence/absence of OTUs and weighted analysis incorporated abundance data of each 
OTU. Due to the important of OTU abundance, typically these plots were used for 
visualising the data. The plots were saved as an image file and the sample labels were 
manually added to the plot using the interactive HTML files within QIIME to show the 
label for each sample.  
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To determine significance between groups, weight unifrac was significance was 
calculated using Mothur based on the phylogenetic tree produced based on the ThetaYC 
measure of dissimilarity (Yue & Clayton 2005). 
 
2.10.6 Statistics  
 
2.10.6.1 Unpaired t-test 
Statistical significance of DGGE bands associated with disease were analysed by 
unpaired t test using GrahpPad QuickCalc online software using the formula; 
 
 
Where x bar 1 and x bar 2 are the sample means, SX1X2 is the pooled sample variance, 
and n1 and n2 are the sample sizes. 
 
2.10.6.2 Tukey’s test 
Tukey’s test was used to compare the sequenced DGGE bands with pre and post 
samples from NEC and sepsis patients, compared to controls. This test is a multiple 
comparisons procedure, used in conjunction with one-way analysis of variance 
(ANOVA), to find means that are significantly different from each other. This analysis 
was computed in Minitab 16 (version 16.1.0) with a 95.0 confidence interval and a 
family error rate of 5. 
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2.10.6.3 P-test of significance 
Martin’s P-test of significance (Martin 2002) was used to determine if significant 
differences were occurring in the NGS data. This analysis compared the profiles of each 
NGS sample with every other sample in the cohort, indicating potential significance 
between and within patients. 100 Monte Carlo randomisations were performed. 
 
2.12 Ethical approval 
 
Initial collection was part of routine service and all samples were collected during the 
course of normal treatment. Ethical approval was obtained from the County Durham 
and Tees Valley Research Ethics Committee to include molecular techniques in August 
2010. For all infant stool samples, prospective parental informed consent was 
documented at the point of donation to have the samples stored for research purpose. 
For EBM, informed consent was documented at the point of donation to have the 
samples stored for research purposes from March 2011. 
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3. Comparison of culture dependent and molecular techniques in 
elucidating the gut microbiota of preterm infants 
Abstract 
Aim: The gut microbiota is a highly complex ecosystem increasingly associated with 
disease pathophysiology. Despite revolutionary advances in traditional culture and 
molecular based techniques, the coherence of these techniques remains elusive. We 
aimed to compare the performance of these techniques in assessing the gut microbiota 
of preterm infants.  
Methods: Faecal samples (n=17) from preterm infants (n=11) were subjected to 
quantitative aerobic and anaerobic culture and 16S rRNA molecular based analysis 
using PCR-DGGE and 454 pyrosequencing. qPCR was further used to validate the 
results of the techniques by exploring both the total bacterial load and the load of the 
Lactobacilli genus. 
Results: Both culture and pyrosequencing identified Staphylococcus, Enterobacter, and 
Klebsiella as the most prevalent organisms. Despite the increased coverage by 
pyrosequencing over culture, the techniques elucidated comparable profiles. Although 
some taxa were only identified by culture, employing genus specific primers in qPCR 
allowed identification of these taxa.  
Conclusion: Specific primers are required to examine specific taxa. Some functionally 
significant taxa were only identified by culture demonstrating this technique may still 
offer important insights in the analyses of clinical samples. To fully elucidate complex 
ecosystems it is paramount to implement an integrative approach to overcome 
limitations of any single technique.  
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3.1 Introduction 
 
Culture based techniques have been continuously optimised over the last century, most 
notably with the implementation of both selective media and the ability to incubate 
cultures anaerobically (Vaz-Moreira et al. 2011). Nevertheless, it is estimated that only 
20% of the gut microbiota can be cultivated (Eckburg et al. 2005). Therefore, molecular 
techniques have increasingly been applied to clinical investigations owing to their much 
greater coverage of the microbial community (Petrosino et al. 2009). 
Molecular fingerprinting techniques include DGGE and TGGE. In bacterial community 
analyses, these techniques are based on the 16S rRNA gene that has distinct conserved 
and variable regions that serve as valuable markers of genetic diversity (Sekirov et al. 
2010). However, such approaches are subject to PCR bias with amplification efficiency 
and artifacts arising due to the formation of heteroduplex and chimeric sequences 
(Thompson et al. 2002; Wang & Qian 2009). Amplicons also require isolation and 
sequencing to identify specific taxa within the community. Recently, high-throughput 
454 pyrosequencing has been employed in clinical research. This technique offers a 
greater depth of coverage of the samples and allows sequences to be classified to the 
genus level. However, this technique is not absent of PCR bias (Schloss et al. 2011).  
Understanding how culture and molecular approaches compare is important in 
characterising the microbial community in the gut of preterm infants and is essential if 
aetio-pathogenic factors are to be explored. There is currently a lack of studies which 
asses the coherence of culture dependent and molecular techniques, particularly in a 
clinical context. Diagnosis and intervention is currently largely directed by the results of 
culture based analyses in clinical microbiology laboratories. This study utilises clinical 
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samples to evaluate findings from each technique, while enhancing current information 
on the composition of the preterm infant gut microbiota.   
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3.2 Results 
 
3.2.1 Patients and samples 
The 11 patients had median gestation of 26wks (range 23-30wks) and birth weight of 
915g (range 520g-1370g). Two infants developed confirmed NEC, two infants 
developed confirmed NEC and sepsis, and four infants developed sepsis (Table 3.1). To 
allow optimal testing of the techniques, samples between day of life 1 and 145 were 
analysed. 
 
3.2.2 Species richness  
A comparison of the species richness identified by each technique indicated that culture 
based analyses, with one exception (34a), gave the fewest number of taxa within each 
sample compared to the two molecular approaches, (Fig 3.1). In the majority of samples 
(11 of 17), DGGE detected the highest number of taxa.  
 
3.2.3 Prevalent bacterial genera 
The most common genera were compared between the three techniques: both culture 
and pyrosequencing identified Staphylococcus, Enterobacter, and Klebsiella as the most 
prevalent (Fig 3.2). In DGGE analyses, unlike the other techniques, Enterococcus spp. 
and Streptococcus spp. were the most common taxa in the samples followed by 
Staphylococcus spp. and Enterobacter spp. The DGGE analyses also failed to detect 
Klebsiella spp. in any sample suggesting that it was not among the most prevalent 
bands. Pyrosequencing and culture approaches detected this genus in 13 and 5 of the 17 
samples respectively. No correlation was observed between the CFU/g from culture and 
the respective number of reads from pyrosequencing.  
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Table 3.1 – Demographic data for the clinical cohort 
Patient Sample 
Gestation 
Age 
(weeks) 
Birth 
Weight 
(grams) 
Delivery 
Mode 
Sex NEC Sepsis DOL  
13 
13a 
23 600 Vaginal Male Y Y 
34 
13b 39 
13c 48 
13d 53 
13e 60 
2 
2a 
24 520 Caesarean Female N Y 
41 
2b 48 
20 20 26 915 Vaginal Male Y N 11 
33 33 26 995 Caesarean Male N Y 145 
11 11 25 825 Vaginal Male Y Y 6 
6 6 30 1370 Caesarean Male N N 6 
35 35 26 570 Caesarean Male N Y 36 
37 37 28 1090 Vaginal Female N N 1 
34 
34a 
25 800 Vaginal Male N Y 
6 
34b 24 
28 28 28 1250 Caesarean Male N N 1 
29 29 28 1180 Caesarean Male Y N 1 
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Figure 3.1 – Species richness identified by each technique independent of sequence information 
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1 0 
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1 0 
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Figure 3.2 – Prevalence of individual genera detected in each sample by pyrosequencing and culture. Schematic representation showing which 
genus was detected in each sample per technique. Single pyrosequencing reads removed from analysis. P = Pyrosequencing, C = Culture.
9
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3.2.4 Genera mismatches 
Culture only identified 23% of the genera detected in pyrosequencing, whereas 
pyrosequencing identified 97% of the genera found by culture. Those genera identified 
only by culture within specific individual samples were Acinteobacter, Enterobacter, 
Lactobacillus, and Staphylococcus (Fig 3.2). Noteworthy is these genera were detected 
by molecular techniques in other samples, but a mismatch occurred in 4 samples (13c, 
13e, 37, and 34a). To further explore the discrepancy in the detection of Lactobacillus 
spp. conventional PCR and quantitative-PCR (qPCR) using Lactobacillus-specific 
primers was carried out on longitudinal samples (13a - 13e), where culture identified 
lactobacillus in multiple samples not detected by molecular techniques (Table 3.2). Both 
conventional PCR (data not shown) and qPCR (Table 3.2 and Appendix 8) detected 
Lactobacillus in every sample and showed the abundance was greatest in sample 13c. 
The two samples where Lactobacillus was detected by molecular techniques (13c and 
13d) had the largest copy number of the genus. Notably, culture was capable of 
detecting Lactobacillus in the sample which contained the smallest copy number of 
Lactobacillus.   
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Table 3.2 – Counts of bacteria and Lactobacillus in longitudinal stool samples as 
determined by qPCR 
Sample 
Total bacterial 
16S rRNA 
copy No. (g) 
Lactobacillus 
16S rRNA 
copy No. (g) 
% 
a
 
13a 2.34E+09 5.09E+06 0.22 
13b 3.60E+08 1.04E+07 2.87 
13c 2.64E+09 6.54E+07 2.47 
13d 2.58E+08 1.84E+07 7.14 
13e 2.88E+10 1.64E+06 0.01 
a 
Lactobacillus load expressed as the percentage of total bacteria 
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3.2.5 Constrained ordination analysis 
Constrained ordination analyses using CCA was applied to pyrosequencing and DGGE 
data to aid the interpretation of the variation in taxa composition between samples and 
whether they were associated with environmental or patient demographic data. The 
CCA revealed similar trends in the data from each technique with the final figures 
closely representing horizontally flipped versions of each other (Fig 3.3). For both 
techniques, the principal axis of variation can be interpreted as the disease state and 
longitudinal samples are shown to cluster together. However, the significance values 
based on the association between the continuous and discrete variables and community 
structure differed between techniques. Only gestational age (P=0.046) in the 
pyrosequencing analyses was a statistically significant driver of community structure. 
Analysis based on the pyrosequencing data also explained the most variance within the 
data, with the 2 principle axes explaining 52% of variance (Fig 3.3A) compared to 34% 
of the variance in the DGGE analysis (Fig 3.3B).  
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Figure 3.3 - Multivariate analysis on pyrosequencing and DGGE profiles. CCA based on the normalised data from each technique. Clinically 
insignificant taxa and unsequenced bands were included in the analysis but removed from the final graph for clarity. (A) Pyrosequencing CCA. (B) 
DGGE CCA. CS+ = caesarean birth, CS- = vaginal birth, GA = gestational age, BW = birth weight. Acin = Acinetobacter, Bac = Bacteroides, Bifid = 
Bifidobacterium, Citro = Citrobacter, Crono = Cronobacter, Etb = Enterobacter, Etc = Enterococcus, Esch = Escherichia, Flavo = Flavobacteria, 
Kleb = Klebsiella, Ltb = Lactobacillus, Ltc = Lactococcus, Pseu = Pseudomonas, Prop = Propionibacterium, Ser = Serratia, Sphi = Sphingomonas, 
Staph = Staphylococcus, Strep = Streptococcus 
9
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3.3 Discussion 
 
The techniques utilised in this study are commonly used for studying clinical samples 
(Björkström et al. 2009; Lindberg 2010; Morowitz et al. 2010). Here, the focus is not on 
the role of the gut microbiota in disease, but rather on comparing and contrasting the 
data derived from molecular techniques with those derived from culture based 
approaches, in a clinical context. 
In accordance with the findings from previous studies, facultative anaerobes including 
enterobacteria, enterococci and staphylococci were the most frequently detected genera 
by all techniques (Gewolb et al. 1999). However, the two most abundant taxa detected 
using DGGE (Enterococcus spp. and Streptococcus spp.) differed from those most 
commonly detected by culture and pyrosequencing (Staphylococcus, Enterobacter, and 
Klebsiella). Despite this, the three techniques were comparable in identifying the other 
predominant members of the bacterial community and, although differences occurred 
between the bacterial profiles elucidated by the molecular techniques, the overall 
constrained ordination analysis revealed comparable findings.  
This study demonstrated, in agreement with previous work, that molecular techniques 
allow for greater coverage of the microbial community when compared with traditional 
culture based approaches (O’Sullivan, 2000; Mshvildadze et al., 2010). It is important 
to note that culture methods were employed to provide some validation of the data 
provided by molecular methods. The culture data used in this study reflected the routine 
approach used in clinical microbiology laboratories, which is routinely used to inform 
clinical intervention and treatment. Thus, more exhaustive culture techniques involving 
a wider range of selective media incubated for many days would have been likely to 
yield additional species. Our aim was to obtain a snapshot of the predominant flora in 
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the sample, using only 19 culture plates per sample, and to see if the species detected by 
culture were also detected using molecular techniques. Overall, DGGE detected the 
greatest number of taxa (11 of 17 samples). This may reflect the fact that a single 
organism may contain multiple copies of the 16S RNA gene leading to multiple bands 
and thus potentially distorting the true representation of the microbial community (Kang 
et al. 2010).  
There were several samples for which the culture-based approach identified genera that 
both DGGE and pyrosequencing were unable to detect. This suggests that, despite the 
improved coverage of samples by molecular techniques, some less abundant taxa may 
be missed (Vaz-Moreira et al. 2011). For example, DGGE did not show Klebsiella to be 
a prevalent genus, a result that could have clinically significant implications as 
Klebsiella has been associated with NEC in both culture and molecular studies (Carlisle 
et al. 2011; Westra-Meijer et al. 1983). It is also noteworthy that Lactobacillus was 
missed by both molecular approaches in a number of samples. This genus is considered 
to be functionally significant in infant gut development (Lin et al. 2008) and has been 
problematical to detect in previous studies that utilised DGGE and pyrosequencing to 
investigate the preterm gut microbiota (LaTuga et al. 2011). We found that 
pyrosequencing only detected Lactobacillus in samples which contained the largest 
copy number of the genus (Table 3.2). This inability of molecular techniques to detect 
organisms successfully isolated in culture may be due to large amounts of DNA from 
non-viable bacteria in the sample or by inefficient DNA extraction from certain taxa 
(Harris 2003; Zoetendal et al. 2006). Furthermore, it has been demonstrated that minor 
adaptions to primer sequences may facilitate detection of previously problematic 
sequences, without affecting the ability to amplify other taxa (Sim et al. 2012). 
Increasing the number of sequence reads per sample will allow for the less abundant 
species to be identified, but this has cost implications.  
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In contrast, culture based studies have been consistent in identifying the presence of 
Lactobacillus in the gut (Björkström et al. 2009; Gewolb et al. 1999). This study 
suggests that although routine clinical culture employed for detection of organisms in 
stool may fail to identify a substantial number of bacteria from the gut microbiota 
(O’Sullivan 2000), it has significant utility in identifying viable bacterial populations 
and in detecting numerically rare but functionally significant bacterial taxa that 
molecular techniques may miss.  
Other issues that need to be addressed in developing molecular approaches as diagnostic 
tools in clinical microbiology are the application of stringent data pipelines to correct 
for sources of error which would ultimately affect downstream analyses. Our data was 
subjected to a filtering pipeline in mothur to minimise the sequencing error rate and 
incidence of chimeras (Schloss et al. 2011). Following filtering, the rarefaction curves 
for the samples in this study show that the entirety of the preterm infants faecal 
microbiota was not fully elucidated with the number of reads employed. It is of 
increasing importance that the reads generated in pyrosequencing are administered to 
stringent quality-filtering as described in depth elsewhere (Schloss et al. 2011).  
The limitations of DGGE are widely acknowledged and extensively reported (Green et 
al. 2009). However, due to the relative ease and lack of cost and time associated with 
generating a community fingerprint it remains a valuable tool in the examination of 
microbial community structures, particularly in analysing how environmental and 
demographic variables can impact on the composition and dynamics of the community 
(Fromin et al. 2002). Conversely if identification through sequencing of bands is 
undertaken then DGGE can become relatively expensive and time consuming. 
Furthermore, due to the limitations associated with PCR bias and multiple copies of 
genes, potentially important clinical and functional groups, such as lactobacilli or 
Klebsiella could be missed (Vaz-Moreira et al. 2011). More broadly, all molecular 
102 
 
techniques focussing on extracted DNA (rather than RNA) neglect organism viability 
and will therefore report information on non-viable bacterial populations as well as taxa 
for which culture conditions were not optimised. This may give a skewed picture of the 
functionally active bacterial community within the clinical sample (Vaz-Moreira et al. 
2011).  
In summary, molecular techniques allowed for much greater coverage of the premature 
infant gut microbiota, although there were some functionally significant taxa only 
identified by traditional culture. Therefore, in order to fully elucidate complex 
ecosystems such as the gut microbiota, it is important to implement an integrative 
approach to overcome limitations of any single technique (O’Sullivan 2000). Moreover, 
when examining specific taxa using a molecular approach, it is paramount to use 
specific primers as universal primers may fail to detect the desired taxa in the total 
community. We have shown that there are instances of coherence between culture and 
molecular based approaches and despite the increased coverage of the latter, the 
techniques elucidated comparable profiles. Consequently, culture based approaches still 
offer important insight in the analyses of clinical samples. 
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4. The preterm gut microbiota: changes associated with necrotising 
enterocolitis and infection  
Abstract  
Aim: To describe gut colonisation in preterm infants using standard culture and 16S 
rRNA profiling, exploring differences in healthy infants and those who developed late 
onset infections. 
Methods: 99 stools from 38 infants (median 27 weeks gestation) underwent routine 
culture at the hospital microbiology laboratory; a subset of 44 stools from 27 infants 
(median 26 weeks gestation) underwent molecular analysis using the 16S rRNA gene. 
Ordination analyses explored effects of patient variables on gut communities.  
Results: Standard microbiological culture identified a mean of 2 organisms (range 0-7) 
and DGGE identified a mean of 12 bands (range 3-18) per patient. Enterococcus 
faecalis and coagulase negative staphylococci (CoNS) were most common by culture 
(40% and 39% of specimens). Meconium was not sterile and no fungi were cultured. 
Bacterial community structures in infants with NEC and sepsis differed from healthy 
infants. Infants who developed NEC carried more CoNS (45% vs 30%) and less 
Enterococcus faecalis (31% vs 57%). 16S identified Enterobacter and Staphylococcus 
presence associated with NEC and sepsis, respectively.  
Conclusions: Important differences were found in the gut microbiota of preterm infants 
who develop NEC/sepsis. The relationship of these changes to current practices in 
neonatal intensive care requires further exploration. 
  
104 
 
4.1 Introduction 
 
The gut microbiota plays a crucial role in development of immune function, 
micronutrient production, absorption, mucosal barrier function, and modulating the 
systemic inflammatory response (Macia et al. 2012). However, bacteria have been 
implicated in the causal pathway for NEC in animal models and by circumstantial 
evidence in preterms (Morowitz et al. 2010). NEC and infection together cause 21% of 
all deaths in infants born <32 weeks gestation (Berrington et al. 2012): both are likely to 
be affected by gut microbiota. Previous studies have demonstrated associations between 
the presence of bacterial species and an increased risk of NEC (Westra-Meijer et al. 
1983; Hoy et al. 1990), but candidate organisms differ between studies and it is unlikely 
a single organism ‘causes’ NEC. Increasing understanding of microbial community 
interaction, revealed by molecular technologies, supports the concept that microbial 
contributions to NEC are mediated by changes in the community interactions and 
structure (Wang et al. 2009; Mai et al. 2011). The gut microbiota development in 
preterm infants is further influenced by policy and practice, reflecting  the exposure to 
breast milk, antibiotics, and probiotics within the NICU (Frank et al. 2011).  
Molecular techniques overcome the limitation of selective media for culturing 
organisms by amplifying universally conserved genes within different taxonomic 
lineages. DGGE is molecular fingerprinting techniques which utilises the highly 
conserved nature of the 16S rRNA gene to identify bacterial taxa. Molecular analysis 
exploring the phylogenetic diversity of the gut microbiota have shown that the bacterial 
diversity increases over time, with shifts in community structure associated with 
changes in diet and health (Morowitz et al. 2011; Koenig et al. 2010). Modelling gut 
microbiota in term infants suggests competition between three phyla Bacteroides, 
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Proteobacteria and Firmicutes, explains most of the community dynamics (Palmer et 
al. 2007; Trosvik et al. 2010).  
In preterm infants, especially those developing NEC or sepsis, data is limited. Many of 
the studies using culture are more than 20 years old when infants and nursery practices 
were considerably different (Blakey et al. 1982; Stark & Lee 1982; Sakata et al. 1985; 
Hall et al. 1990; Hoy et al. 1990; Björkström et al. 2009). Previous molecular studies 
are limited by restricted sampling, small numbers and relatively mature gestations 
studied (Lindberg 2010; France et al. 2007; Wang et al. 2009; Mshvildadze et al. 2010; 
Mai et al. 2011). However, they have demonstrated that bacterial diversity in NEC 
patients appears different from controls, with fewer Firmicutes and a bloom in 
Proteobacteria before NEC onset. More specifically, Enterobacteriaceae have been 
detected more frequently in patients diagnosed with NEC, compared to controls (Mai et 
al. 2011).  
We aimed to improve understanding of the gut microbial community in preterm infants 
and those associated with NEC and sepsis using culture and DGGE, as a first step in 
evaluating medical or environmental practices that might contribute to these changes. 
 
4.2 Results 
 
4.2.1 Patients and samples 
The 38 patients had a median gestation of 27 weeks (range 23-31), birth weight 895g 
(range 520g - 1850g); the 27 patients contributing molecular data did not differ 
significantly from the overall population, 35 infants received breast milk, 29 
antifungals. NEC was diagnosed in 8 infants (4 surgical) of which 7 (4 surgical) 
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contributed molecular data; 13 developed sepsis, of which 9 contributed to the 
molecular data (Table 4.1). Of those with NEC or sepsis, 18 samples were before onset 
of disease and 14 after.  
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Table 4.1 - Demographic data and bacterial species detected using standard culture across all 99 
samples 
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1a 9
1b 
a 16
1c 23
2a 16
2b 24
2c 
a 41
2d 
a 48
2e 56
3a 
a 14
3b 
a 20
3c 
a 27
4 
a 27 580 Cesarean F 24 N N/A Y 13 Y
5 29 1420 Vaginal M 1 N N/A N N/A Y
6a 
a 6
6b 11
7a 2
7b 
a 21
8a 18
8b 
a 25
8c 
a 34
8d 
a 46
9 
a 33 1850 Vaginal M 1 N N/A N N/A Y
10 28 880 Cesarean M 11 Y 10 N N/A Y
11a 
a 6
11b 38
12a 16
12b 
a 30
12c 36
12d 
a 40
12e 
a 44
12f 
a 51
12g 59
13a 25
13b 
a 34
13c 
a 39
13d 
a 48
13e 
a 53
13f 
a 60
14 
a 28 1040 Cesarean F 26 N N/A N N/A Y
15a 17
15b 22
15c 
a 29
15d 
a 38
16a 1
16b 9
16c 22
16d 
a 32
16e 
a 38
17 27 1170 Vaginal M 13 N N/A N N/A Y
18a 7
18b 
a 13
19 
a 26 870 Cesarean M 55 Y 13 Y 10 Y
20a 
a 7
20b 11
20c 18
20d 32
21a 
a 11
21b 20
21c 
a 22
21d 25
21e 32
21f 39
22a 
a 15
22b 
a 23
23a 14
23b 22
23c 29
24 29 1020 Cesarean M 2 N N/A N N/A Y
25a 13
25b 16
25c 20
25d 
a 27
26 28 1360 Cesarean M 13 N N/A N N/A Y
27 25 740 Cesarean M 37 Y 34 N N/A Y
28a 
a 1
28b 11
29a 
a 1
29b 2
29c 9
30a 16
30b 25
30c 56
30d 65
30e 93
31 28 1200 Cesarean F 17 N N/A N N/A Y
32a 17
32b 25
33 
a 26 995 Cesarean M 145 Y 144 N N/A Y
34a 
a 6
34b 17
34c 
a 24
34d 31
35a 13
35b 18
35c 34
35d 
a 36
36 
a 27 1120 Cesarean M 60 Y 77 Y 21 Y
37 
a 28 1090 Vaginal F 1 N N/A N N/A Y
38 24 640 Vaginal F 27 N N/A N N/A Y
8
4
51
38
81
8
23
24 670 Vaginal M N
29 1340 Cesarean F N
26 485 Cesarean M N
25 825
N N/A Y
24 520 Cesarean F Y N N/A Y
N/A
N N/A Y
30 1370 Cesarean M N N N/A Y
N/A
N/A
N N/A Y
28 1160 Vaginal M N N N/A Y
N/A
N/A
Vaginal M Y Y 17 N
24 680 Vaginal F N N N/A YN/A
23 600 Vaginal M Y Y 12 Y
25 635 Vaginal F N N N/A YN/A
24 645 Vaginal M N N N/A Y
27 1365 Vaginal M Y N N/A Y
N/A
3
26 915 Vaginal M N Y 20 N
28 1100 Cesarean M N N N/A Y
N/A
N/A
27 870 Cesarean M N N N/A Y
27 790 Cesarean F N N N/A Y
N/A
N/A
25 810 Vaginal F N N N/A Y
28 1250 Cesarean M N N N/A Y
N/A
N/A
28 1180 Cesarean M N Y 17 N
24 650 Vaginal M Y Y 24 N
N/A
N/A Y26 570 Cesarean M Y N
27 910 Vaginal M Y N N/A Y
25 800 Vaginal M Y N N/A Y
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4.2.2 Standard culture analyses 
In total 31 species were identified. Individual stools contained a mean of 2 different 
species (range 0-7). The most common species were Enterococcus faecalis and CoNS 
(40% and 39% respectively). Infants with NEC were more likely to be colonised with 
CoNS (45% vs 30%) and less likely colonised with Enterococcus faecalis (31% vs 
57%). Only five infants were colonised with lactobacilli and one with Bifidobacterium 
sp. All meconium samples (samples collected on day one) were colonised with at least 
one species (Table 4.1). No fungi were cultured. 
In the subset of stools for which molecular analysis was possible, 24 taxa were 
identified by culture. PCoA was used to study the structure of the community 
determined by culture, the two major principle components explained 37% of the 
variance.  Along the horizontal axis, profiles from healthy infants distributed to the left 
(14 samples from a total of 25) and those from infants with NEC and/or sepsis to the 
right (16 samples from a total of 18) (Fig 4.1A). Samples (11a, 20a, and 29a) collected 
prior to NEC diagnosis also show a distinct cluster. The most significant taxa associated 
with this community shift were Enterococcus faecalis, which were more frequently 
isolated from healthy patients (58% of healthy patients vs. 22% of NEC/sepsis infants), 
and CoNS which were more frequently isolated from NEC/sepsis patients (56% of 
NEC/sepsis vs. 35% healthy) (Table 4.1).  
 
4.2.3 DGGE analyses 
DGGE analyses identified 74 individual taxa (range 3-18, mean 12 per stool). The mean 
diversity of each sample, (Shannon diversity index (H')), was 1.9 ± 0.45 indicative of 
relatively low species diversity. The six DGGE samples from infants less than ten days 
old had a significantly lower H' (1.19) compared to infants ten days or older (H'’=2.04). 
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Community profile variance associated with the categorical variables is shown in Fig 
4.1B. These analyses identify variables significantly associated with changes in the 
community structure. The x axis (presence or absence of NEC/sepsis) explained 19% of 
the variance of gut bacterial community profiles and was significantly different in sepsis 
from healthy infants (P=0.016) (Fig 4.1B), before and after onset of disease and again 
showed the distinct clustering of samples pre NEC. The y axis explained 14% of 
variation associated with gestational age. Bands on the DGGE gels most associated with 
changes in bacterial community associated with NEC and sepsis were Enterobacter, 
Flavobacterium, Staphylococcus and Propionibacterium (Fig 4.2). 
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Figure 4.1 – Multivariate analysis on culture and DGGE. Circles denote healthy patients and squares denote patients diagnosed with NEC and/or 
sepsis. (A) PCoA based on presence and absence of species identified by culture. (B) CCA based on normalised DGGE band matrix. CS+ = caesarean 
birth, CS- = vaginal birth, GA = gestation age. Sequences obtained are displayed – Ba = Bacteroides, Bi = Bifidobacterium, Eb = Enterobacter, Ec = 
Enterococcus, Fl = Flavobacteria, Pr = Propionibacterium, Sp = Sphingomonas, Sa = Staphylococcus, Sr = Streptococcus  
1
1
0
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Figure 4.2 – Representation of a DGGE gel showing which bands were excised and 
sequenced. L - Ladder, 1 - F.symbiont, 2 - E.faecalis, 3 - S.epidermidis, 4 - S.salivarius, 
5 - P.acnes, 6 - E.cloacae, 7 - B.fragilis, 8 - B.longum, 9 - S.mutans, 10 - 
S.aromaticivorans, 11 - E.ludwigii, 12 - E.coli, 13 - V.atypica, 14 - M.populi 
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4.3 Discussion 
 
Both standard culture and molecular techniques indicated differences between the gut 
microbiota of healthy infants and those who develop NEC/sepsis, before and after 
diagnosis. Not surprisingly, molecular approaches had greater resolution in quantifying 
these differences. Our molecular analyses are in agreement with earlier work indicating 
samples of meconium (day 1 stools) were not sterile (Jiménez et al. 2008) and bacterial 
diversity was initially low, increasing with time (Koenig et al. 2010). 
The results of this study suggest certain taxa are more frequently associated with health 
and disease states in premature infants: Enterobacter spp. and Staphylococcus spp. were 
associated by both methods with NEC and have been previously implicated in the 
disease state (Acker & Smet 2001; Morowitz et al. 2010). Both methodologies also 
suggest an association between Enterococcus spp. and Streptococcus spp. and 
remaining healthy: Enterococcus specifically may play a key role in gut development 
(Are et al. 2008). In contrast to Björkström et al. (2009), we identified very little 
colonisation with ‘healthy’ bacteria: only 6 infants were identified as carriers of 
lactobacilli or bifidobacteria, compared to 24/44 of their infants. However, while most 
of our infants received breast milk they were significantly less mature than those in 
Björkström’s study, which is likely to influence the bacterial colonisation. Furthermore, 
discrepancies between the culture based methodology between studies may lead to 
further disparities in the ability to detect specific organisms (Björkström et al. 2009).  
The hypothesis that NEC is due to atypical bacterial community assembly and 
interactions, requires the bacterial community to be studied as a whole. Molecular 
methodologies offer the opportunity to explore whether patient related variables are 
significantly associated with changes in the bacterial community: ordination analyses 
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show variation in species composition between samples and the underlying 
environmental factors - samples with similar communities group more closely. We 
demonstrated that the most significant factor associated with bacterial community 
structural change was NEC and sepsis: our data highlight changes in the gut microbiota 
that precede disease. Profiles prior to NEC diagnosis did not cluster with healthy 
patients, as shown by others (Wang et al. 2009). These changes may be modulated by a 
variety of factors including genetic predisposition, feeding practices, maternal dietary 
changes in breast fed infants, medical interventions within neonatal intensive care 
(antibiotics etc.), and may be closely or more distantly temporally linked to disease 
onset. Gestational age, the single most important risk factor for development of NEC 
(Martin & Walker 2008; Chauhan et al. 2008), was not found to be significant in 
shaping the bacterial community (P=0.09). This suggests that increased immaturity per 
se is not significantly associated with a bacterial community associated with NEC and 
sepsis, an important finding. The greater prevalence of Enterobacteriaceae and 
Staphylococcaceae associated with NEC and sepsis (Fig 4.1B) was more significant. 
Caesarean section, previously implicated with increased NEC (Marques et al. 2010), 
also showed a weak association with the bacterial community associated with increased 
incidence of NEC/sepsis.  
The ability to define and then replicate a ‘healthy’ preterm gut microbiota would be of 
practical benefit to preterm infants, but whether changes in the gut microbiota observed 
are a consequence of changes that cause NEC/sepsis, or vice versa remains unclear. 
This study demonstrates how some clinical factors can help explain some variance, but 
not all. Some changes observed predate disease diagnosis, suggesting that microbiomic 
changes may be part of a causal pathway. However, the number of informative samples 
in this study is relatively small as sampling was convenience rather than targeted, thus 
infants contribute variably to the overall analysis. Much larger datasets will be required 
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to more precisely elucidate how these factors operate independently and when 
combined. As some of the factors that influence the gut microbiota (antimicrobial 
choices and duration) are within clinical control, further exploration of the detailed 
effects of these is needed. Other potentially important gut microbiota manipulations, 
such as the delivery of probiotics (Embleton & Yates 2008) and lactoferin (Venkatesh 
& Abrams 2010) to preterm infants will also require careful evaluation in the future and 
may further enhance our understanding. Current evidence suggests that probiotics might 
be protective against NEC but not sepsis (Deshpande et al. 2007). However, the 
mechanism of action in relation to the gut microbiota is poorly studied and there are 
currently no studies exploring whether long term detrimental effects might occur (Neu 
2011). 
Clinical effects of changes in the gut microbiota may be delayed by days or weeks, and 
detailed sampling over long time periods is required to fully understand these. 
Manipulations of the gut microbiota made by early medical decisions may also have 
very long lasting (metabolic/allergic) effects which require further evaluation, and 
tracking of these infants into later (adult) life may be illuminating. Given the significant 
mortality and morbidity of these disease states to preterm infants, further exploration of 
the gut microbiota should be considered an important research priority. 
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5. Bacterial and fungal viability in the preterm gut: necrotising 
enterocolitis and sepsis 
Abstract 
Aim: Evidence suggests that microbial communities in the preterm gut may influence 
the development of NEC and sepsis. Existing data often neglect fungi and whether 
bacteria were metabolically active or not. We sought to characterize the bacterial and 
fungal stool flora of preterm neonates and organism viability and evaluate any 
associations with NEC and sepsis. 
Methods: Stool samples (n=136) from 32 patients (<32 weeks gestation) were collected 
between birth and day of life 95. Seven infants developed NEC and 13 developed 
sepsis. Stools were analysed by PCR-DGGE for assessment of the total bacterial and 
fungal communities by analysis of 16S rRNA and 28S rRNA respectively. In a subset of 
the cohort consisting of 65 samples (25 infants) the viable (RNA) bacterial and fungal 
communities were analysed. Analyses were performed to examine the possible effects 
of demographic or treatment related factors and the development of NEC or sepsis. 
Results: In total 80 (66 viable) bacterial species were identified overall, and 12 fungal 
taxa (none viable). Total bacterial communities significantly differed between healthy 
infants and those with NEC or sepsis, with Sphingomonas spp. significantly associated 
with NEC. Significant drivers of community structure differed based on total or viable 
analysis. Antifungal prophylaxis was associated with altered bacterial community and 
reduced bacterial richness observed in week 4 correlated with high antibiotic exposure.  
Conclusions: Total and viable communities differ in preterm infants, and non-viable 
fungal species are present in infants on prophylaxis. Exploration of viability and non-
bacterial contributors to the total community may increase understanding of NEC and 
sepsis.   
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5.1 Introduction 
 
Prematurity remains the leading predisposition to neonatal death and long term 
disability (LaTuga et al. 2011), with infection and NEC increasing in preterm infants 
(Berrington et al. 2012). Associated mortality and long term consequences for survivors 
underpin the need for improved understanding and prevention of both prematurity and 
the associated morbidities (Stoll et al. 2004). Recent interest has focused on the role of 
the gut microbiota in the pathogenesis of NEC and sepsis. 
The bacterial community within the gut microbiota plays a crucial role in the 
development of immune function, micronutrient production and absorption, mucosal 
barrier function, and modulation of the systemic inflammatory response (Macia et al. 
2012). Although bacterial colonisation is considered a pre-requisite for NEC, no single 
causative bacterial agent has been identified (Kaufman & Fairchild 2004). Studies 
reporting specific bacterial associations with NEC suggest a role for Proteobacteria taxa, 
commonly Enterobacteriaceae (Carlisle et al. 2011; Mai et al. 2011). Preterm neonates 
also show delayed colonisation by ‘healthy commensal’ organisms, especially 
bifidobacteria and lactobacilli, potentially attributable to medical management of 
prematurity (Schwiertz et al. 2003; Jacquot et al. 2011). 
The diversity of the total gut microbiota in term neonates increases over time with 
abrupt community shifts associated with diet changes or antibiotic treatments (Koenig et 
al. 2010). Total community analysis is based on DNA and will include both 
metabolically active (live) and dead microorganisms. Analyses based on the total gut 
microbiota provide a phylogenetic picture of the community, but do not reflect the 
viable community (Tannock et al. 2004), which differs from the total community in 
adults (Peris-Bondia et al. 2011). Viable community analysis is based on RNA and 
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includes only metabolically active microorganisms but RNA imposes increased 
problems due to the potential for degradation, compared with DNA. RNA is unstable at 
room temperature and requires stringent sample handling procedures to ensure the 
sample is transported to the laboratory without degradation or a shift in microbial 
profiles. To prevent this degradation during transit it is paramount the sample is stored 
in an RNA stabilisation reagent (Hernandez et al. 2009). 
The fungal community within the gut microbiota of preterm infants remains relatively 
unexplored, despite the importance of candidal infection in neonates and increasing 
anti-fungal prophylaxis within NICUs (Manzoni et al. 2009; Manzoni et al. 2011; 
Vergnano et al. 2011). A study which relied on cultivation identified 16 of 30 patients 
had no evidence of fungal colonisation, but found fungal sepsis to be a significant lethal 
factor in the surgical mortality of NEC (Smith et al. 1990). In necrotising pancreatitis, 
although the initial severity was comparable, patients with fungal infection tended to 
have a more complicated course and worse outcomes compared with those with 
bacterial infection (Grewe et al. 1999). In this study, a low dose of antifungal 
prophylaxis was advised in the management of necrotising pancreatitis, however, how 
antifungal prophylaxis affects the neonatal gut microbiota remains largely unknown.  
We aimed to examine total (DNA) and viable (RNA) bacterial and fungal communities 
in the gut of preterm infants exposed to current NICU practices, exploring potential 
associations of the gut microbiota with a diagnosis of sepsis or NEC, antifungal 
prophylaxis, gender, birth mode, gestational age, birth weight, and postnatal age.  
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5.2 Results 
 
5.2.1 Clinical Characteristics 
Demographic information is in Table 5.1 and details of all individual infant antibiotic 
exposure are presented in Appendix 9. In total, 32 patients contributed to the analysis of 
the total community and 25 patients contributed to viable analysis. The demographics of 
the subset used in the viable analysis did not differ significantly from the complete 
cohort. 30 infants (23 from viable subset) received some breast milk and 30 (23 from 
viable subset) received antifungal prophylaxis (fluconazole). None received probiotics 
or prebiotics. Seven developed NEC (3 surgical): four contributed to the viability 
analysis. 6 samples predated and 12 post-dated NEC diagnosis. Thirteen infants 
developed sepsis with 5 infants having more than one episode: 10 contributed to the 
viability analysis. 22 samples predated and 32 post-dated sepsis diagnosis. Organisms 
causing sepsis were detected by blood culture and identified as: 10 coagulase negative 
staphylococci (CONS), 1 Staphylococcus aureus, 2 Enterococcus faecalis, 2 
Escherichia coli, 1 Klebsiella pneumoniae, 1 Pseudomonas aeruginosa, 1 Micrococcus 
luteus, and 1 Candida parapsilosis. 
 
5.2.2 Total communities 
DGGE identified 80 individual species (mean 14 per stool, range 2-26). Interestingly, 
mean numbers of total bacterial species did not differ between healthy, NEC, and sepsis 
patients (Table 5.1). The most prevalent bacteria, identified by sequencing DGGE bands 
(see Methods 2.7), belonged to the genera Enterococcus, Streptococcus, and 
Escherichia (Appendix 9). DGGE analyses identified 12 fungal species (mean 2 per 
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stool, range 0-6). Half of infants in the cohort carried at least one fungal species, half 
showed no fungal colonisation. For most individual infants where fungi were identified 
they were in every sample with high intra-patient concordance. No fungal species were 
observed in any stool from any infant who developed NEC (all on fluconazole) (Table 
5.1). Based on the DGGE ladder, Candida spp. were the most abundant fungi (61%) 
with C. albicans and C. glabrata responsible for 30% and 29% respectively. 
Constrained ordination using CCA was carried out on the total bacterial community that 
explained 35% of the total variance (Fig 5.1). The principal axis, explained 19% of the 
variance separating patients according to disease state with healthy infants clustered 
separately from infants with NEC or sepsis. Patients with NEC (P=0.002) or sepsis 
(P=0.002) had significantly different profiles compared to healthy infants. Only 
colonisation with Sphingomonas spp. was significantly (P=0.0001) associated with 
NEC. Delivery mode (P=0.01) and gender (P=0.012) also influenced the bacterial 
community. Only 2 patients did not receive antifungal prophylaxis resulting in 
significantly different (P=0.03) bacterial profiles. Interestingly, the bacterial community 
was not significantly influenced by gestational age and birth weight. 
The role of the bacterial community in NEC and sepsis was further assessed using PLS-
DA to explore the gut microbiota pre disease diagnosis and post disease diagnosis when 
the patients will be subject to practises within the NICU (Fig 5.2). Healthy controls 
were found to cluster together. Samples predating and following disease diagnosis 
clustered distinctly from healthy controls.  
Overall, the species richness in the total bacterial community increased with increasing 
postnatal age in all infants. However, the species richness of the fungal community 
remained relatively constant with a low richness observed throughout the initial weeks 
of life (Fig 5.3).  
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Table 5.1 – Demographic data and species richness from whole patient cohort 
 
Healthy 
(Patients = 17 / Samples = 80) 
NEC
a
 
(Patients = 7 / Samples = 18) 
Sepsis 
(Patients = 8 / Samples = 38) 
Median gestational age 
(weeks) 
26 (range 23 - 29) 27 (range 24 - 31) 25 (range 24 - 28) 
Median birth weight 
(grams) 
780 (range 495 - 1435) 920 (range 705 - 1660) 810 (range 615 - 1030) 
Gender ratio: 
male/female 
8 / 9 5 / 2 7 / 1 
Birth mode ratio: 
Vaginal/Caesarean 
10 / 7 3 / 4 5 / 3 
Deceased 0 0 1 
Mean taxa (per sample)    
Total Bacterial 14 14 14 
Viable Bacterial 6 5 5 
Total Fungal 2 0 3 
Viable fungal 0 0 0 
a
 Patients diagnosed with both NEC and sepsis are presented as NEC (n=6) 
1
2
0
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Figure 5.1 – CCA based on the total bacterial community. Comparison of patient 
profiles (Healthy patients (○), patients diagnosed with NEC (), and patients diagnosed 
with sepsis (■)) with discrete variables (▲) including; N = NEC (P=0.002), S = sepsis 
(P=0.002), AF = antifungal treatment (P=0.03), CS = caesarean / Vag = vaginal birth 
(P=0.01), M = male / F = female (P=0.012) and continuous explanatory variables (--►) 
including; GA = Gestation age (P=0.148), DOL = day of life (P=0.002). Sequenced 
bands () include – Eb = Enterobacter, Es = Escherichia, Sp = Sphingomonas, Sa = 
Staphylococcus, Sr = Streptococcus 
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Figure 5.2 - PLS-DA exploring disease status on the gut microbiota. Grouped according to disease state. Groups are as follows – 1 = healthy, 2 = 
pre sepsis, 3 = post sepsis, 4 = pre NEC / pre sepsis, 5 = pre NEC / post sepsis, 6 = post NEC / pre sepsis, 7 = post NEC / no sepsis, 8 = post NEC / 
post sepsis. Numbers adjacent to each point refer to patients (Appendix 9). Lowercase letters refer to longitudinal samples from each patient.  
1
2
2
 
 123 
 
Figure 5.3 – Species richness. Total bacterial and fungal communities colonising the preterm neonate.  
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5.2.3 Viable communities 
DGGE analyses on the viable bacterial community demonstrated the presence of 66 
individual species (mean 6 per stool, range 1-14). There was no statistical difference 
between the numbers of viable bacterial species detected in infants with NEC or sepsis 
compared with healthy infants (Table 5.1). The most abundant viable bacteria matched 
the total community (Enterococcus, Streptococcus, and Escherichia spp.) (Appendix 9), 
but the constrained ordination differed (Fig 5.4). While both CCAs explained the same 
variance in the first 2 axes (35%), only gestational age (P=0.002), day of life (P=0.004), 
and sepsis (P=0.004) had a significant effect on the viable community (Table 5.2). 
Colonisation with Sphingomonas spp. remained significantly associated with NEC 
(P=0.0001).  
To ensure the differences between the total and viable analysis was not a result of 
differences between the cohort size, an additional CCA using DNA matched to the 
viable cohort was also performed. This confirmed the bacterial analysis on the full 
cohort, showing gender (P=0.002) and birth mode (P=0.012) to be significant and 
gestation age to be insignificant in shaping the gut microbiota (Appendix 9). This is 
further supported by cluster analysis where a dendrogram based on the Bray-Curtis 
coefficient showed samples largely cluster based on sample, rather than grouping based 
on DNA or RNA analysis (Fig 5.5). This can be visualised on the DGGE gels where the 
DNA and RNA samples were ran out alongside one another; typically the most 
abundant bands from the DNA profile are observed in the RNA profile (Appendix 9). 
No viable fungi were detected in any sample (Table 5.1). To ensure this was not a 
methodological issue, cultured isolates of C. albicans were spiked into stool and the 
RNA methodology followed. The C. albicans species were successfully detected by 
PCR-DGGE.  
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Figure 5.4 – CCA based on the viable bacterial community. Comparison of patient 
profiles (Healthy patients (○), patients diagnosed with NEC (), and patients diagnosed 
with sepsis (■)) with discrete variables (▲) including; N = NEC (P=0.188), S = sepsis 
(P=0.004), AF = antifungal treatment (P=0.144), CS = caesarean / Vag = vaginal birth 
(P=0.366), M = male / F = female (P=0.166) and continuous explanatory variables (--
►) including; GA = gestation age (P=0.002), DOL = day of life (P=0.004). Sequenced 
bands () include - Bi = Bifidobacteria, Eb = Enterobacter, Es = Escherichia, Sp = 
Sphingomonas, Sr = Streptococcus 
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Table 5.2 – Comparison of the P Values from the total and viable CCA  
Variable 
Total CCA 
(P Value) 
Viable CCA 
(P Value) 
NEC 0.002 0.188 
Sepsis 0.002 0.004 
Antifungal treatment 0.03 0.144 
Delivery mode 0.01 0.366 
Gender 0.012 0.166 
Gestation age 0.148 0.002 
DOL
a
 0.002 0.004 
a
DOL – Day of life 
 127 
 
Figure 5.5 – Cluster analysis based of both DNA matched to the RNA samples 
from the subset of the cohort. Dendrogram based on the Bray-Curtis coefficient.
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5.2.4 Effects of increasing age on the total and viable bacterial communities 
Total bacterial samples were matched with the corresponding viable sample to compare 
changes with increasing age. Diversity increased from week 1 of life, although this 
increase was not continuous, with fluctuations in the bacterial community structure 
occurring throughout the first 9 weeks (Fig 5.6). Trends were similar for total and viable 
communities but numbers of bacteria deemed viable were lower than that of the total 
community. Overall the diversity and richness of the samples increased over the first 9 
weeks correlating with reduced antibiotic exposure as well as increasing age, but a 
reduction was noted in week 4 when the diversity was more established and antibiotic 
administration was still relatively high. Numbers of samples available each week were 
variable preventing further statistical analysis of this current cohort. 
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Figure 5.6 - A comparison of the total and viable bacterial Shannon diversity (H') with the total number of antibiotics administered each 
week. Error bars represent the standard error of mean. 
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5.3 Discussion 
 
We have explored two novel aspects of the preterm faecal microbiota: fungal 
colonisation and the role of organism viability. Total bacterial profiles of infants with 
NEC and total and viable profiles of infants with sepsis were significantly different 
from healthy infants, supporting a role for bacterial colonisation in the pathophysiology 
of these diseases (Stenger et al. 2011). This is a descriptive study not a case-control 
study, which aimed to describe variables related to the development of the gut 
microbiota in preterm neonates over a period of time. Subsequent analyses will be 
subject to influence by practices within the NICU that confound associations, making 
the direction of effect unclear and the apparent effect of the disease states may not be 
causal. However, when examining samples pre and post disease diagnosis, using PLS-
DA we observed that samples before disease onset still group separately from healthy 
patients (Wang et al. 2009). This suggests differences in the gut microbiota predate the 
onset of disease. 
Importantly and to our knowledge uniquely, Sphingomonas spp. colonisation was 
significantly associated with NEC in both the total and viable analysis. This genera 
belongs to the Proteobacteria phylum, recently reported to increase before NEC onset 
(Carlisle et al. 2011; Mai et al. 2011). Sphingomanads have previously been identified 
within biofilms formed in water supply systems although this would appear to be an 
unlikely route of colonisation within NICU where most water to which infants are 
exposed is sterilised (Koskinen et al. 2000). Further work is needed to determine if the 
association of Sphingomonas spp. with NEC remains significant in a larger cohort and 
elucidate mechanisms of pathogenicity, which will include sampling the neonatal 
intensive care environment.  
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Unlike other studies we have shown no significant difference between the number of 
total bacterial species, whether total or viable, in populations of infants with NEC or 
sepsis compared with healthy infants. Differences in our findings between other studies 
may depend on the timing of sampling in relation to disease onset (Wang et al. 2009; 
Smith et al. 2012). Surprisingly gestation only influenced viable data, and birth weight 
was never found to have a significant effect on the gut microbiota, despite the well-
recognised importance of these factors for the development of NEC (Stoll 1994; Guthrie 
et al. 2003; Lin et al. 2008; Caplan & Frost 2011). The most prevalent genus of bacteria 
identified in our total and viable analyses (Enterococcus, Streptococcus, and 
Escherichia) agreed with those previously identified (Schwiertz et al. 2003; Magne et 
al. 2005; Mshvildadze et al. 2010; LaTuga et al. 2011). Interestingly, Staphylococcus 
spp. were not found amongst the most common organisms despite these taxa 
contributing to the majority of positive blood cultures and being previously reported as 
a prevalent genus in the gut (Jacquot et al. 2011; Madan et al. 2012). This may reflect 
specific antibiotic preferences used within individual units. 
Fungal colonisation was identified in half the infants but no viable fungi were detected 
in this cohort with almost universal fluconazole use. The stability of fungal profiles 
within individuals suggests that fungal DNA persists in the gut long after fluconazole 
prophylaxis due to its fungistatic properties successfully inhibiting replication. 
Although small in number (n = 2), the infants who did not receive fluconazole had 
significantly different total bacterial profiles, although again this could be confounded 
by their clinical differences that resulted in them not requiring fluconazole. 
Interestingly, fluconazole has direct antibacterial properties especially against Gram 
positives (Sud & Feingold 1982). There may also be community effects from liberating 
niches that would otherwise be occupied by fungi. For example, Pseudomonas 
aeruginosa colonisation increases in the murine lung following antifungal drug 
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administration, which has important implications in lung injury (Ader et al. 2011). 
Despite fluconazole use identified fungal species were dominated by Candida spp 
(Fairchild et al. 2002; Cahan & Deville 2011). Consistent with previous reports, we also 
did not find a correlation between fungal colonisation and mortality or NEC (Cahan & 
Deville 2011).  
A major benefit of assessing the viable community rather than just the total community 
is that it potentially gives insight into taxa that are driving major metabolic activities 
and participating in microorganism/host interactions, and thus may give insight into 
strategies to alter outcomes (Tannock et al. 2004; Peris-Bondia et al. 2011). However, 
the importance of separately assessing the viable community within preterm infants is 
currently unclear as no previous studies have explored viability. We found important 
differences in the variables deemed to be significantly driving bacterial community 
structure based on either total or viable analysis. While sepsis was found to be 
significant in both analyses, gestational age was only significant for the viable 
community and gender and birth mode were only significant for the total community. 
Analyses incorporating the viable portion of the gut microbiota may gain increasing 
importance when assessing potentially important gut microbiota manipulations. Of 
current interest are the use of probiotics (Embleton & Yates 2008), prebiotics 
(Szajewska 2010) and lactoferrin (Venkatesh & Abrams 2010), however the mechanism 
of action and effect of such treatments on the gut microbiota require further research 
(Shanahan 2010).  
LaTuga et al. recently showed a low to moderate total bacterial diversity with a mean H' 
of 1.02 from a cohort that was younger with a lower gestation compared to ours 
(LaTuga et al. 2011). We report relatively high total bacterial diversity (mean H' of 
2.04) but our associated viable bacterial diversity was lower with a mean H' of 1.18. It 
has also been shown that antibiotic administration decreases the numbers of anaerobic 
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bacteria in the gut microbiota, with counts of bifidobacteria particularly reduced 
(Penders et al. 2006). Our results support this with bifidobacteria being detected in 
8.8% of the total community and only 3.1% of the viable community. From week 5 
onwards both the total and viable community generally show an increasing diversity 
and richness, by which stage the majority of patients were no longer receiving antibiotic 
treatment. 
Molecular based research into the association of the total bacterial community with 
NEC has increased our understanding of the disease: the complex multifactorial 
pathophysiology appears to be influenced by a variety of bacterial genera, individually, 
or promoting shifts in communities. Stool samples allow for non-invasive elucidation of 
the gut microbiota; however the stool microbiota may not precisely represent the gut 
microbiota (Durbán et al. 2011). The stool microbiota is thought to represent a 
combination of shed mucosal bacteria and a separate nonadherent luminal population 
(Eckburg et al. 2005). Employing molecular techniques allows greater coverage of the 
microbial community with only 20% of the gut microbiota reported to be cultivable 
(Eckburg et al. 2005). This may allow detection of important species not readily 
cultivated such as Spingomonas spp. here associated with NEC. High throughput next 
generation sequencing platforms, such as 454 pyrosequencing, are becoming increasing 
employed in clinical research due to the detection of low abundance taxa (Sekirov et al. 
2010). However, as in DGGE, pyrosequencing is also subject to PCR bias (Petrosino et 
al. 2009).  
This novel study employing a relatively large cohort helps to further elucidate total as 
well as viable organisms of the gut microbiota in association with NEC and sepsis. We 
show abnormal bacterial colonisation in association with the development of NEC and 
sepsis, with colonisation by Sphingomonas spp. significantly associated with NEC. 
While antifungal prophylaxis significantly affects the total bacterial community, the 
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presence of fungal species in the gut was not demonstrated to affect bacterial richness. 
Further work is needed to investigate the role of community microbial dynamics in the 
pathophysiology of NEC and infection, while additional exploration of the total and 
viable communities may add further to our understanding. 
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6. Development of the preterm gut microbiota in twins at risk of 
necrotising enterocolitis and sepsis 
Abstract 
Aim: The preterm gut microbiota is a complex dynamic community influenced by 
genetic and environmental factors and is implicated in the pathogenesis of NEC and 
sepsis. We aimed to explore the longitudinal development of the gut microbiota in 
preterm twins to determine how shared environmental and genetic factors may influence 
temporal changes and compared this to the expressed breast milk (EBM) microbiota.  
Methods: Stool samples (n = 173) from 27 infants (12 twin pairs and 1 triplet set) and 
EBM (n = 18) from 4 mothers were collected longitudinally. All samples underwent 
PCR-DGGE (denaturing gradient gel electrophoresis) analysis and a selected subset 
underwent 454 pyrosequencing.  
Results: Stool and EBM shared a core microbiota dominated by Enterobacteriaceae, 
Enterococcaceae, and Staphylococcaceae. The gut microbiota showed greater similarity 
between siblings compared to unrelated individuals. Pyrosequencing revealed a 
reduction in diversity and increasing dominance of Escherichia sp. preceding NEC that 
was not observed in the healthy twin. Antibiotic treatment had a substantial effect on the 
gut microbiota, reducing Escherichia sp. and increasing other Enterobacteriaceae. 
Conclusions: This study demonstrates related preterm twins share similar gut 
microbiota development, even within the complex environment of neonatal intensive 
care. This is likely a result of shared genetic and immunomodulatory factors as well as 
exposure to the same maternal microbiota during birth, skin contact and exposure to 
EBM. Environmental factors including antibiotic exposure and feeding are additional 
significant determinants of community structure, regardless of host genetics.  
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6.1 Introduction 
 
The gut microbiota is crucial to both health (immunomodulation, protection, nutrition 
and metabolism) and disease (inflammation, diabetes, obesity and allergy) (Sekirov et 
al. 2010). Due to the complexities of both the microbial community and factors that 
affect it, exploring individual variables (including diet, medical interventions/exposures 
and genetic components) is challenging. Studying twins or higher order multiples may 
provide unique insights, with previous studies suggesting the gut microbiota may be 
subject to host genetics. Healthy twins have been shown to develop a comparable gut 
microbiota after term birth (Palmer et al. 2007), in childhood (Stewart et al. 2005) and 
into adulthood (Zoetendal et al. 2001), suggesting genetic or shared environmental 
factors shape the gut community. Existing evidence is confounded by the genetic 
diversity of humans as well as strong environmental effects (Benson et al. 2010). Twin 
studies, therefore, offer important insights into the significance of the host genetic 
background in affecting GIT microbiota development. Nevertheless, there is currently a 
lack of research exploring the temporal changes of the gut microbiota in preterm twins.  
Preterm neonates provide a unique cohort to study the dynamics of the gut microbiota 
due to intensive care practises and the susceptibility of these infants to complex disease. 
For example, NEC and sepsis are complex diseases which together affect over 20% of 
all preterm infants and are associated with differential microbiota development 
compared to term infants (Berrington et al. 2013). Understanding how heritable traits 
affect the gut microbiota may help elucidate the interactions influencing disease states 
(Benson et al. 2010). Studying twins with NEC or sepsis may help elucidate the role of 
specific exposures that may be key to reducing incidence of these diseases. Indeed, 
Benson et al. (2010) hypothesised that genetic heritability to complex diseases might 
involve the predisposition to particular patterns of microbial colonisation. 
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For term infants vaginal delivery and receipt of maternal breast milk are key factors that 
facilitate the development of a ‘healthy’ microbiota. Breast milk contains many 
immunomodulatory factors that support growth and prevent infection including 
lysozyme, lactoferrin, and oligosaccharides as well as live bacteria which regulate host-
microbe interactions (Cabrera-Rubio & Collado 2012) and modify infant gut microbiota 
development (Martín et al. 2009). Preterm infants are less likely to experience vaginal 
birth or only receive breast milk feeds and are more likely to experience many medical 
interventions that affect the microbiota. To what extent the infant gut microbiota reflects 
the maternal breast milk microbiota is currently unclear. However, due to a lack of 
similarity with siblings from a different birth and the high similarity observed in both 
monozygotic and dizygotic twins, it is conceivable that the environmental exposures 
including diet is influential in shaping the neonatal gut microbiota (Palmer et al. 2007). 
In a twin cohort we aimed to explore the longitudinal development of the gut bacterial 
community after preterm birth by analysis of stool and EBM. In addition we focused on 
the development of NEC in one set of twins with regular longitudinal sampling and 
where only one infant was diagnosed with NEC. 
 
6.2 Results 
 
6.2.1 Patients and samples 
Demographic information from each patient is summarised in Table 6.1 and further 
details based on each individual sample can be found in the appendix (Appendix 10 - 
disc). In total, 27 patients (12 twin pairs and 1 triplet set) contributed to the study. No 
patients received probiotics or prebiotics. Five patients developed NEC with one case 
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causing fatality (patient 29); all NEC cases were treated by medical intervention with 
non-requiring surgery. Five patients developed sepsis (two of whom also had NEC) 
with two infants having multiple episodes and one case causing fatality (patient 92). 
Cultured organisms included CoNS, Klebsiella pneumonia, Staphylococcus aureus, and 
Pseudomonas. Specific genotyping information was not available and therefore the 
classification of twin zygosity was based on chorionicity data: different sex twins are 
dizygotic, same-sex twins are either monochorionic (monoaminotic (1 sac) or 
diamniotic (2 sacs)) which are always monozygotic, or dichorionic diaminotic which 
could be monozygotic or dizygotic. For the triplets, two (patients 145/148) were 
monochroionic monoaminotic and the other (patient 147) was born in a different sac. 
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Table 6.1 Summary of patient demographics 
Pat. 
No. 
Del. 
Mode 
GA 
(week) 
Birth 
Wt 
(g) 
Sex Chorionicity NEC 
NEC 
Diag. 
(DOL
a
) 
BC
b
+ 
BC
b
 
(DOL
a
) 
Organism 
22 
CS 
27 870 M Dichorionic 
Diamniotic 
N 
 
N 
  
23 27 790 F N 
 
N 
  
28 
CS 
28 1250 M Monochorionic 
Diamniotic 
N 
 
N 
  
29 28 1180 M Y 17 N 
  
39 
CS 
25 780 M Dichorionic 
Diamniotic 
N 
 
Y 15 CoNS
d
 
41 25 820 M N 
 
Y 15 S.aureus 
46 CS 26 830 M 
Dichorionic 
Diamniotic 
N 
 
N 
  
47 Vag 26 760 F Y 45 Y 3 / 8 
CoNS
d
/ 
Pseudomonas 
sp. 
51 
CS 
27 1060 M Dichorionic 
Diamniotic 
Y 16 Y 17 / 56 
CoNS
d
 / 
CoNS
d
 
55 27 1100 M N 
 
N 
  
68 
Vag 
26 760 M Dichorionic 
Diamniotic 
N 
 
N 
  
70 26 860 M N 
 
Y 40 CoNS
d
 
92 
CS 
25 740 M Dichorionic 
Diamniotic 
N 
 
Y 8 K.pneumonia 
93 25 670 M N 
 
N 
  
100 
CS 
27 1050 M Monochorionic 
monoamniotic 
N 
 
N 
  
101 27 910 M N 
 
N 
  
112 
Vag 
25 700 F Dichorionic 
Diamniotic 
N 
 
N 
  
113 25 680 M N 
 
Y 57 CoNS
d
 
135 
CS 
29 910 F Monochorionic 
Monoamniotic 
(TTTS)
c
 
N 
 
Y 54 
S.aureus+ 
K.pneumoniae 
136 29 1275 F N 
 
N 
  
139 
CS 
30 1470 M Dichorionic 
Diamniotic 
Y 28 N 
  
140 30 1455 F N 
 
N 
  
145 
CS 
31 990 M Monochorionic 
Monoamniotic 
N 
 
N 
  
148 31 1455 M N 
 
N 
  
147 31 1540 M 
Dichorionic 
Diamniotic 
N 
 
N 
  
151 
Vag 
27 1020 F Dichorionic 
Diamniotic 
N 
 
N 
  
154 27 1060 M Y 21 N 
  
a
Day of life. 
b
Blood culture. 
c
TTTS – Twin to Twin Transfusion Syndrome. dCoNS – 
Coagulase negative Staphylococcus. 
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6.2.2 Stool profiles  
PLS-DA of all samples from all patients based on DGGE data demonstrated twin pairs 
had comparable profiles which were distinct from unrelated individuals (Fig 6.1A). 
Samples which fell outside the ellipse (indicating Hotellings T
2
 range, at 95% 
confidence) belonged to the triplets or were associated with late onset infection. 
Specifically, this comprised sample 139t collected one day post NEC diagnosis as well 
as samples 39c and 41b collected three days prior and on the day of sepsis diagnosis, 
respectively. Based on DGGE analysis of the cohort (Fig 6.1A), a subset of longitudinal 
samples from the triplets (represented by red squares) and twin pair discordant for NEC 
(represented by orange circles), which showed significant variation in community 
development, were selected for pyrosequencing. The pyrosequencing data was analysed 
at the genus level using weighted UniFrac. 
The pyrosequencing data was based on a subset of stool samples with focus on the 
triplets and twin pair discordant for NEC (Appendix 10). Rarefaction curves generated 
from the pyrosequencing data show for the majority of samples the curves surpass 
exponential phase and are plateauing out (Fig 6.2). Therefore, the majority of diversity 
within these samples has been captured, but the rarer lower abundant OTUs may not 
have been detected. The pyrosequencing profiles were analysed using weighted 
UniFrac. In accordance with the DGGE data, samples grouped with their related twin, 
showing high intra-sample similarities in the development of the gut microbiota (Fig 
6.1B). This is reflected in the bar plots which show each set of twins and the triplets 
developed a distinct gut microbiota (Fig 6.3). Proteobacteria and Firmicutes dominated 
samples in both DGGE and pyrosequencing. From pyrosequencing, 5 OTUs were found 
in the core microbiota, that is genera present in over 85% of in stools (Seekatz et al. 
2013), from the families Enterobacteriaceae, Enterococcaceae, and Staphylococcaceae.  
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Figure 6.1 - Community profiles of gut (stool) microbiota from preterm multiples. Subjects are symbolised based on related multiples. A) Partial 
least squares discriminant analysis (PLS-DA) based on DGGE data of all stool samples. The ellipse indicates Hotellings T
2
 range, at 95% confidence. 
Selected sample labels removed for clarity. B) Weighted UniFrac PCoA based on pyrosequencing data at genus level, generated from a subset of stool 
samples. Triplet samples (patients 145, 147, and 148; red squares) and discordant twins (patients 139 (NEC) and 140; orange circles).  
1
4
1
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Figure 6.2 - Rarefactions curves. Produced in QIIME to 5000 sequences comparing all samples  (stool and expressed breast milk). 
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Figure 6.3 - Order level bar plot of all samples (stool and expressed breast milk) which underwent 454 pyrosequencing. 
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6.2.3 Comparison of breast milk with respective stool samples 
The DGGE profiles of all extracted EBM samples were compared with the respective 
stool sample. EBM samples showed a relative lack of diversity making them cluster 
near the origin: despite this PLS-DA did reveal EBM samples clustered with the stool 
samples of the respective set of multiples (Fig 6.3A). There are cases where different 
EBM samples from the same mother cluster separately showing the EBM microbiome 
was not stable (e.g. BM148e / BM147b / BM145a / BM145i or BM139b / BM139f / 
BM139q). 
EBM from the triplet set and twin set (patients 139/140) also underwent 
pyrosequencing. EBM samples from each mother showed high intra-sample similarity 
(Fig 6.3B). For twins 139/140 the EBM profiles (BM139/BM140) clustered closely 
with the respective stool (139s/140s). This clustering was less robust in the triplet set 
although triplet EBM (BM145/BM147/BM148) was still more similar to triplet stool 
(145a/147b/148b) than stool of other infants. Noteworthy, due to the inclusion of only 
two sets of multiples, principal component 1 (74%) represents a large amount of the 
variance. The similarity of EBM samples with stool can be visualised in the bar plot 
(Fig 6.2). Three OTUs were found in the core microbiota in EBM and, like in the stool 
core microbiota, were from families Enterobacteriaceae, Enterococcaceae, and 
Staphylococcaceae. 
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Figure 6.4 - Comparison of breast milk with respective stool profiles. Subjects are symbolised based on related multiples. A) Partial least squares 
discriminant analysis (PLS-DA) based on DGGE data of all breast milk (EBM) samples matched to respective stools. The ellipse indicates Hotellings 
T
2
 range, at 95% confidence. B) Weighted UniFrac PCoA based on pyrosequencing data at genus level, generated from a subset of EBM and respective 
stool samples. 
1
4
5
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6.2.4 Comparison of sequenced DGGE bands 
All the DGGE bands which were excised and sequenced (n = 17) corresponded to 6 
different bacterial genera; Actinomyces, Corynebacterium, Enterobacter, Enterococcus, 
Klebsiella, and Propionibacterium (Appendix 10). The richness of these sequenced 
OTUs were compared at genus level with development of NEC or sepsis. 
Corynebacterium and Enterococcus were significantly (P = 0.001) more abundant prior 
to NEC diagnosis, with the latter being present in much greater abundance across all 
groups (Fig 6.5A). Levels of Actinomyces was shown to be significantly (P = 0.001) 
higher following NEC diagnosis. Only Propionibacterium was found to be significantly 
affected by sepsis with the richness increasing significantly (P = 0.001) following 
diagnosis (Fig 6.5B). 
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Figure 6.5 – Bar plot showing the average abundance of sequenced DGGE bands. Abundance based on DGGE band intensity. Act - Actinomyces, 
Cor - Corynebacterium, Eba - Enterobacter, Eco - Enterococcus, Kle - Klebsiella, Pro - Propionibacterium. A) Abundance of each genus in NEC. B) 
Abundance of each genus in sepsis. * Denotes significance. 
0
0.0002
0.0004
0.0006
0.0008
0.001
0.0012
0.0014
0.0016
Act Cor Eba Eco Kle Pro
A
v
er
ag
e 
ab
u
n
d
an
ce
 o
f 
g
en
er
a 
Control
Pre NEC
Post NEC
0
0.0001
0.0002
0.0003
0.0004
0.0005
0.0006
0.0007
0.0008
0.0009
Act Cor Eba Eco Kle Pro
Control
Pre Sepsis
Post Sepsis
A B 
* 
* 
* 
* 
1
4
7
 
 148 
 
6.2.5 Gut microbiota in NEC (twin set 139/140) 
A reduction in diversity was observed in patient 139 at least 5 days before NEC was 
apparent clinically (Fig 6.6A), which was not shared by the twin. A less pronounced 
reduction in diversity did occur in the control twin (140) earlier in development (day 
18) that coincided with antibiotic administration and diversity was quickly re-
established when antibiotics ceased, a recovery not seen in the infant with NEC over the 
same time scale.  
To gain insight into the taxa involved in this dysbiosis, matched samples were selected 
for 454 pyrosequencing based on prominent changes in the DGGE profiles. 
Pyrosequencing of matched twin samples (full profiles in the bar plot; Fig 6.3) 
incorporated the 12 most abundant OTUs into the analysis (Fig 6.6). These results are in 
accordance with the DGGE data and allow greater detail about specific contributors to 
the overall diversity to be observed. While community structure in the twins was 
initially comparable, twin 139 showed reducing diversity with an increasing abundance 
of Escherichia sp., before NEC diagnosis on day 28 (Fig 6.6B). Conversely, in the 
sibling there is an increase in diversity and Escherichia sp. was present in much lower 
abundance (Fig 6.6C). After antibiotic receipt (day 16 in twin 140 and day 28 in twin 
139) both twins demonstrate reduced Escherichia sp. abundance and an increased 
abundance of other Enterobacteriaceae, rapidly reversing in twin 140 on antibiotic 
cessation. In twin 139 NEC and subsequent antibiotic treatment significantly (P = 
0.028) altered the bacterial community in comparison to its sibling, with a new notable 
bloom in Klebsiella sp. and a smaller increase in Parascardovia sp. (family – 
Bifidobacteriaceae). 
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Figure 6.6 - Development of gut microbiota in twin pair 139/140 mapped to life events. 
P – Penicillin, G – Gentamicin, F- Fluctoxacillin, A - Amoxycillin, M – Metronidazole, s –
Start of antibiotics, 
e
 – End of antibiotics, 72hr – full enteral feed (at least 150 ml/kg/day) 
sustained for 72 hours. a) Shannon Diversity indices (H') of twin pair based on DGGE data. 
b) Turnover of the most prevalent bacterial OTUs throughout the first 36 days of life in twin 
139 where antibiotics were prescribed for NEC. c) Turnover of most prevalent bacterial 
OTUs throughout the first 34 days of life in twin 140 where antibiotics were prescribed due 
to pyrexia (fever).  
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6.3 Discussion 
 
In this study, we hypothesised that the bacterial community in related twins and a set of 
triplets would be comparable and reflect maternal EBM community. In cases of twin 
pairs discordant for NEC, we hypothesized that they would show differences in 
microbial community development prior to NEC onset.  
We have demonstrated in a preterm population with multiple clinical exposures that the 
development of the gut microbiota is more similar between genetically related 
individuals than between other preterm infants. However, due to similar environmental 
exposures encompassed by related individuals, this may not be a direct result of host 
genetics. Interestingly, community structure was similar for all triplets even though two 
(145/148) were monochorionic monoamniotic and the other (147) was dichorionic. This 
suggests that shared factors (genetic or environmental) are important in determining the 
gut microbiota even in an environment with many complex variable factors that also 
affect community development (Ley et al. 2005; Palmer et al. 2007). 
Proteobacteria and Firmicutes dominated the gut microbiota over the initial weeks of 
life as previously reported (Mshvildadze et al. 2010). Stool and EBM shared a core 
microbiota of the families Enterobacteriaceae, Enterococcaceae, and 
Staphylococcaceae. Others describing the EBM microbiota noted the presence of 
Streptococcaceae which in was present in low abundance in our maternal cohort 
(Collado et al. 2009; Hunt et al. 2011). We also detected a low abundance of 
bifidobacteria and lactobacilli in stool and EBM despite their reported prevalence by 
others (Penders et al. 2006; Collado et al. 2009; Martín et al. 2009). This may be 
attributable to differences among subjects, unit flora, and detection by differing 
techniques (Hunt et al. 2011), but occurred despite the use of optimised universal 
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primers in pyrosequencing designed to facilitate the detection of Bifidobacteria (Sim et 
al. 2012). This might be attributable to differences between cohorts, with significantly 
preterm infants having delayed colonisation with bifidobacteria; geographical or 
demographic differences may also account for the low prevalence of this organism 
(Palmer et al. 2007). In accordance with the results of this study, previous studies have 
shown that the milk microbiota is not stable throughout lactation and EBM appeared to 
be an ongoing source of new flora contributing to the dynamic nature of the bowel 
microbiota (Cabrera-Rubio & Collado 2012). Furthermore, genera which typically 
reside on adult skin including Staphylococcus, Corynebacterium, and 
Propionibacterium were found in high abundance in the gut microbiota suggesting skin 
contact may be an important source of bacterial acquisition, even within the nursery 
environment (Cogen et al. 2008). 
The importance of the gut microbiota in disease is increasingly recognised, despite a 
lack of consistent causative agent between studies. DGGE analysis of the whole cohort 
showed levels of Corynebacterium and Enterococcus were significantly elevated prior 
to NEC diagnosis. This is contrary to our routine culture based analysis where 
Enterococcus faecalis was more commonly isolated from control infants (Chapter 4, 
section 4.2.2). This suggests that molecular based approaches, which take species 
abundance into account, may offer important insights otherwise missed by traditional 
approaches. Interestingly, Enterococcus faecalis has recently been suggested as a 
potential biomarker in predicting NEC (Braniste & Pettersson 2012). Following 
diagnosis of NEC and subsequent antibiotic administration, the community showed 
elevated levels of Actinomyces.  
While there was no significant dominance of a genus prior to sepsis, Propionibacterium 
was significantly more abundant following diagnosis and antibiotic treatment. This is in 
accordance with recent work, where dysbiosis of the normal microbiota led to sepsis 
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and not enrichment of a potential pathogen (Mai et al. 2013). Interestingly, following 
antibiotic treatment for either NEC or sepsis, members of the Actinobacteria phylum 
were significantly more abundant; correspondingly, this phylum is usually associated 
with control infants (Mai et al. 2011). 
In a focused temporal exploration from a twin pair (139/140) discordant for NEC, we 
showed clear changes attributable to antibiotic exposure and NEC development, with 
effects on the dominance of Escherichia sp. and the abundance of other 
Enterobacteriaceae sp. (Madan et al. 2012). The significantly different community 
observed in sample 139t is likely attributable to a temporary bloom in Klebsiella sp. 
following NEC diagnosis, which was reduced in the subsequent sample following broad 
spectrum antibiotic administration. While there are few comparable studies in NEC, a 
twin study methodology has been utilised in other IBD, such as ulcerative colitis and 
Crohn’s disease. Interestingly, analogous to NEC, dysbiosis is a major factor in the 
pathogenesis of these diseases, consistent with a lack of a single causative agent 
(Lepage et al. 2011). Specifically, a decreased diversity in the gut microbiota of 
ulcerative colitis and Crohn’s disease patients compared to healthy controls has been 
noted, (Gophna et al. 2006; Wang et al. 2009) and multiple studies report increased 
abundances of Proteobacteria, particularly Escherichia sp. (Darfeuille-Michaud et al. 
2004; Sasaki et al. 2007). This increase in Proteobacteria is an emerging theme in NEC 
pathogenesis (Mai et al. 2011), but is probably one of several factors needed for NEC 
development. Escherichia spp. are reported pathogens (Kaper et al. 2004) and the 
association of this genus with inflammatory mediated disease warrants further 
investigation. 
Our use of molecular approaches for community profiling circumvents the known 
limitations of culturing human gut species (Eckburg et al. 2005). We utilised cost 
effective DGGE to educate sample selection for 454 pyrosequencing. Studies on 
 153 
 
preterm infants, especially of multiple births, are difficult due to the exclusivity of the 
cohort and thus only 27 patients could be included. With the exception of the twin set 
139/140, twins discordant for disease often lacked informative longitudinal samples, in 
part due to feeding being suspended resulting in reduced excrement. Although the 
number and timing of samples collected from each set of twins was generally 
comparable, varying numbers of samples were collected between twin sets which may 
bias some analysis. The data generated using DGGE and pyrosequencing were in 
agreement, perhaps due to primer sets encompassing the V3 hypervariable region of the 
16S rRNA genome in both analyses. Pyrosequencing allows larger fragments to be 
amplified allowing the use of bifidobacteria-optimised universal primers. Despite this, 
bifidobacteria was not found to be a prevalent genus (Palmer et al. 2007) which requires 
further study due to the potential use of this taxa as probiotic in therapeutic intervention 
(Embleton & Yates 2008). 
In summary, this study represents a unique temporal analysis of the gut microbiota in 
preterm twins, cared for within the complex environment of neonatal intensive care. 
Although twins discordant for late onset infection showed differences in gut microbiota 
development, overall, related infants harboured bacterial communities more similar to 
each other than nonrelated infants. As well as shared genetic and immunomodulatory 
factors, this is likely a result of exposure to the same maternal microflora during birth, 
skin contact and exposure to EBM. We have also shown that other environmental 
factors, particularly antibiotic exposure, have additional significant effects on the gut 
microbiota in genetically related infants. These findings reflect other studies in which 
antibiotics have been shown to alter the gut microbiota in term (Palmer et al. 2007) and 
adult popultions (Simões & Maukonen 2013) and the exact role of individual antibiotics 
in altering the preterm gut microbiota warrants further investigation. We have further 
noted potential concurrence between community changes associated with other 
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inflammatory mediated diseases, such as ulcerative colitis and Crohn’s disease, and 
those increasingly reported to occur in NEC.  
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7. Next generation sequencing of the gut microbiota in preterm 
neonates: A case-control study 
Abstract 
Aim: The gut microbiota is significantly associated with the development of NEC and 
sepsis. Previous studies are limited by cohort size, poor sampling, and methodological 
restrictions. We aimed to extensively explore the differential community development 
in patients with NEC and sepsis, matched to controls. 
Methods: In total, 42 preterm infants were enrolled contributing a total of 747 stool 
samples. Patients were split into two groups consisting of 21 patients where 7 patients 
developed proven NEC and/or sepsis matched to 14 controls. All samples were analysed 
on the MiSeq and paired end reads underwent contig assembly and processing in 
Mothur.  
Results: The gut microbiota was relatively unstable in the initial weeks of life. The core 
microbiome consisted of Klebsiella Oxytoca, Escherichia coli, Staphylococcus, 
Enterococcus, and Veillonella. The diversity of the gut microbiota generally increased 
over time and was not consistently reduced prior to disease diagnosis. However, 
increases in the abundance of certain OTUs were observed prior to NEC diagnosis, 
particularly with Escherichia coli. Organisms isolated in blood culture for the diagnosis 
of sepsis were typically abundant in the gut. Caesarean delivery resulted in increased 
colonisation by Staphylococcus, but after 3 weeks of life the effect of birth mode was 
lost. Gestational age had a significant (P = 0.001) influence of the bacterial community.  
Conclusions: The preterm gut microbiota is a complex and dynamic community with a 
multitude of factors influencing its development. Gestational age had important 
influences on the community. While no consistent associations between reduced 
diversity or increased dominance prior to disease diagnosis were observed, Escherichia 
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coli was prevalent prior to diagnosis of NEC. A diverse community seems to be 
important to the health of a neonate supporting the notion of probiotics to stabilise the 
gut microbiota.  
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7.1 Introduction 
 
The gut microbiota has received significant interest over the past decade, with the use of 
NGS technologies helping to reveal the true diversity of this complex ecosystem 
(Fukatsu 2012). Pyrosequencing provided the majority of early NGS data. More 
recently the Illumina SBS platform has been favoured, owing to its ability to accurately 
identify homopolymer runs and with the introduction of the bench top MiSeq the 
technology has become more accessible and increasingly affordable (Luo et al. 2012). 
Indeed, the MiSeq was recently reported to be the best bench top sequencing platform 
currently available (Loman et al. 2012). However, despite constantly improved 
chemistry, NGS techniques are still subject to PCR bias, including amplification 
efficiency and artifacts arising due to the formation of heteroduplex and chimeric 
sequences (Thompson et al. 2002; Wang & Qian 2009). 
While the preterm gut microbiota is considerably less diverse than that of healthy term 
neonates, previous studies have lacked the coverage to accurately determine its true 
diversity (Arboleya et al. 2012). Deep sequencing has been implemented in a small 
cohort of 11 preterm infants and revealed an extremely diverse community consisting of 
bacteria, fungi, viruses, bacteriophage, and surprisingly roundworm (LaTuga et al. 
2011). Data from the human genome project suggests a huge number of reads is 
required to fully elucidate complete diversity (Schatz et al. 2010). This is due to the 
presence of low abundance, often transient taxa in the community which require deep 
coverage in order to identify them. In contrast, the dominant taxa tend to show greater 
temporal stability  and typically represent the core microbiome, which are all the OTUs 
that are present in all samples over a certain percentage cut-off (Jalanka-Tuovinen et al. 
2011). In a preterm population we have previously shown a core community of 5 OTUs 
from the Enterobacteriaceae, Enterococcaceae, and Staphylococcaceae familes at 85% 
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cut-off (Chapter 6; Stewart et al. 2013). However, the importance of the non-core 
organisms are increasingly recognised as important as improved sequencing technology 
has facilitated the coverage of these taxa (Matsuda et al. 2009; van der Gast et al. 2011). 
Previous preterm gut microbiome studies have lacked the sequencing coverage to 
accurately explore this satellite community, which may have important implications in 
health and disease (Sobhani et al. 2011). 
It has been reported that by one year of age an infant’s gut microbiota is reflective of an 
adult community with increased Bacteroides and a reduction in Proteobacteria as well 
as greater stability, in the absence of medical intervention (Palmer et al. 2007). In 
comparison, the neonatal gut microbiota is less stable, with antibiotics known to 
significantly delay and alter its development (Mai et al. 2013). This may have important 
consequences for the preterm infant where delayed establishment of a diverse 
community can predispose the infant to NEC and sepsis. NEC and sepsis are both 
significant diseases which primarily affect the preterm population, with gut microbiota 
development significantly different compared to healthy controls (Mai et al. 2013; 
Stewart et al. 2013). Reports that the gut microbiota undergoes shifts and reduction in 
its diversity prior to disease diagnosis suggests that it is, in part, involved in the 
pathogenesis of NEC (Wang et al. 2009). Therefore, further information regarding the 
microbial involvement in the pathogenesis of these diseases may offer important 
information to improve the ability for both early detection and the subsequent clincal 
management.  
NEC and sepsis are difficult diseases to diagnose with current staging criteria deemed 
outdated. Typically the patient will not present with the symptoms of NEC (abdominal 
distension) or sepsis (pyrexia) until the advanced stages of disease progression. Thus, 
subsequent management of the disease often needs to be more invasive leading to 
increased morbidity (Berrington et al. 2012). Medical management of NEC and sepsis 
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is based on antibiotic treatment for a minimum of 5 days. Where medical management 
is insufficient and in the more severe cases of NEC, the patient may undergo surgery to 
remove the necrotic tissue.  
In an ideal study one would recruit a cohort of diseased patients matched to healthy 
controls. Regular longitudinal sampling to monitor the development of the gut 
microbiota as well as robust sampling preceding and following disease diagnosis would 
be essential if the aetiology of disease was to be explored. However, current data on the 
preterm gut microbiota is often limited by scarce and irregular sampling making 
resulting conclusions superficial (Mai et al. 2013; Mai et al. 2011; Wang et al. 2009). In 
clinical microbial ecology, comparison between diseased and healthy patients is 
challenging due to the number of confounding variables which exist between patients 
due to differing host genetics and environmental/clinical exposures. Preterm infants are 
subject to intensive care practise which involve being housed in sterile incubators with 
limited environmental microbial exposure (Claud et al. 2013).  
To overcome the limitations of previous studies, we have investigated a large cohort of 
patients with NEC and/or sepsis, matched to healthy controls. Robust longitudinal 
sampling allowed the most informative samples to be selected retrospectively. All 
samples underwent NGS on the MiSeq platform to achieve a high depth of coverage.  
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7.2 Results 
 
7.2.1 Patients and samples 
Demographic information from each patient is summarised in Table 7.1 and further 
details based on each individual sample can be found in Appendix 11 (disc). A total of 
42 preterm infants were enrolled in the study contributing a total of 747 stool samples. 
Patients were split into two groups; Extremely Preterm (group “EP”: gestational age 23 
- 26 weeks) and Very Preterm (group “VP”: gestation age 27 – 30 weeks). Each group 
consisted of 21 patients where 7 patients developed proven NEC and/or sepsis matched 
to 14 patients who acted as controls. Of the diseased patients in the EP group, 4 patients 
developed NEC only with 1 fatality, 1 patient developed sepsis with Staphylococcus 
hominis and Staphylococcus epidermidis and was later diagnosed with NEC, 1 patient 
developed sepsis with CoNS and was deemed to have died of NEC which was not 
diagnosed until death, and 1 patient developed sepsis with Escherichia coli. Of the 
diseased patients in the VP group, 2 patients developed NEC and 5 patients developed 
sepsis with 2 cases of Staphylococcus aureus and single cases of CoNS, Enterococcus 
faecalis, and Streptococcus agalactiae. No fatalities occurred in the VP group. No 
patient in the cohort received probiotics or prebiotics. 
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Table 7.1 – Demographic summary of each group 
Group Averages 
Extremely Preterm  
(GA
a
 23 – 26 wks) 
Very Preterm  
(GA 27 – 30 wks) 
Diseased 
(n=7) 
Control 
(n=14) 
Diseased 
(n=7) 
Control 
(n=14) 
GA
a
 (wks) 25 25 28 28 
Birth Weight (g) 653 845 1165 1224 
Birth Mode  
(CS
b
 / Vaginal) 
2 / 5 5 / 9 4 / 3 8 / 6 
Gender  
(Male / Female) 
1 / 6 8 / 6 6 / 1 12 / 2 
Fatalities 2 0 0 0 
NEC 5 0 2 0 
NEC + Sepsis 1 0 0 0 
Sepsis 1 0 5 0 
a
Gestational age;  
b
Caesarean 
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7.2.2 Overview of preterm gut microbiota development in whole cohort 
Sequencing by synthesis (SBS) resulted in sample coverage of over 99% for all samples 
(Appendix 11 - disc). This facilitated subsequent analysis as the majority of low 
abundance OTUs were detected. Culturing and subsequent identification of isolates by 
MALDI-TOF and full length 16S sequencing identified an unclassified 
Enterobacteriaceae OTU as Klebsiella oxytoca and an important Escherichia OTU as 
Escherichia coli. Overall, a core microbiome present in over 85% of samples consisted 
of 5 OTUs corresponding to K. oxytoca, E. coli, Staphylococcus, Enterococcus, and 
Veillonella. The OTUs with presence in every sample corresponded to Escherichia, 
Staphylococcus, and Enterococcus (Appendix 11). Although not present in the core 
microbiome (85% cut-off), Bifidobacterium was found to be an abundant taxon (Table 
7.2). 
To investigate the role of delivery mode on the development of the gut microbiota 
patients who contributed week 1 stool (n = 26) were analysed. The first stool collected 
in each week, up to week 7, were included to visualise the average profile for both 
caesarean and vaginal delivery (Fig 7.1). The Bray-Curtis index, which takes into 
account abundance, was used to compare the relatedness of the communities each week. 
Profiles over the first 3 weeks of life show the least similarity, with an increased 
abundance of Staphylococcus in caesarean infants. Greatest variation occurred in week 
2 with notable dominance by Staphylococcus in caesarean infants. From week 4 the 
Staphylococcus dominance in caesarean samples is lost and profiles show greater 
similarity. Profiles from week 7 showed the greatest similarity. 
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 Table 7.2 – Abundance of bacterial OTUs from whole cohort 
   
Average 
per 
sample 
(%) 
Core 
cut-
off 
(%) 
Taxonomy 
29.97 95 Proteobacteria; Gammaproteobacteria; Enterobacteriales; Enterobacteriaceae; unclassified 
21.48 100 Proteobacteria; Gammaproteobacteria; Enterobacteriales; Enterobacteriaceae; Escherichia 
15.17 100 Firmicutes; Bacilli; Bacillales; Staphylococcaceae; Staphylococcus 
14.22 100 Firmicutes; Bacilli; Lactobacillales; Enterococcaceae; Enterococcus 
3.40 75 Actinobacteria; Actinobacteria; Bifidobacteriales; Bifidobacteriaceae; Bifidobacterium 
2.08 85 Firmicutes; Negativicutes; Selenomonadales; Veillonellaceae; Veillonella 
1.49 <50 Bacteroidetes; Bacteroidia; Bacteroidales; Bacteroidaceae; Bacteroides 
1.31 60 Firmicutes; Bacilli; Lactobacillales; Streptococcaceae; Streptococcus 
1.10 60 Proteobacteria; Gammaproteobacteria; Pseudomonadales; Pseudomonadaceae; Pseudomonas 
0.99 <50 Proteobacteria; Gammaproteobacteria; Enterobacteriales; Enterobacteriaceae; Morganella 
0.88 <50 Actinobacteria; Actinobacteria; Actinomycetales; Actinomycetaceae; Actinomyces 
0.64 55 Firmicutes; Clostridia; Clostridiales; Clostridiaceae_1; Clostridium_sensu_stricto 
0.50 <50 Proteobacteria; Gammaproteobacteria; Pseudomonadales; Moraxellaceae; Acinetobacter 
0.48 <50 Proteobacteria; Gammaproteobacteria; Pasteurellales; Pasteurellaceae; unclassified 
0.46 <50 Proteobacteria; Gammaproteobacteria; Pseudomonadales; Pseudomonadaceae; Pseudomonas 
0.45 <50 Proteobacteria; Gammaproteobacteria; Enterobacteriales; Enterobacteriaceae; Yersinia 
0.41 55 Firmicutes; Clostridia; Clostridiales; Clostridiales_Incertae_Sedis_XI; Finegoldia 
0.38 <50 Actinobacteria; Actinobacteria; Actinomycetales; unclassified; unclassified 
0.35 70 Proteobacteria; Betaproteobacteria; Burkholderiales; Oxalobacteraceae; Herbaspirillum 
0.33 <50 Firmicutes; Clostridia; Clostridiales; Clostridiales_Incertae_Sedis_XI; Peptoniphilus 
0.29 50 Actinobacteria; Actinobacteria; Actinomycetales; Corynebacteriaceae; Corynebacterium 
0.28 <50 Proteobacteria; Gammaproteobacteria; Enterobacteriales; Enterobacteriaceae; Proteus 
0.24 <50 Actinobacteria; Actinobacteria; Actinomycetales; Corynebacteriaceae; Corynebacterium 
0.22 <50 Firmicutes; Bacilli; Lactobacillales; Streptococcaceae; Streptococcus 
0.21 <50 Firmicutes; Bacilli; Lactobacillales; Lactobacillaceae; Lactobacillus 
0.19 <50 Actinobacteria; Actinobacteria; Actinomycetales; Actinomycetaceae; Actinomyces 
0.18 <50 Firmicutes; Bacilli; Lactobacillales; Streptococcaceae; Streptococcus 
0.16 <50 Firmicutes; Bacilli; Lactobacillales; Lactobacillaceae; Lactobacillus 
0.14 <50 Firmicutes; Clostridia; Clostridiales; Clostridiales_Incertae_Sedis_XI; Anaerococcus 
0.13 <50 Proteobacteria;Gammaproteobacteria;Xanthomonadales;Xanthomonadaceae;Stenotrophomonas 
0.12 <50 Proteobacteria; Alphaproteobacteria; Rhizobiales; Brucellaceae; Brucella 
0.12 <50 Fusobacteria; Fusobacteria; Fusobacteriales; Fusobacteriaceae; Fusobacterium 
0.11 <50 Actinobacteria; Actinobacteria; Actinomycetales; Dermabacteraceae; Dermabacter 
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Figure 7.1 – Effect of birth mode on bacterial community development over the 
first 7 weeks of life in whole cohort. Legend shows 12 most abundant taxa. Similarity 
scores based on Bray-Curtis index where 1 represents identical communities.  
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7.2.3 Comparison of the extremely preterm vs very preterm gut microbiota 
The study design allowed for the comparison of EP and VP infants. Applying weighted 
UniFrac statistical analysis, which considers branch length of the phylogenetic tree, 
revealed gestational age had a significant effect (P = 0.001) on the gut microbiota 
development. This significant difference can be visualised by generation of 
phylogenetic trees (Fig 7.2). The diameter of the circle at each node is proportional to 
abundance of this OTU. The segments within each circle consist of all the samples 
where the OTU was detected, relative to the abundance within each sample. Clinically 
important OTUs that differed significantly include Lactobacillus (P = <0.001), and 
Ureaplasma (P = <0.001) which were greater in EP and Pseudomonas (P = <0.001) 
which was greater in EP (full list in Appendix 11). 
The difference between the EP and VP was further explored by plotting the normalised 
abundance of both the dominant and satellite OTUs for healthy infants over the initial 
weeks of life (Fig 7.3). Only the first sample per patient in each week was included. 
This revealed the individual nature of each infants gut microbiota. The 5 OTUs from the 
core microbiome contributed a significant proportion to the communites throughout, 
although the dominant organism varied within and between patients. However, these 
taxa became less abundant in the later weeks of life. In contrast, the satellite taxa 
became more abundant. The abundance of Bifidobacterium, satellite taxa, generally 
increased in the later weeks, with particular presence around week 10 resulting in 
reduced dominance by the core microbiome. Patient 234 (VP group) had a very distinct 
gut microbiota that was almost entirely dominated by K. oxytoca.  
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Figure 7.2 – Phylogenetic tree of all samples based on gestational age. The diameter 
of the circle at each node is proportional to abundance of this OTU. The segments 
within each circle consist of all the samples where the OTU was detected, relative to the 
abundance within each sample.  A) Extremely preterm. B) Very preterm.
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    B) 
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Figure 7.3 – Development of the core and satellite gut microbiota in each healthy 
infant over the initial weeks of life. Legend shows satellite and core communities 
which are divided into the top and bottom graphs, respectively. Number indicates the 
individual patient number of the respective profiles (full patient data in appendix 11 - 
disc) A) Extremely preterm. B) Very preterm.  
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7.2.4 Development of NEC and sepsis  
Due to the important significance between the groups based on gestational age, these 
groups were analysed independently for the association of the gut microbiota with NEC 
and sepsis pathogenesis. PLS-DA revealed a distinct bacterial community between the 
diseased samples, both pre and post onset, and the control samples (Fig 7.4). Within the 
diseased samples there was also separation of samples from NEC patients with sepsis 
patients. This applied to both gestational groups. Both the EP and VP groups also 
showed that a relatively large number of samples which predate NEC diagnosis fell 
outside the ellipse (indicating Hotellings T
2
 range, at 95% confidence) and were thus 
significantly different. In the EP group, post sepsis samples grouped with post NEC 
samples, whereas in the VP group the post sepsis samples showed greatest similarity to 
the pre sepsis samples.  
The Shannon diversity (Hʹ) was used to explore the diversity of diseased samples 
proceeding and following disease diagnosis, matched to two controls (Fig 7.5). 
Diversity variation was greatest in the initial weeks of life and increased from relatively 
low diversity initially to a more diverse community prior to discharge from the NICU. 
No consistent Hʹ trend was observed prior to disease diagnosis within diseased infants 
compared to the control infants, although in general the Hʹ decreased following disease 
diagnosis and subsequent antibiotic treatment.  
 
 173 
 
Figure 7.4 – PLS-DA plots comparing the bacterial profiles of all samples from 
each gestational group according to disease. A) Extremely preterm. B) Very preterm.
A) 
B) 
Control 
Pre Sepsis 
Post Sepsis 
Pre NEC 
Post NEC 
Control 
Pre Sepsis 
Post Sepsis 
Pre NEC 
Post NEC 
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Figure 7.5 – Shannon diversity indices of each infant. Dotted blue lines represent 
sepsis diagnosis and dotted red lines represent NEC diagnosis. Disease infants are blue 
with each sample represented by triangles. Matched controls are either red with each 
sample represented by a square or green red with each sample represented by a triangle. 
A) Extremely preterm. B) Very preterm. 
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In a more focused exploration of the change in the total bacterial community in NEC 
and sepsis, area charts from the diseased patients were generated and antibiotic 
exposure mapped onto the graphs. Further details regarding the specific antibiotics and 
duration of administration are presented in Table 7.3. Antibiotic exposure was greatest 
in the EP group. E. coli was more prevalent in the EP group and the abundance of this 
organism increased prior to NEC in the majority of patients (Fig 7.6). Patient 171 from 
the EP group was an exception, where an increase in K. Oxytoca abundance prior to 
diagnosis of medical NEC was observed. Notably, this patient had the highest gestation 
from the EP group. Two patients (180 and 178), both in the EP group, died while on the 
NICU. In the final sample from both of these infants the community is dominated by E. 
coli. 
For NEC development in the VP group, E. coli abundance also increased in patient 139 
prior to diagnosis and unique to this patient was a large abundance of Actinomyces spp. 
from day 16 of life. However, E. coli was not abundant in the other patient from the VP 
groups diagnosed with NEC (patient 174). Although no pre NEC sample was obtained 
14 days prior to NEC diagnosis in this patient, the community remained stable from the 
preceding and post diagnosis samples.  
In patients diagnosed with sepsis, the dominant organism in the gut prior to diagnosis 
often correlates with the species isolated in blood culture. In patient 130 there was a 
dominance of Staphylococcus prior to positive blood culture, in which Staphylococcus 
aureus was isolated. In other cases, the organism identified by blood culture appears in 
the community transiently. For example, Streptococcus only appears in patient 173 in 
the three days prior to positive blood culture with Streptococcus agalactiae. While 
shifts in the community were observed prior to and following disease diagnosis, no 
significant difference occurred in the ecological dominance of a single taxon from the 
bacterial community in NEC and sepsis patients, matched to controls (Fig 7.7). 
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Table 7.3 – Antibiotic information patients with NEC and/or sepsis 
  
Patient 
Number 
Abx 
start 
(days)  
Abx 1 
(days of 
usage) 
Abx 2 
(days of 
usage) 
Abx 3 
(days of 
usage) 
Abx 4 
(days of 
usage) 
Abx 5 (days 
of usage) 
E
x
tr
em
el
y
 p
re
te
rm
 
180 
0 P (2) G (2) 
   
15 A (3) F (3) G (3) 
  
17 T (9) 
    
19 M (18) 
    
28 Me (10) G (7) 
   
43 M (2) V (2) C (2) 
  
181 
0 P (2) G (2) 
   
13 V (3) 
    
14 F (9) 
    
27 T (1) C (1) V (2) G (4) Me (17) 
33 G (3) 
    
37 G (3) 
    
41 G (3) 
    
53 A (2) F (2) G (2) 
  
61 A (2) F (2) G (2) 
  
163 
0 P (2) G (2) 
   
8 M (7) V (7) C (7) 
  
20 A (2) F (2) G (2) 
  
22 V (3) C (5) 
   
42 V (7) M (7) C (7) 
  
69 V (2) C (2) 
   
77 V (2) C (2) M (2) 
  
86 F (2) G (2) 
   
161 
0 
6 
19 
20 
27 
61 
P (2) 
C (7) 
C (6) 
M (5) 
M (10) 
A (5) 
G (2) 
V (7) 
V (6) 
 
A (10) 
 
M (7) 
 
 
G (10) 
 
 
 
199 
0 P (2) G (2) 
   
23 A (4) F (4) G (6) 
  
25 M (10) 
    
27 V (8)  C (8) 
   
67 F (6) 
    
74 C (2) V (2) 
   
178 
0 P (2) G (2) 
   
6 C (3) V (2) 
   
13 V (2) C (5) 
   
14 M (9) 
    
15 L (14) 
    
29 C (1) M (1) V (1) 
  
171 
0 P (3) G (3) 
   
9 V (2) C (2) 
   
13 A (3) G (3) F (3) 
  
17 A (4) G (5) F (4) 
  
19 M (8) 
    
21 V (6) C (6)       
V
er
y
 p
re
te
rm
 
130 
0 P (2) G (2) 
   
1 A (7) M (7) 
   
8 V (3) C (3) 
   
21 V (2) C (2) 
   
23 F (14) 
    
31 G (6) 
    
63 A (2) F (2) G (2) 
  
251 
0 P (2) G (2) 
   
8 V (7) C (3) 
   
172 
0 
15 
P (2) 
F (5) 
G (2) 
G (5) 
 
A (5) 
  
173 
0 P (5) G (5) 
   
26 F (2) A (8) G (2) 
  
166 Not available 
  
174 
0 P (5) G (5) 
   
5 V (2) C (2) 
   
25 A (2) M (7) C (7) 
  
41 V (2) 
    
139 
0 P (2) G (2) 
   
28 F (4) A (4) G (4) M (4)   
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Figure 7.6 – Area charts of all diseased infants showing all phylotypes to genus 
level. Only the most abundant genera are in the legend for clarity. Dotted blue lines 
represent sepsis diagnosis and dotted red lines represent NEC diagnosis. Dotted black 
lines show antibiotic start day as per table 7.3. A) Extemely preterm. B) Very preterm. 
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Figure 7.7 – Box plots of dominance of the bacterial community preceding disease 
diagnosis matched to controls. Box represents first and third quartile and the line with 
each box represents the median. Dominance scores of 1 represent a community 
consisting of a single taxon. A) Dominance in infants diagnosed with NEC. B) 
Dominance in infants diagnosed with sepsis. 
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7.3 Discussion 
 
The gut microbiota has been previously shown to significantly differ between diseased 
patients and controls, suggesting a role in the etiology of NEC and sepsis. Elucidating 
the complex changes of this community prior to disease diagnosis will facilitate 
improved diagnostics, treatment, and prevention of significant morbidities. This study 
represents the largest such study to date, employing NGS to explore the gut microbiota 
in preterm infants while on the NICU. The sequence depth and subsequent coverage of 
the bacterial community in each sample involved in this study is far greater than 
previous studies (Wang et al. 2009; Mai et al. 2011), facilitating the detection of low 
abundance OTUs. 
The influence of delivery mode on the gut microbiota of the neonate has received much 
attention. Significant differences have been reported based on delivery mode for the 
meconium and skin flora of neonates immediately following birth. Specifically, 
caesarean and vaginal delivery results in an initial gut microbiota of organisms that 
reflect the typical skin and vaginal microbiota, respectively (Biasucci et al. 2008; 
Dominguez-Bello et al. 2010). The results in this study support these findings with 
Staphylococcus, a common skin organism, being dominant from week 1 to 3 of life in 
caesarean delivered infants (Dominguez-Bello et al. 2010). This study advances on 
previous data in the neonate and shows that the difference observed between delivery 
modes is lost after week 3. By week 4 of life, infants developed an increasingly 
comparable gut microbiota, independent of delivery mode. This is in contrast to 
suggestions by others that the gut microbiota in infants born by caesarean delivery can 
be disrupted for up to 6 months (Grönlund et al. 1999). Using culture based approaches, 
differences were also reported in the gut microbiota 7 years after birth (Salminen et al. 
2004). The difference in results between studies might be attributable to antibiotics, 
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specifically penicillin and gentamicin, which are administered to all neonates in this 
preterm cohort for 48 hours following birth. Thus, the antibiotics may prevent the long-
term establishment of the pioneering organisms into the gut, allowing organisms which 
are introduced in subsequent weeks to colonise (Pérez-Cobas et al. 2012). This is 
further supported by the results of delivery mode on the gut microbiota where large 
numbers of pioneering organisms are no longer detectable after the initial week of life.  
In association with previous studies, K. oxytoca, E. coli, Staphylococcus, Enterococcus, 
and Bifidobacterium were the most abundant genera throughout the entire cohort 
(Mshvildadze et al. 2010; Claud et al. 2013; Stewart et al. 2013). The most abundant 
OTU corresponded to an unclassified Enterobacteriaceae but no sequence matched this 
OTU by more than 97%, despite this family being particularly well studied. Mai et al. 
(2011) also detected an Enterobacteriaceae which did not match any sequence in 
Genbank by more than 97%. We were able to successfully isolate this OTU in culture 
and identify it as K. oxytoca suggesting further important annotation of databases is 
required. The abundant organisms largely reflected the core microbiome, which is 
representative of prevalent organisms but included Veillonella and excluded 
Bifidobacterium. Veillonella is a common member of the oral and gut flora and its 
prevalence might reflect the implications of this organism in lactate fermentation and 
biofilm formation (Periasamy & Kolenbrander 2010; Madan et al. 2012).  
While members of the core microbiome dominated in the initial weeks, in the later 
weeks of life this dominance is less pronounced, with satellite organisms increasing in 
overall abundance. The bacterial profiles for each infant were specific to the individual. 
The abundance of Bifidobacterium colonisation in preterm neonates has varied 
considerably between studies but was found to be an abundant member of the 
community in this study. The levels of Bifidobacterium were observed to increase 
around week 10 of life and could represent a substantial proportion of the community in 
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some healthy patients. This may have important implication in probiotic therapy as 
increased levels of Bifidobacterium prevent dominance by a potentially pathogenic 
organism. Interestingly, Lactobacillus is also proposed as another potential probiotic 
candidate but was found in low abundance in all patients, in agreement with a previous 
study (Cox et al. 2010). Other OTUs from the satellite population which have important 
clinical implications were found in relatively high abundance in some patients, but 
appeared rather transiently. These satellite organisms, such as Streptococcus and 
Pseudomonas, are not well studied in the preterm gut but their presence warrants further 
consideration. Pseudomonas aeruginosa is an opportunistic pathogen which can cause 
healthcare-associated infections in the NICU, with increased risk in low birth weight 
preterm infants (Jefferies et al. 2012). 
Gestational age, relative to prematurity, is known to be the most significant risk factor 
associated with NEC (Berrington et al. 2013). However, studies exploring the role of 
the gut microbiota in NEC pathogenesis neglect to consider that both the community 
itself and its influence in causing NEC may differ between EP and VP infants. This 
study represents the first to consider this and importantly we demonstrate a significant 
difference (P = 0.001) in the bacterial communities between these groups. While the 
dominant bacterial genera were comparable between the two groups, significant 
differences were reported for some lower abundant OTUs. Of particular clinical 
importance are Lactobacillus (P = <0.001), and Ureaplasma (P = <0.001) which were 
greater in VP and Pseudomonas (P = <0.001) which was greater in EP. The 
administration of antibiotics was increased in the EP group compared to the VP group 
which may account, in part, for the significance of gestational age in the development of 
the bacterial community in the preterm gut. 
The significant difference between the gut microbiota of the EP and VP group warrants 
consideration when exploring the pathogenesis of disease. Although control samples 
 186 
 
cluster distinctly from diseased samples in both groups, important differences were 
found between the groups. In the EP group, the post disease samples from both NEC 
and sepsis cluster together whereas the post disease samples are still comparable to the 
pre disease samples in the VP group. This may reflect a greater effect of antibiotic 
treatment in changing the gut microbiota in the more premature group (Lafeber et al. 
2008). Increased antibiotic administration has been associated with the development of 
NEC and increased use of antibiotics in the EP group may contribute to the increased 
cases of NEC in this group. Antibiotics can significantly alter the gut microbiota and 
may cause dysbiosis (Hawrelak & Myers 2004). It is currently unclear whether a 
dysbiosis event occurs prior to disease diagnosis and, indeed, if this is causative or an 
effect of disease progression. For example, Wang et al. (2009) reported a reduction in 
diversity prior to NEC diagnosis but it is unclear if this was causative to NEC or a result 
of elevated inflammation. This is consistent with findings from other IBD conditions, 
including ulcerative colitis and Crohn’s disease, where a decrease in diversity is 
observed prior to diagnosis (Gophna et al. 2006). However, in this study a reduction in 
diversity was not a factor in the predisposition for NEC or sepsis per se. Despite 
abundant OTUs in the community prior to diagnosis, the dominance of a single OTU 
did not consistently reduce when comparing diseased patients to matched controls. This 
is in accordance with a recent publication by Mai et al. (2011) which also employed 
NGS technology. 
Temporal analysis with regular sampling is key to elucidating the changes of the 
dynamic preterm gut microbiota, which might be attributable to disease onset. The 
Escherichia genus has important clinical considerations in this study and the abundance 
of this genus was notably increased in the EP group, compared to the VP group. While 
diseased patients were found to harbour unique profiles, 6 of 8 NEC patients from the 
whole cohort had increase of E. coli prior to diagnosis. Within the EP group, two 
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patients (180 and 178) died while on the NICU and the final sample from both patients 
was dominated by E. coli. It should be noted that the E. coli was also detected in control 
infants. However, as outlined in chapter 6, this organism has received particular 
attention in recent studies exploring the role of the gut microbiota in inflammatory 
mediated conditions and the correlation between studies warrants further investigation 
(Gophna et al. 2006; Sasaki et al. 2007; Lepage et al. 2011).  
In accordance with previous studies, the pathogenesis of sepsis was also associated with 
the gut microbiota (Madan et al. 2012; Mai et al. 2013; Stewart et al. 2013). However, 
unlike Madan et al. (2012) and Mai et al. (2013), sepsis was not associated with a 
reduction in diversity to the normal gut microbiota development in this study. In 
previous studies the sepsis cohort was more premature than the control group. We have 
shown prematurity to significantly influence the bacterial community development 
regardless of disease status, thus it is feasible that findings from studies where 
gestational age is not matched are confounded. In this study, the organisms detected by 
blood culture were always present in the gut microbiota and, in the majority of cases, 
were one of the abundant members of the community. The sepsis only case in the EP 
group (patient 181) was diagnosed by blood culture as E. coli, with this organism being 
the most abundant in the gut of this infant. Staphylococcus was causative to sepsis in the 
majority of cases and this organism was also abundant in the gut microbiota of these 
infants. This is in accordance with Madan et al. (2012), where Staphylococcus was 
dominant in the community prior to positive blood culture in which Staphylococcus 
aureus was isolated.  
Probiotics have been proposed as a potentially useful supplement to preterm neonates. 
Evidence from this study suggests that a diverse gut microbiota may prevent the 
predisposition of NEC and sepsis to preterm infants. While current research into 
probiotic supplementation yields mixed results in terms of efficiency, it should be noted 
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that probiotics are not considered dangerous, nor have they been shown to have a 
detrimental effect on the host (Li et al. 2013; Nair & Soraisham 2013; Pärtty et al. 
2013). Evidence suggests probiotics can be effective at colonising the gut as 
supplementing Lactobacillus casei increased the abundance of this organism in infant 
stool and stabilised the gut microbiota (Cox et al. 2010). They may further improve 
intestinal permeability and modulate the development and persistence of an appropriate 
mucosal immune response (Embleton & Yates 2008). Studies exploring the potential 
benefit of probiotic administration should consider the mechanistic effect on the gut 
microbiota, particularly the role in reducing dominance by potentially pathogenic 
organisms which is feasible based on existing evidence (Cox et al. 2010). 
In summary, the preterm gut microbiota is a complex and dynamic community with a 
multitude of factors influencing its development. Mode of delivery initially results in 
different colonisation patterns and increased Staphylococcus in caesarean delivery. 
However, the community is more comparable regardless of delivery mode following 
week 3 of life. An important consideration in this study was the effect of gestational age 
on the bacterial community. Increased prematurity is regarded as the most significant 
risk factor in the care of neonates. A significant difference between the profiles of 
extremely preterm (>27 weeks gestation) and very preterm (27-30 weeks gestation) was 
reported. The differential development of the gut microbiota as a result of gestational 
age should be considered in future studies exploring the gut microbiota. While no 
consistent associations between reduced diversity and increased dominance prior to 
disease diagnosis were observed, E. coli was particularly abundant prior to diagnosis of 
NEC. A diverse community seems to be important to the health of a neonate supporting 
the notion of probiotics to stabilise the gut microbiota. Further evidence on the observed 
changes in the gut microbiota compared to the inflammatory state of the gut is 
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warranted to ascertain if the inflammation is driving these shifts and subsequent disease 
onset, or vice versa. 
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8. Concluding remarks 
 
8.1 Summary 
 
The development of the preterm neonatal gut microbiota is complex and highly 
individual. Assessing its association with clinical factors is challenging. This thesis has 
employed a range of genomic techniques to explore the total and viable bacterial and 
fungal communities. The fungal community was found to be patient specific, 
metabolically inactive and showed a relatively low diversity. There was also no 
association of the fungal community in the pathogenesis of NEC and sepsis. The 
bacterial community was also patient specific but more diverse than the fungal 
community. The viable bacterial community reflected the profiles of the total 
community. Thus subsequent investigations focused on the total bacterial community 
owning to ease of working with DNA compared to RNA. 
The gut microbiota was dominated by two phyla; Proteobacteria and Firmicutes. Within 
these phyla the dominant genera were Escherichia, Staphylococcus, and Enterococcus. 
This dominance became less pronounced from the sixth week of life, with rarer taxa 
increasing in overall abundance. Bifidobacterium was abundant when exploring the V4 
region using the MiSeq NGS platform but this was not the case in previous studies 
based on the PCR-DGGE of the V3 region and traditional culture. Lactobacillus was 
found in low abundance regardless of methodology or cohort.  
The influence of delivery mode on the gut microbiota and the potential long term 
consequences are important. The results in this thesis show Staphylococcus, a common 
skin organism, being dominant from week 1 to 3 of life in caesarean delivered infants. 
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By week 4 of life, however, infants developed comparable gut microbiota to those 
delivered vaginally. This supports our early DGGE findings that birth mode did not 
significantly alter the bacterial community suggesting that birth mode does not 
influence the long-term establishment of the preterm gut microbiota. 
Gestational age was demonstrated to alter the development of the bacterial community 
with significant differences between the abundances of clinically important OTUs. 
These differences might be attributable to antibiotics which are administered for 48 
hours following birth preventing the long-term establishment of the pioneering 
organisms into the gut. The number of days of antibiotic administration is also increased 
in more preterm infants.  
The power of the initial studies was limited by the size of the cohort and regularity of 
longitudinal sampling, but important differences between NEC and/or sepsis patients 
were found, compared to controls. Infants diagnosed with disease showed altered 
community development preceding and following disease diagnosis. In some cases this 
correlated with reduced diversity and increased dominance by a single OTU, but this 
did not apply to all cases. The Escherichia genus was associated with the pathogenesis 
of NEC with this genus increasing in dominance prior to NEC diagnosis, although, like 
the reduction in diversity, this observation was not seen universally in all patients. The 
pathogenesis of sepsis was also associated with the gut microbiota. Organisms detected 
by blood culture were present in the gut and, in the majority of cases, were one of the 
abundant members of the community.  
Shifts in community structure and dominance by particular bacterial organisms might be 
causative to preterm disease pathogenesis. Overall, a stable and diverse community 
seems to be important to the health of a neonate. 
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8.2 Future work 
 
The focus of this thesis has been on the microbial community present in the gut of 
preterm infants. This allows important insights into the ecology of microbes in this 
complex niche. To better understand the functional implications resulting from the 
shifts in the community or to elucidate if these shifts are driven by precursors such as 
inflammation it is important to adopt a systems biology approach. This involves 
implementation of a range of ‘omic’ techniques into experimental design, such as 
transcriptomics, proteomics, and metabolomics. Applying these techniques in parallel 
will help address the complexity involved in disease pathogenesis, especially relating to 
the functional aspects.  
Proteomics provides information on which proteins are up- or down- regulated in 
response to demographic variables. This work is difficult on stool samples that are 
naturally rich in proteases (enzymes which cause the breakdown of proteins). However, 
proteomic analyses of serum is possible and serum represents a very useful tool, 
especially since bloods are taken from all infants on the NICU and, whereas stool 
samples can reduce around disease diagnosis, serum sampling increases (Embleton et 
al. 2013). Proteomic studies on necrotic gut tissues removed from patients who undergo 
surgery for NEC may provide useful insights into the events at the site affected by the 
disease. Because healthy tissue is also present either side of the necrotic area, a useful 
comparison between healthy and disease tissue is possible. A two-dimensional 
differential gel electrophoresis (2D DiGE) approach is often used. This involves the 
isoelectric focusing of samples on a strip which is then loaded into an acrylamide gel 
and electrophoresis carried out. Labelled proteins then appear as spots on the gels and 
the intensity of the spot relates to the abundance so the higher the intensity the more is 
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being produced. Spots of interest which are up or down regulated can then be removed 
from the gel and identified by mass spectroscopy (MS). Since samples can contain vast 
amounts of albumin it is necessary to run 2D gels. The large area relating to the albumin 
can be identified and removed from the analysis; otherwise the albumin peak in the MS 
spectrum would dominate preventing the detection of potentially important proteins. 
Unlike genomics and proteomics which provide information on the genotype, 
metabolomics and the identification of low molecular weight compounds can be linked 
to phenotype. Stool samples that remain from the metagenomic studies could undergo 
extraction for metabolomics. These extractions can also be done on urine, serum, and 
tissue and involve homogenising the sample in solutions such as PBS and liquid 
chromatography mass spectrometry (LCMS) grade methanol before centrifugation and 
passing the supernatant through a 0.22 µm filter (Marchesi et al. 2007; Sellitto et al. 
2012; Lee et al. 2013). These samples can then undergo LCMS analysis by passing the 
samples through a column. Fractioned metabolites are then read by MS and the 
resulting profiles can be searched against small molecule databases such as KEGG to 
identify the features. This will provide information pertaining to the host metabolite 
expression and when compared with demographic data can identify if metabolites of 
interest are up or down regulated. For example, specific metabolites may be present in 
higher amounts in patients with NEC compared to controls. This might have important 
implications in the prediction and prevention of the disease.  
The work in this study was based on sampling from a single NICU and sampling only 
occurred while the patients were on the NICU. However, follow up studies would offer 
the opportunity to determine the impact of prematurity on long-term development of gut 
microbiota and pathologies associated with premature birth. To examine this, samples 
post discharge could be requested and sent back to the lab by post. Sampling from other 
NICUs would also allow comparisons of different clinical management to be assessed. 
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This would further increase the power of studies by increasing the number of diseased 
patients sampled and would eradicate the possibility that resulting conclusions are 
NICU specific. 
Probiotics is currently an area of active debate with some studies demonstrating 
potential importance in reducing disease incidence and other studies reporting no 
effects. It will be important to determine the optimum ‘cocktail’ of species to use in the 
probiotic as well as the route of administration, dose, age at which to start and stop 
treatment, and the gestational cut-off of treatment. It is also currently unknown whether 
the probiotic strains are just transient colonisers during treatment or if the strains 
colonise long term. Information on the usefulness of prebiotics either instead of 
probiotics or in combination (synbiotics) is also limited. Future work should address 
these points and explore the immediate and long term effect of supplementation on the 
preterm gut microbiome. 
Adherent-invasive Escherichia coli (AIEC) are commonly isolated from ileal biopsies 
in Crohn’s disease (Small et al. 2013). AIEC are pathogenic and can colonise the 
intestinal mucosa by adhering to and invading intestinal epithelial cells to replicate 
intracellularly, as well as survive and replicate extensively within macrophages which 
induces the secretion of large amounts of TNF-α (Rolhion & Darfeuille-Michaud 2007). 
Potentially important to clarifying cause or effect, a recent report showed that the 
generation of nitrate by the host during the inflammatory response confers a growth 
advantage to commensal E. coli in anaerobic respiration (Winter et al. 2013). This 
ability to utilise the by-products of reactive oxygen and nitrogen species, produced 
during inflammation, may account for increase in abundance of this species in diseased 
patients owing to a growth advantage over other fermenting bacteria. Thus, the host 
inflammatory response can selectively enhance the growth of E. coli which should be 
considered when inferring the relationship between abundance of E. coli and NEC. 
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The dominant OTUs prior to disease diagnosis and the organisms isolated in positive 
blood culture are typically common residents of a normal healthy gut microbiota (Park 
et al. 2005). While no consistent differences occur between the diversity of diseased and 
control patients, it is plausible that dominant organisms in the community contribute to 
disease pathogenesis. One mechanism by which these otherwise normal members of the 
gut microbiota switch on pathogenesis is quorum sensing. Quorum sensing molecules 
(QSMs) are secreted by bacteria and when they reach a defined concentration they can 
activate bacterial proliferation and switch on a number of virulence genes (Chandran et 
al. 2003). Indeed, it has been proposed that the beneficial effect of antibiotics in the 
treatment of intestinal inflammation might be attributable, in part, to their effect on the 
quorum sensing related bacterial behaviour (Struss et al. 2012). When exploring the role 
of the gut microbiota it is crucial to know if the shifts in the bacterial community 
observed prior to diagnosis are causative to disease pathogenesis, or simply a 
subsidiarity effect of other factors such as inflammation. Interestingly, QSMs have been 
proposed as potential biomarkers to measure intestinal inflammatory activity (Kumari et 
al. 2008), which may help ascertain whether the bacterial community is driving disease 
pathogenesis, or vice versa. 
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Appendix 1 - Enzymatic lysis buffer 
 
Pre-treatment of Gram-positive bacteria (DNeasy Blood and Tissue Kit) enzymatic lysis 
buffer: 
20 mM Tris·Cl, pH 8.0 
2 mM sodium EDTA 
1.2% Triton® X-100 
Immediately before use, add lysozyme to 20 mg/mL 
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Appendix 2 – 50× TAE Buffer  
 
TAE buffer was prepared at 50x concentrate then diluted as required.  
 
Step 1 – 200 mL EDTA pH 8.0 
 
37.22 g EDTA 
200 mL dH2O 
 
A beaker containing the EDTA and ~150 mL dH2O was placed on to a magnetic stirrer 
and the pH was measured throughout. Sodium hydroxide pellets were added to the 
solution until the solution was at pH 8.0. dH2O was added to achieve a final volume of 
200 mL.  
 
Step 2 – Make up 2 L 
 
484g Tris base ultrapure  
114.2 mL Glacial acetic acid  
200 mL EDTA pH 8.0  
dH2O to 2L 
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The Tris base was weighed and placed into a 1L Duran bottle along with the glacial 
acetic acid and the EDTA which was prepared fresh as described above. dH2O was 
added to achieve a final volume of 2 L.  
 
To make 1 L of 1× TAE: dilute 20 mL of 50x TAE in 980 mL dH2O. 
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Appendix 3 – Dyes  
 
Bromophenol blue (6x concentrate)  
 
Bromophenol blue was prepared at 6× concentrate and diluted appropriately with the 
sample as required. 
  
0.025 g Bromophenol blue  
4.0 g Sucrose  
dH2O to 1 L  
 
DCode Dye  
 
DCode dye was added to the high denaturing solution so that the efficacy of mixing 
between denaturing solutions in DGGE gel pouring could be established. 
 
0.05 g Bromophenol blue  
0.05 g Xylene cyanol  
1× TAE to 10 mL  
 
DGGE loading dye (2× concentrate)  
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DGGE loading dye was prepared at 2× concentrate and diluted appropriately with the 
sample as required. 
 
Step 1 - 2% (w/v) solution of bromophenol blue and xylene cyanol 
A 2% (w/v) solution of bromophenol blue and a 2% (w/v) solution of xylene cyanol 
were prepared by dissolving 0.002g of each solid in 1 mL dH2O.  
 
Step 2 – Make up 10 mL 
 
0.25ml 2% (w/v) bromophenol blue  
0.25ml 2% (w/v) xylene cyanol  
7.0ml 100% glycerol  
2.5ml dH2O 
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Appendix 4 – DGGE denaturing solutions 
Table showing how to prepare each denaturing solution 
Reagent  
Bacterial  Fungal 
34% 55% 40% 60% 
40% (v/v) acrylamide 
(37.5:1 
acrylamide:bisacrylamide)  
30 mL 30 mL 30 mL 30 mL 
50x TAE  2 mL  2 mL  2 mL  2 mL  
Deionised formamide  13.6 mL 22 mL 16 mL 24 mL 
Urea (electrophoresis 
grade)  
14.28 g  23.1 g  16.8 g 25.2 g 
dH2O  To 100 mL  To 100 mL  To 100 mL  To 100m L  
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Appendix 5 – SOC media 
 
Step 1 – Prepare solutions 
 
1M NaCl  
0.5844 g NaCl  
dH2O to 10 mL 
 
1M KCl  
0.7455 g KCl  
DH2O to 10 mL  
 
2M Mg2+ stock  
2.330 g MgCl2 • 6H2O  
2.465 g MgSO4 • 7H2O  
dH2O to 10 mL filter sterilise with a 0.22 μM filter  
 
2M glucose  
3.603 g Glucose  
dH2O to 10 mL filter sterilise with a 0.22 μM filter  
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Step 2 – Make the media 
 
To make the media add; 
 
2.0 g Tryptone  
0.5 g Yeast extract  
1 mL 1M NaCl  
1 mL 1M KCl  
dH2O to 100 mL 
 
Autoclave and allow to cool to room temperature. Then add;  
 
1 mL 2M Mg
2+
  
1 mL 2M Glucose  
Check the pH is 7.0, adjust accordingly if it is not. 
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Appendix 5 – Luria-Bertani media  
 
Basic recipe (per 1 L)  
 
Tryptone 10 g  
Yeast Extract 5 g  
Sodium Chloride 5 g  
Agar 15 g (For broth omit agar from the recipe) 
 
Autoclave and allow to cool to 50 °C and pour ~20 mL in to each Petri plate 
 
 
Antibiotic selection media  
 
Proceed as described above to make up the basic recipe (omit agar for broths). When the 
media has cooled to 50 °C add Ampicillin (100 μg/mL). For plates pour as described 
above and for broths dispense 5mL aliquots into sterile glass universals. 
 
JM109 LB plates (LB/ampicillin/IPTG/X-Gal) 
 
Once the media from the basic recipe has cooled to 50 °C add Ampicillin (100 μg/mL), 
IPTG (0.5 mM), and X-Gal (80 μg/mL) to the media and pour as described above.
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Appendix 6 - Dendrogram (DICE coefficient) to confirm clustering of ladder lanes 
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Appendix 7 – Sequence identities of excised DGGE bands from chapters 3 - 5 
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Table showing the DGGE band sequence identities for chapters 3-5 
  Rf Value Closest Match Max Identity 
M
o
st
 a
b
u
n
d
an
ta
 
0.022 Enterococcus faecalis 98% 
0.036 Enterococcus faecalis 100% 
0.089 Enterococcus faecalis 100% 
0.17 Propionibacterium acnes 100% 
0.267 Streptococcus salivarius 99% 
0.325 Enterococcus faecalis 100% 
0.391 Streptococcus mutans 98% 
0.48 Escherichia coli  100% 
0.501 Escherichia coli 100% 
N
E
C
 O
n
ly
b
 
0.102 Staphylococcus epidermidis 100% 
0.136 Staphylococcus epidermidis 99% 
0.18 Staphylococcus epidermidis 100% 
0.19 Enterobacter cloacae 98% 
0.298 Propionibacterium acnes 100% 
0.348 Bacteroides fragilis 98% 
0.374 Bifidobacterium longum 96% 
0.404 Streptococcus mutans 99% 
0.456 Sphingomonas aromaticivorans 95% 
0.469 Enterobacter ludwigii  99% 
0.549 Enterobacter cloacae 85% 
0.647 Methylobacterium populi 100% 
N
E
C
 a
n
d
 s
ep
si
sc
 
0.027 Flavobacteria symbiont 99% 
0.149 Streptococcus salivarius 100% 
0.204 Enterococcus faecalis 98% 
0.514 Veillonella atypica 98% 
0.607 Enterococcus faecalis 100% 
a
Bands present in the 25% most abundant (not already sequenced due to involvement in 
NEC); 
b
Bands associated with patients diagnosed with NEC; 
c
bands associated with 
patients diagnosed with both NEC and sepsis 
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Appendix 8 – Comparison of culture dependent and molecular techniques in 
elucidating the gut microbiota of preterm infants 
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Example of qPCR standard curve  
2
3
6
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Appendix 9 – Bacterial and fungal viability in the preterm gut: necrotising 
enterocolitis and sepsis
 238 
 
Table showing disease state and antibiotic regime for each individual infant 
 
Abbreviations: DOL = day of life, Abx = antibiotic, Dur = duration (days). Antibiotics include A = Amoxicillin, Ap = Amphotericin, C = Ceftazadime, 
Cx = Cefotaxime, F = Flucloxacillin, G = Gentamicin, L = Linezolid, M = Metronidazole, Mr = Meropenem, P = Penicillin, T = Tazocin, V = 
Vancomycin.
2
3
8
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CCA of the DNA profiles based on the same subset of samples that underwent 
RNA analysis 
19% 
1
5
%
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Example DGGE gel demonstrating the DNA and RNA profiles of samples from 
patient 42 
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Appendix 10 – Development of the preterm gut microbiota in twins at risk of 
necrotising enterocolitis and sepsis 
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See attached disc in rear of thesis for: 
Table showing the full demographic information inclusive of every sample in the twin 
study 
2
4
8
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Loadings plot generated in SIMCA based on the DGGE stool data to accompany 
Figure 1. Grouping based on sets of multiples. 
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S5 - Loadings plot generated in SIMCA based on the DGGE expressed breast milk 
data matched to respective stool to accompany Figure 1. Grouping based on sets of 
multiples.  
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Loadings plot generated in SIMCA to identify which bands were associated with late onset infection. Grouped by disease state; 1 = control, 2 = 
Pre NEC, 3 = Pre sepsis, 4 = Post sepsis, 5 = Post NEC.  
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Table showing DGGE band BLASTn sequence identities 
  OTU  Closest Match 
Accession 
Number 
Pre NEC 24 Enterococcus JX304745.1 
Post 
NEC 
23 Enterococcus JX304745.1 
10 Corynebacterium DQ778040.1 
77 Corynebacterium  GQ260084.1 
60 Enterococcus HE979846.1 
74 Enterococcus JX304745.1 
4 Enterobacter JN886722.1 
Pre 
Sepsis 
25 Propionibacterium JX262688.1 
54 Actinomyces AJ243894.1 
Post 
Sepsis 
55 Klebsiella DQ303436.1 
6 Enterobacter JX847659.1 
9 Enterobacter JX847659.1 
1 Enterococcus  JX304745.1 
7 Enterococcus  JX304745.1 
Control 
40 Enterobacter FR773881.1 
45 Enterococcus JX304745.1 
66 Enterococcus JX304745.1 
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Appendix 11 – Next generation sequencing of the gut microbiota in preterm 
neonates: A case-control study 
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See attached disc in rear of thesis for: 
Table showing the full demographic and MiSeq data summary for each sample  
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Number of OTUs present in all samples from 50% - 100%. 
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Taxonomy P value 
Firmicutes; Bacilli; Lactobacillales; Streptococcaceae; Streptococcus <0.001 
Proteobacteria; Betaproteobacteria; Burkholderiales; Sutterellaceae; Sutterella <0.001 
Firmicutes; Clostridia; Clostridiales; Lachnospiraceae; unclassified <0.001 
Firmicutes; Clostridia; Clostridiales; Ruminococcaceae; unclassified <0.001 
Tenericutes; Mollicutes; Mycoplasmatales; Mycoplasmataceae; Ureaplasma <0.001 
Actinobacteria; Actinobacteria; Bifidobacteriales; Bifidobacteriaceae; Gardnerella <0.001 
Actinobacteria; Actinobacteria; Bifidobacteriales; Bifidobacteriaceae; Bifidobacterium <0.001 
Firmicutes; Clostridia; Clostridiales; Lachnospiraceae; unclassified <0.001 
Firmicutes; Bacilli; Lactobacillales; Lactobacillaceae; Lactobacillus <0.001 
Actinobacteria; Actinobacteria; Actinomycetales; Corynebacteriaceae; Corynebacterium <0.001 
Firmicutes; Negativicutes; Selenomonadales; Veillonellaceae; Megasphaera <0.001 
Firmicutes; Bacilli; Lactobacillales; Lactobacillaceae; Lactobacillus <0.001 
Firmicutes; Clostridia; Clostridiales; Eubacteriaceae; Anaerofustis <0.001 
Actinobacteria; Actinobacteria; Bifidobacteriales; Bifidobacteriaceae; Bifidobacterium <0.001 
Actinobacteria; Actinobacteria; Actinomycetales; Actinomycetaceae; Actinomyces <0.001 
Firmicutes; Bacilli; Lactobacillales; Carnobacteriaceae; unclassified <0.001 
Firmicutes; Bacilli; unclassified; unclassified; unclassified <0.001 
Proteobacteria; Gammaproteobacteria; Pseudomonadales; Pseudomonadaceae; Pseudomonas <0.001 
Bacteroidetes; Bacteroidia; Bacteroidales; Prevotellaceae; Prevotella <0.001 
Bacteroidetes; Bacteroidia; Bacteroidales; Prevotellaceae; Prevotella <0.001 
Actinobacteria; Actinobacteria; Actinomycetales; Micrococcaceae; Rothia <0.001 
Firmicutes; Bacilli; Lactobacillales; Leuconostocaceae; Leuconostoc <0.001 
Firmicutes; Bacilli; Lactobacillales; Lactobacillaceae; Lactobacillus <0.001 
Proteobacteria; Alphaproteobacteria; Rhizobiales; Rhizobiaceae; Rhizobium <0.001 
Actinobacteria; Actinobacteria; Bifidobacteriales; Bifidobacteriaceae; Alloscardovia <0.001 
Firmicutes; Bacilli; Bacillales; Staphylococcaceae; unclassified <0.001 
Actinobacteria; Actinobacteria; Actinomycetales; Actinomycetaceae; Actinomyces <0.001 
Firmicutes; Negativicutes; Selenomonadales; Veillonellaceae; Veillonella <0.001 
Proteobacteria; Epsilonproteobacteria; Campylobacterales; Campylobacteraceae; Campylobacter <0.001 
Fusobacteria; Fusobacteria; Fusobacteriales; Leptotrichiaceae; Leptotrichia <0.001 
Bacteroidetes; Bacteroidia; Bacteroidales; Prevotellaceae; Prevotella <0.001 
Firmicutes; Bacilli; Lactobacillales; Enterococcaceae; unclassified <0.001 
Firmicutes; Clostridia; Clostridiales; Clostridiales_Incertae_Sedis_XI; Peptoniphilus <0.001 
Firmicutes; Bacilli; Lactobacillales; Carnobacteriaceae; Alloiococcus <0.001 
Proteobacteria; Gammaproteobacteria; Enterobacteriales; Enterobacteriaceae; unclassified <0.001 
Actinobacteria; Actinobacteria; Bifidobacteriales; Bifidobacteriaceae; Bifidobacterium <0.001 
Proteobacteria; Gammaproteobacteria; Enterobacteriales; Enterobacteriaceae; unclassified <0.001 
Proteobacteria; Alphaproteobacteria; unclassified; unclassified; unclassified <0.001 
Firmicutes; Bacilli; Bacillales; unclassified; unclassified <0.001 
Firmicutes; Bacilli; unclassified; unclassified; unclassified <0.001 
Proteobacteria; Alphaproteobacteria; Rhizobiales; Methylobacteriaceae; Methylobacterium <0.001 
Proteobacteria; Alphaproteobacteria; Rhizobiales; Phyllobacteriaceae; Phyllobacterium <0.001 
All significantly different OTUs between EP and VP group determined by MetaStats  
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Actinobacteria; Actinobacteria; Actinomycetales; unclassified; unclassified <0.001 
Actinobacteria; Actinobacteria; Actinomycetales; Corynebacteriaceae; Corynebacterium <0.001 
Firmicutes; Clostridia; Clostridiales; Clostridiales_Incertae_Sedis_XI; Anaerococcus <0.001 
Proteobacteria; Betaproteobacteria; Burkholderiales; Comamonadaceae; Comamonas <0.001 
Proteobacteria; Alphaproteobacteria; Sphingomonadales; Sphingomonadaceae; Sphingomonas <0.001 
Bacteroidetes; Bacteroidia; Bacteroidales; Bacteroidaceae; Bacteroides <0.001 
Proteobacteria; Gammaproteobacteria; Enterobacteriales; Enterobacteriaceae; unclassified <0.001 
Proteobacteria; Gammaproteobacteria; Enterobacteriales; Enterobacteriaceae; Escherichia <0.001 
Actinobacteria; Actinobacteria; Coriobacteriales; Coriobacteriaceae; Slackia <0.001 
Firmicutes; Clostridia; Clostridiales; Lachnospiraceae; Dorea <0.001 
Proteobacteria; Gammaproteobacteria; Enterobacteriales; Enterobacteriaceae; unclassified <0.001 
Proteobacteria; Gammaproteobacteria; Pseudomonadales; Moraxellaceae; Acinetobacter <0.001 
Firmicutes; Clostridia; Clostridiales; Lachnospiraceae; Clostridium_XlVa <0.001 
Firmicutes; Bacilli; Lactobacillales; Streptococcaceae; Streptococcus <0.001 
Bacteroidetes; Bacteroidia; Bacteroidales; Bacteroidaceae; Bacteroides <0.001 
Bacteroidetes; Bacteroidia; Bacteroidales; Bacteroidaceae; Bacteroides <0.001 
Actinobacteria; Actinobacteria; Actinomycetales; Propionibacteriaceae; Propionibacterium <0.001 
Firmicutes; Bacilli; unclassified; unclassified; unclassified <0.001 
Proteobacteria; Gammaproteobacteria; Enterobacteriales; Enterobacteriaceae; Tatumella <0.001 
Firmicutes; Negativicutes; Selenomonadales; Veillonellaceae; Dialister <0.001 
Proteobacteria; Betaproteobacteria; Burkholderiales; Comamonadaceae; Delftia <0.001 
Firmicutes; Clostridia; Clostridiales; Clostridiales_Incertae_Sedis_XI; Anaerococcus 0.001 
Firmicutes; Bacilli; Lactobacillales; unclassified; unclassified 0.001 
Proteobacteria; Alphaproteobacteria; Rhodobacterales; Rhodobacteraceae; Paracoccus 0.001 
Proteobacteria; Betaproteobacteria; Burkholderiales; Comamonadaceae; Acidovorax 0.001 
Firmicutes; Bacilli; unclassified; unclassified; unclassified 0.001 
Actinobacteria; Actinobacteria; Actinomycetales; Dermacoccaceae; Dermacoccus 0.001 
Firmicutes; Bacilli; Lactobacillales; Enterococcaceae; Enterococcus 0.001 
Actinobacteria; Actinobacteria; Bifidobacteriales; Bifidobacteriaceae; Bifidobacterium 0.001 
Firmicutes; Bacilli; Lactobacillales; Streptococcaceae; Streptococcus 0.001 
Proteobacteria; Gammaproteobacteria; Enterobacteriales; Enterobacteriaceae; Morganella 0.001 
Proteobacteria; Gammaproteobacteria; Pseudomonadales; Pseudomonadaceae; Pseudomonas 0.001 
Actinobacteria; Actinobacteria; Actinomycetales; unclassified; unclassified 0.001 
Firmicutes; Bacilli; Lactobacillales; Streptococcaceae; Streptococcus 0.001 
Actinobacteria; Actinobacteria; Actinomycetales; Actinomycetaceae; Actinomyces 0.001 
Actinobacteria; Actinobacteria; Actinomycetales; Corynebacteriaceae; Corynebacterium 0.001 
Firmicutes; Negativicutes; Selenomonadales; Veillonellaceae; Negativicoccus 0.001 
Bacteroidetes; Bacteroidia; Bacteroidales; Porphyromonadaceae; Parabacteroides 0.001 
Proteobacteria; Gammaproteobacteria; Aeromonadales; Aeromonadaceae; Aeromonas 0.001 
Firmicutes; Clostridia; Clostridiales; Clostridiaceae_1; Clostridium_sensu_stricto 0.001 
Firmicutes; Clostridia; Clostridiales; Clostridiaceae_1; Clostridium_sensu_stricto 0.001 
Fusobacteria; Fusobacteria; Fusobacteriales; Fusobacteriaceae; Fusobacterium 0.001 
Firmicutes; Bacilli; Lactobacillales; Lactobacillaceae; Lactobacillus 0.001 
Actinobacteria; Actinobacteria; Actinomycetales; Corynebacteriaceae; Corynebacterium 0.001 
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Proteobacteria; Deltaproteobacteria; Desulfovibrionales; Desulfovibrionaceae; Bilophila 0.001 
Actinobacteria; Actinobacteria; Actinomycetales; Actinomycetaceae; Actinobaculum 0.001 
Bacteroidetes; Bacteroidia; Bacteroidales; Bacteroidaceae; Bacteroides 0.001 
Actinobacteria; Actinobacteria; Coriobacteriales; Coriobacteriaceae; Olsenella 0.001 
Firmicutes; Bacilli; Lactobacillales; Aerococcaceae; Facklamia 0.001 
Firmicutes; Clostridia; Clostridiales; unclassified; unclassified 0.001 
Firmicutes; Bacilli; Lactobacillales; Streptococcaceae; Streptococcus 0.001 
Bacteroidetes; Bacteroidia; Bacteroidales; Bacteroidaceae; Bacteroides 0.001 
Actinobacteria; Actinobacteria; Coriobacteriales; Coriobacteriaceae; Atopobium 0.001 
Firmicutes; Bacilli; Lactobacillales; Aerococcaceae; Globicatella 0.001 
Proteobacteria; Gammaproteobacteria; unclassified; unclassified; unclassified 0.001 
Firmicutes; Clostridia; Clostridiales; Clostridiales_Incertae_Sedis_XI; Anaerococcus 0.002 
Proteobacteria; Alphaproteobacteria; Caulobacterales; Caulobacteraceae; Caulobacter 0.002 
Proteobacteria; Gammaproteobacteria; unclassified; unclassified; unclassified 0.002 
Proteobacteria; Betaproteobacteria; Rhodocyclales; Rhodocyclaceae; unclassified 0.002 
Firmicutes; Bacilli; Lactobacillales; Lactobacillaceae; Lactobacillus 0.002 
Firmicutes; Negativicutes; Selenomonadales; Veillonellaceae; Veillonella 0.002 
Proteobacteria; Gammaproteobacteria; Enterobacteriales; Enterobacteriaceae; unclassified 0.002 
Firmicutes; Bacilli; Lactobacillales; unclassified; unclassified 0.002 
Proteobacteria; Alphaproteobacteria; Sphingomonadales; Sphingomonadaceae; Sphingomonas 0.002 
Firmicutes; Bacilli; Bacillales; Bacillales_Incertae_Sedis_XI; Gemella 0.003 
Proteobacteria; Gammaproteobacteria; Enterobacteriales; Enterobacteriaceae; unclassified 0.004 
Proteobacteria; Gammaproteobacteria; Enterobacteriales; Enterobacteriaceae; unclassified 0.004 
Proteobacteria; Gammaproteobacteria; Pasteurellales; Pasteurellaceae; unclassified 0.004 
Tenericutes; Mollicutes; Mycoplasmatales; Mycoplasmataceae; Mycoplasma 0.004 
Proteobacteria; Betaproteobacteria; Burkholderiales; Burkholderiaceae; Cupriavidus 0.004 
Proteobacteria; Alphaproteobacteria; Sphingomonadales; Sphingomonadaceae; unclassified 0.004 
Firmicutes; Clostridia; Clostridiales; Clostridiales_Incertae_Sedis_XI; Anaerococcus 0.004 
Firmicutes; Clostridia; Clostridiales; unclassified; unclassified 0.004 
Actinobacteria; Actinobacteria; Actinomycetales; Actinomycetaceae; Trueperella 0.004 
Firmicutes; Clostridia; Clostridiales; Clostridiales_Incertae_Sedis_XI; Anaerococcus 0.004 
Actinobacteria; Actinobacteria; Actinomycetales; Actinomycetaceae; Actinomyces 0.005 
Firmicutes; Clostridia; Clostridiales; Ruminococcaceae; Butyricicoccus 0.006 
Actinobacteria; Actinobacteria; Actinomycetales; Corynebacteriaceae; Corynebacterium 0.007 
Actinobacteria; Actinobacteria; Bifidobacteriales; Bifidobacteriaceae; Bifidobacterium 0.007 
Firmicutes; Negativicutes; Selenomonadales; Veillonellaceae; Veillonella 0.007 
Bacteroidetes; Flavobacteria; Flavobacteriales; Flavobacteriaceae; Chryseobacterium 0.007 
Firmicutes; Clostridia; Clostridiales; Peptostreptococcaceae; Clostridium_XI 0.007 
Actinobacteria; Actinobacteria; Actinomycetales; Micrococcaceae; Micrococcus 0.008 
Actinobacteria; Actinobacteria; Actinomycetales; Actinomycetaceae; Actinomyces 0.008 
Actinobacteria; Actinobacteria; Actinomycetales; Nocardiaceae; Rhodococcus 0.008 
Firmicutes; Negativicutes; Selenomonadales; Veillonellaceae; Veillonella 0.009 
Actinobacteria; Actinobacteria; Actinomycetales; unclassified; unclassified 0.009 
Proteobacteria; Gammaproteobacteria; Xanthomonadales; Xanthomonadaceae; Stenotrophomonas 0.010 
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Firmicutes; Clostridia; Clostridiales; Clostridiales_Incertae_Sedis_XI; Finegoldia 0.011 
Firmicutes; Bacilli; Bacillales; Bacillaceae_1; Bacillus 0.011 
Proteobacteria; Betaproteobacteria; Burkholderiales; Burkholderiaceae; Ralstonia 0.012 
Firmicutes; Bacilli; unclassified; unclassified; unclassified 0.013 
Firmicutes; Negativicutes; Selenomonadales; Veillonellaceae; Veillonella 0.013 
Proteobacteria; Gammaproteobacteria; Enterobacteriales; Enterobacteriaceae; Escherichia 0.014 
Firmicutes; Bacilli; Bacillales; Staphylococcaceae; Staphylococcus 0.014 
Firmicutes; Bacilli; Lactobacillales; Streptococcaceae; Streptococcus 0.015 
Actinobacteria; Actinobacteria; Bifidobacteriales; Bifidobacteriaceae; unclassified 0.015 
Firmicutes; Bacilli; Lactobacillales; unclassified; unclassified 0.015 
Firmicutes; Negativicutes; Selenomonadales; Veillonellaceae; Veillonella 0.015 
Actinobacteria; Actinobacteria; Actinomycetales; Corynebacteriaceae; Corynebacterium 0.016 
Firmicutes; Clostridia; Clostridiales; Clostridiales_Incertae_Sedis_XI; Anaerococcus 0.016 
Firmicutes; Clostridia; Clostridiales; Lachnospiraceae; unclassified 0.016 
Firmicutes; Negativicutes; Selenomonadales; Veillonellaceae; Veillonella 0.016 
Firmicutes; Clostridia; Clostridiales; Clostridiales_Incertae_Sedis_XIII; Mogibacterium 0.016 
Firmicutes; Bacilli; Bacillales; Bacillaceae_2; unclassified 0.016 
Firmicutes; Clostridia; Clostridiales; Lachnospiraceae; Clostridium_XlVa 0.018 
Proteobacteria; Gammaproteobacteria; Enterobacteriales; Enterobacteriaceae; unclassified 0.019 
Proteobacteria; Alphaproteobacteria; Rhizobiales; Brucellaceae; Brucella 0.020 
Bacteroidetes; Bacteroidia; Bacteroidales; Prevotellaceae; Prevotella 0.020 
Proteobacteria; Gammaproteobacteria; Oceanospirillales; Halomonadaceae; Halomonas 0.023 
Firmicutes; Clostridia; Clostridiales; unclassified; unclassified 0.023 
Firmicutes; Bacilli; Bacillales; Alicyclobacillaceae; Tumebacillus 0.029 
Firmicutes; Bacilli; Lactobacillales; Enterococcaceae; Enterococcus 0.030 
Firmicutes; Negativicutes; Selenomonadales; Veillonellaceae; Veillonella 0.030 
Proteobacteria; Gammaproteobacteria; unclassified; unclassified; unclassified 0.030 
Firmicutes; Negativicutes; Selenomonadales; Veillonellaceae; Veillonella 0.030 
Proteobacteria; Gammaproteobacteria; Enterobacteriales; Enterobacteriaceae; Morganella 0.030 
Firmicutes; Bacilli; unclassified; unclassified; unclassified 0.030 
Proteobacteria; Gammaproteobacteria; Enterobacteriales; Enterobacteriaceae; unclassified 0.030 
Bacteroidetes; Flavobacteria; Flavobacteriales; Flavobacteriaceae; unclassified 0.030 
Actinobacteria; Actinobacteria; Coriobacteriales; Coriobacteriaceae; Atopobium 0.030 
Proteobacteria; Gammaproteobacteria; Pseudomonadales; Moraxellaceae; Psychrobacter 0.030 
Proteobacteria; Alphaproteobacteria; Rhizobiales; Methylobacteriaceae; Methylobacterium 0.030 
Bacteroidetes; Bacteroidia; Bacteroidales; Prevotellaceae; Prevotella 0.030 
Proteobacteria; Gammaproteobacteria; Enterobacteriales; Enterobacteriaceae; unclassified 0.031 
Firmicutes; Bacilli; Bacillales; unclassified; unclassified 0.031 
Fusobacteria; Fusobacteria; Fusobacteriales; Leptotrichiaceae; Leptotrichia 0.031 
Bacteroidetes; Flavobacteria; Flavobacteriales; Flavobacteriaceae; Chryseobacterium 0.031 
Actinobacteria; Actinobacteria; Coriobacteriales; Coriobacteriaceae; Eggerthella 0.031 
Aquificae; Aquificae; Aquificales; Hydrogenothermaceae; Sulfurihydrogenibium 0.031 
Firmicutes; Bacilli; Bacillales; Bacillaceae_1; Geobacillus 0.031 
unclassified; unclassified; unclassified; unclassified; unclassified 0.035 
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Proteobacteria; Gammaproteobacteria; Enterobacteriales; Enterobacteriaceae; Proteus 0.037 
Bacteroidetes; Bacteroidia; Bacteroidales; Bacteroidaceae; Bacteroides 0.037 
Proteobacteria; Gammaproteobacteria; Enterobacteriales; Enterobacteriaceae; Escherichia 0.037 
Bacteroidetes; Sphingobacteria; Sphingobacteriales; Sphingobacteriaceae; Pedobacter 0.039 
unclassified; unclassified; unclassified; unclassified; unclassified 0.040 
Actinobacteria; Actinobacteria; Coriobacteriales; Coriobacteriaceae; Eggerthella 0.041 
Firmicutes; Clostridia; Clostridiales; Clostridiaceae_1; Clostridium_sensu_stricto 0.042 
Proteobacteria; Alphaproteobacteria; Rhizobiales; Methylobacteriaceae; Methylobacterium 0.044 
Firmicutes; Clostridia; Clostridiales; Lachnospiraceae; Clostridium_XlVa 0.046 
Firmicutes; Bacilli; unclassified; unclassified; unclassified 0.047 
Firmicutes; Bacilli; Bacillales; unclassified; unclassified 0.049 
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